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ABSTRACT 
Over the past 30 years, transcription factor nuclear factor kappa B (NF-κB) has 
been extensively characterized in organisms ranging from flies to humans, where it is 
known to play key roles in developmental and immune-related processes. More recently, 
DNA sequencing approaches have identified homologs of NF-κB and many upstream 
signaling components in basal phyla, including Cnidaria (sea anemones, corals, hydras, 
and jellyfish), Porifera (sponges), and single-celled protists, including Capsaspora 
owczarzaki and some choanoflagellates. However, little is known about the activity and 
regulation of NF-κB proteins in these basal organisms. In this dissertation, the structure, 
activity, and biology of NF-κB in three basal phyla is examined and the extent of 
conservation with more derived organisms as well as phylum-specific properties are 
investigated. In the coral Orbicella faveolata (Of) a simplified but nearly complete Toll-
like receptor (TLR)-to-NF-κB pathway exists, but basal to cnidarians, there are fewer 
upstream signaling molecules present. For example, in the poriferan Amphimedon 
queenslandica (Aq) and the protist Capsaspora owczarzaki (Co), singular NF-κBs and 
some upstream signaling proteins are encoded in their genomes, but no canonical TLRs 
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exist. In contrast, the expanded family of choanoflagellates, including the 
choanoflagellate Acanthoeca spectabilis (As), contains TLR-like and up to three NF-κB-
like homologs, although their domain structures differ from NF-κB pathway members of 
higher organisms. Of-NF-κB, Aq-NF-κB, and Co-NF-κB all resemble the mammalian 
NF-κB protein p100 in that they contain an N-terminal DNA-binding domain, a C-
terminal Ankyrin (ANK) repeat domain, and similar DNA binding-site profiles. C-
terminal truncation results in translocation of these basal NF-κBs to the nucleus and 
increases their DNA-binding and transcriptional activation activities. Nevertheless, unlike 
mammalian NF-κB p100, the C-terminal sequences of Aq-NF-κB do not inhibit its DNA-
binding activity. The three As-NF-κB-like proteins all consist of primarily the N-terminal 
conserved Rel Homology domain sequences of NF-κB, but lack C-terminal ANK repeats. 
All three As-NF-κB proteins constitutively enter the nucleus of human and Co cells, but 
differ from one another in DNA-binding and transcriptional activation activities. 
Furthermore, all three As-NF-κB proteins can form heterodimers, indicating that NF-κB 
diversified into multi-subunit families at least two times during evolution. Expression of 
IKKs induce proteasome-dependent C-terminal processing of Of-NF-κB and Aq-NF-κB 
in human cells, and processing requires C-terminal serines. In contrast, C-terminal 
processing of Co-NF-κB is not induced by co-expression of IKK in human cells and no 
IKK homolog exists in the Co genome, suggesting that IKK-mediated processing of NF-
κB is a mechanism that evolved solely in animals. Treatment of Of and sponge tissue 
with lipopolysaccharide (LPS), a ligand for mammalian innate immunity, results in gene 
expression changes consistent with NF-κB pathway mobilization in Of and increases both 
 
 viii 
DNA-binding activity and processing of sponge NF-κB. Furthermore, sponge tissue 
contains constitutive NF-κB site DNA-binding activity, as well as nuclear and processed 
NF-κB. Moreover, exogenously expressed Co-NF-κB localizes to the nucleus in Co cells. 
Together, these data suggest that the mechanism as well as level of activation of NF-κB 
in basal organisms is different from what is observed in higher organisms. Additionally, 
NF-κB mRNA and DNA-binding levels differ across three life stages of Capsaspora, 
suggesting distinct roles for NF-κB in these life stages. RNA-seq and GO analyses 
identify possible gene targets and biological functions of Co-NF-κB. Overall, these data 
represent the first functional characterization of NF-κB signaling proteins in an 
endangered coral, in any organisms basal to cnidarians (i.e., an evolutionary important 
sponge), and outside the Kingdom Animalia (protists). These findings suggest that these 
seemingly simple organisms contain conserved innate immune-like pathways that may be 
regulated by NF-κB and provide information about the evolution and diversification of 
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For nearly a century, the field of immunology has been primarily concerned with 
the study of human wellness and disease. These studies have revealed the concerted 
complexity of the body’s daily biological warfare, which relies on the proper function of 
signal transduction pathways to turn on genes important for defense and preservation. 
Until about a decade ago, it was unknown what types of genetic complexity early-
branching organisms possessed for combatting disease. However, increased genomic and 
transcriptomic sequencing has revealed that these basal organisms contain ancient 
toolkits for many conserved signaling molecules and pathways, including those involved 
in immunity. This thesis will focus on one of those ancient pathway homologs, and how 
it has become apparent to the growing field of comparative immunology that a key 
immunity-related gene regulatory protein (transcription factor NF-κB) likely plays 
biologically conserved and unique roles in basal organisms. 
 
1.1  Introduction to transcription factor NF-κB 
The Nuclear Factor-κB (NF-κB) superfamily comprises a group of related 
transcription factors that have been intensively studied for their involvement in 
development and immunity since their near simultaneous discovery in a retrovirus, flies, 
and mice almost 35 years ago (Gilmore and Temin, 1986; Steward, 1987; Ghosh et al., 
1990; Gilmore, 1990; Kieran et al, 1990). Indeed, there are now approximately 100,000 
 





papers on NF-κB, the vast majority focusing on mammals, flies, and viruses. However, 
with the proliferation of genomic and transcriptomic sequencing over the past decade, it 
has been discovered that many organisms ostensibly less complex than insects have NF-
κB-like genes (Putnam et al., 2007; Srivastaba et al., 2010; Shinzato et al., 2011; Gilmore 
and Wolenski, 2012; Suga et al., 2013; Baumgarten et al., 2015; Richter et al., 2018; 
Gold et al., 2019).  
All NF-κB proteins are related by an N-terminal DNA-binding and dimerization 
region called the Rel Homology Domain (RHD) containing a nuclear localization 
sequence (NLS), and the RHD allows them to enter the nucleus, bind to specific DNA 
sites (“κB sites”), and activate or repress transcription of target genes for specified 
biological outcomes (Gilmore, 2006). In vertebrates and flies, the NF-κB superfamily can 
be divided into two subfamilies: the NF-κB proteins that consist of vertebrate p100 and 
p105 and Drosophila Relish; and the Rel proteins, which include vertebrate RelA, RelB, 
and c-Rel, as well as Drosophila Dif and Dorsal (Gilmore, 2006). Thus, flies and 
vertebrates all contain multiple NF-κB proteins that, for the most part, show complete 
combinatorial diversity by forming homodimers and heterodimers, which have distinct 
DNA target site specificities. The two subfamilies can be distinguished phylogenetically 
by sequence alignment of their RHDs, and by sequences C-terminal to the RHD. That is, 
NF-κB proteins contain C-terminal inhibitory Ankyrin (ANK) repeat domains and Rel 
proteins contain C-terminal transactivation domains (Figure 1.1). The ANK repeats, 
either within the NF-κB proteins themselves or in a separate family of NF-κB inhibitors 





sequestering them in the cytoplasm. Activation of the pathway by an appropriate 
upstream signal results in the degradation of the ANK repeat inhibitor, thus allowing the 
NF-κB dimer to enter the nucleus and bind DNA (Gilmore, 2006; Hayden and Ghosh, 
2008). NF-κB p100 and p105 proteins also contain a C-terminal death domain (DD) that 
is important for protein-protein interactions with other members of the DD superfamily, 
which serve as adaptors in signaling pathways and/or to recruit other proteins into 
signaling complexes (Hayden and Ghosh, 2008). 
Many evolutionarily conserved receptors can elicit downstream signals to activate 
NF-κB translocation to the nucleus. These receptors, which include Toll-like receptors 
(TLRs) and interleukin-1 receptors (IL-1Rs), interact with cytoplasmic adaptor proteins 
(e.g., MYD88 and MAL) to initiate downstream signaling (Hayden and Ghosh, 2008). 
Once the pathway is activated, a series of phosphorylation events leads to the degradation 
of the ANK repeat inhibitor sequences, freeing NF-κB to translocate from the cytoplasm 
to the nucleus. In vertebrates, activation of NF-κB generally happens in one of two ways. 
In the canonical pathway, activation of an IκB kinase β (IKKβ) complex results in 
phosphorylation of an independent IκB protein, and phosphorylated IκB then undergoes 
ubiquitination and proteasomal degradation to liberate the NF-κB dimer. In the non-
canonical pathway, activation of the related kinase IKKα leads to phosphorylation of a 
serine cluster located C-terminal to the ANK repeats on the p100 protein (Sun, 2011). 
These phosphorylations result in proteasomal processing of the inhibitory ANK repeats 
on p100 until the proteasome reaches a glycine-rich region (GRR). At the GRR the 





enter the nucleus (Sun, 2011). Similar pathways exist in flies, except the p100 homolog 
Relish has no GRR and the truncated, active form of Relish is generated by a site-specific 
proteolytic cleavage that removes the ANK repeat region (Stöven et al., 2003). 
Genomic and transcriptomic sequencing data strongly suggest that NF-κB was 
also pervasive through early evolution, based on the presence of NF-κB-like homologs in 
many extant organisms basal to flies and vertebrates. NF-κB homologs have been 
identified in single-celled pre-metazoans such as the protists Capsaspora owczarzaki 
(Suga et al., 2013), which acts as a symbiont in the hemolymph of the fresh-water snail 
Biomphalaria glabrata, and choanoflagellates (Richter et al., 2018), which are aquatic 
unicellular colonial organisms that have been proposed to be the closest living relatives to 
multicellular animals. NF-κBs have also been identified in a variety of multicellular basal 
marine metazoans, including poriferans (sponges) and cnidarians (corals, sea anemones, 
hydras, and jellyfish) (Putnam et al., 2007; Srivastava et al., 2010; Shinzato et al., 2011; 
Baumgarten et al, 2015; Gold et al., 2019). In most of these basal organisms, there are 
single NF-κB proteins, which, as discussed in this chapter, most closely resemble NF-κB 
subfamily proteins such as Relish and p100. Curiously, no NF-κB homologs have been 
found in nematodes (e.g., Caenorhabditis elegans and Caenorhabditis briggsae) or 
ctenophores, where the pathway appears to have been lost. 
Only recently have several studies investigated how transcription factor NF-κB 
and its upstream and downstream pathways function in early-branching organisms. This 
chapter aims to provide insight into how this highly conserved transcription factor and its 





evolution and biological processes likely controlled by NF-κB, and discuss areas of basal 
NF-κB knowledge that remain unanswered. 
 
1.2 Structure of basal NF-κB proteins  
Many basal eukaryotes have NF-κB proteins that are structurally and 
phylogenetically most similar to vertebrate NF-κB proteins rather than Rel proteins. In 
most cases, these organisms have single p100-like RHD-ANK repeat NF-κB proteins that 
often possess C-terminal serine residues known in vertebrates to be required for 
processing of p100 via the non-canonical NF-κB pathway (see Chapter 1.2, “Activity and 
regulation of basal NF-κBs”). For example, the protist Capsaspora, the sponge 
Amphimedon queenslandica, and several cnidarians all have NF-κB proteins with an 
RHD and C-terminal ANK repeats encoded on the same transcript (Gauthier and 
Degnan, 2008; Stefanik et al., 2014; Mansfield et al., 2017; Voolstra et al., 2017; 
Cunning et al., 2018; Shinzato et al., 2018; Williams et al., 2018). Many ANK repeat-
containing proteins are found throughout the genomes of archaea, bacteria, and all plants 
and animals (Al-Khodor et al., 2010; Jernigan and Bordenstein, 2014). Accordingly, it is 
likely that during the evolution of eukaryotes there arose a primitive RHD-only protein, 
which developed the ability to interact with a pre-existing ANK repeat-containing 
protein. At some point, these interacting RHD and ANK-repeat genes fused to create the 
more modern single RHD-ANK-repeat protein. Nevertheless, some basal organisms have 
NF-κB-like proteins without C-terminal ANK repeat domains. Among protists, several 





domains (Richter et al., 2018).  
Choanoflagellates comprise a sister group to all metazoans, and are part of a 
diverse group of single-celled, colony-forming organisms that live in waters around the 
world. Although the genomes of the classically studied choanoflagellates Monosiga 
brevicollis and Salpingoeca rosetta do not contain NF-κB homologs (Hoffmeyer and 
Burkhardt, 2016), a large-scale transcriptomic analysis of 19 choanoflagellates (Richter et 
al., 2018) showed that 12 had transcripts that encode RHD-containing NF-κB-like 
sequences (Richter et al., 2018). However, none of these choanoflagellate NF-κB-like 
proteins appears to have C-terminal ANK repeat domains (Figure 1.1). Moreover, several 
choanoflagellate NF-κB-like proteins also have extended N-terminal domains that are not 
present in any other NF-κB proteins (Figure 1.1, Table 1.1). Overall, these 19 
choanoflagellate transcriptomes encode zero, one, two, or three NF-κB-like proteins, 
none of which has C-terminal ANK repeats. Indeed, it is not yet known whether 
choanoflagellate NF-κBs are regulated by an ANK repeat-containing IκB-like inhibitor. 
The lack of ANK repeats in choanoflagellate NF-κB proteins and the wide diversification 
of NF-κBs among choanoflagellates are likely a result of 600 million years of 
independent evolution among the diverse species of choanoflagellates. Furthermore, this 
gene expansion mirrors the increasing number and complexity of NF-κBs seen 
throughout metazoans. In contrast to what is seen in choanoflagellates, the protist 
Capsaspora does contain a bipartite RHD-ANK protein (Suga et al., 2013). Thus, the 
earliest NF-κB with an RHD-ANK fusion likely arose in the protist lineage that led to 





Although the choanoflagellate and Capsaspora NF-κBs differ from one another in 
their overall structures (i.e., especially the absence of a C-terminal ANK-repeat region in 
choanoflagellates), they share two motifs within their RHDs (Figure 1.2, Motifs 7 and 10 
in teal and yellow) that are not present in any metazoan NF-κB protein. Among 
choanoflagellate NF-κBs, there is a great deal of sequence diversity, which is consistent 
with the overall genetic differences among choanoflagellates wherein the average 
phylogenetic distance between any two choanoflagellate species is greater than the 
phylogenetic distance between sponges and mammals (Richter et al., 2018). 
Nevertheless, a Bayesian tree analysis of the choanoflagellate RHDs identified to date 
clusters them as an outgroup to several fly and vertebrate NF-κBs and Rels, which 
demonstrates a clear divergence of the choanoflagellate NF-κBs from the metazoan NF-
κB superfamily (Figure 1.3A). In general, the NF-κB proteins within a single 
choanoflagellate species that has multiple NF-κB proteins (e.g., Salpingoeca 
helianthicam) are highly related (Figure 1.3A), suggesting that they arose by gene 
duplication events. However, it is important to note that some RHD subdomains are not 
present in the single-celled pre-metazoan lineages. For example, Capsaspora and 
choanoflagellate NF-κB proteins have low homology in the dimerization sequence, and 
choanoflagellates do not have an NF-κB-like NLS. On the other hand, all metazoan and 
pre-metazoan NF-κB sequences contain a highly conserved sequence that is important for 
DNA binding (Figure 1.3B).   
Among poriferans, the fully sequenced genome of the demosponge Amphimedon 





the human p100 NF-κB protein: that is, it has an RHD, NLS, GRR, six ANK repeats, and 
a DD (Gauthier and Degnan, 2008) (Figure 1.1). However, between the GRR and the 
ANK repeats, A. queenslandica NF-κB contains a region that has no known function and 
no homology to any other protein (Gauthier and Degnan, 2008) (Figure 1.1, yellow). 
More limited sequencing data indicate that other sponges also contain NF-κB-like 
transcripts, which, to date, only contain RHD sequences (Riesgo et al., 2014). Many of 
these sponge NF-κB-like proteins appear to be much shorter than the prototypical NF-κB 
proteins, but this may simply be due to lack of sequence coverage; for example, 
Corticium candelabrum is reported to have a transcript for NF-κB that consists of only 86 
amino acids that are similar to the beginning of the RHD (Riesgo et al., 2014).  
All characterized cnidarians appear to contain single NF-κB proteins, but the 
overall structures of these NF-κB proteins have diverged, in some cases, likely by gene-
splitting events. Thus, many cnidarians (the anemones Edwardsiella lineata (Stefanik et 
al., 2014) and Exaiptasia pallida (Mansfield et al., 2017) and the corals Acropora 
digitifera, Stylophora pistillata, Orbicella faveolata, and Pocillopora damicornis 
(DeSalvo et al., 2010; Voolstra et al., 2017; Cunning et al., 2018) have prototypical 
RHD-ANK repeat bipartite proteins, whereas others have separate RHD and ANK 
repeat proteins. In the best studied example of the latter, the sea anemone Nematostella 
vectensis has a single 440 amino acid NF-κB-like protein that is most similar to the 
processed vertebrate p50/p52 NF-κB proteins based on phylogenetic analysis of RHD 
amino acid sequences, intron-exon structure of the RHD, and the presence of a GRR 





an IκB-like ANK-repeat protein with substantial homology to C-terminal sequences of 
the ANK-repeat domains of vertebrate p100 and p105 (Sullivan et al., 2007). Four lines 
of evidence support the hypothesis that separate N. vectensis NF-κB and IκB genes 
arose due to a gene splitting event: 1) the existence of RHD-ANK repeat bipartite 
proteins in more basal organisms (e.g., Capsaspora, A. queenslandica); 2) the presence 
of remnant GRR sequences at the C terminus of N. vectensis NF-κB; 3) the homology 
of the separate N. vectensis IκB protein to mammalian NF-κB protein C-terminal ANK 
repeats; and 4) the presence of an intact RHD-ANK protein in the closely related 
anemone E. lineata (Stefanik et al., 2014). Similar to N. vectensis, the hydras 
Hydractinia symbiolongicarpus (Zárate-Potes et al., 2019) and Hydra magnipapillata 
(Fanzenburg et al., 2012) and the jellyfish Aurelia (Gold et al., 2019) have separate 
RHD-only NF-κB proteins and IκB-like genes, all of which likely came about due to 
gene-splitting events, which are common in cnidarians (Chapman et al., 2010; Gacesa 
et al., 2015). 
 
1.3 Activity and regulation of basal NF-κBs  
The activity and regulation of NF-κB proteins in vertebrates are now known in 
great detail. Many of these properties are conserved in basal NF-κBs, however, there are 
clear exceptions, and many things about NF-κB proteins from organisms basal to 
cnidarians are unknown.  
Although not formally shown, either biochemically or structurally, it is likely that 





bound by vertebrate NF-κB proteins p50 and p52. Nevertheless, the absence of a clearly 
defined dimerization sequence in the pre-metazoan NF-κBs does raise the possibility that 
they bind DNA as monomers, similar to what has been found for the NFAT proteins 
(Stroud and Chen, 2003). However, consistent with the basal NF-κBs binding DNA as 
dimers, the NF-κB protein/κB site DNA complexes seen in electrophoretic mobility shift 
assays using two sea anemone NF-κB proteins migrate in a manner suggesting that the 
NF-κB proteins are dimers (Wolesnki et al., 2011; Mansfield et al., 2017). Furthermore, 
based on protein-binding microarrays (PBMs), the NF-κB proteins of Capsaspora, the 
sponge A. queenslandica, and two sea anemones bind to a set of κB sites that are more 
similar to the sites bound by mammalian NF-κB proteins than by Rel proteins (Ryzhakov 
et al., 2013; Mansfield et al., 2017), a biochemical finding that is consistent with their 
overall structural organization and phylogenetic data. 
Most basal NF-κB proteins appear to be activators of κB site-containing 
promoters/enhancers. That is, the RHD sequences of sea anemone cnidarian NF-κB 
proteins function as activators of transcription when expressed in reporter gene assays in 
yeast and human cells (Wolenski et al., 2011; Mansfield et al., 2017). The ability of these 
basal NF-κBs to function as independent activators of transcription is more similar to 
Relish, which can act as a homodimeric transcriptional activator (Stöven et al., 2003), 
than to mammalian p50/p52 proteins, which are generally activators of transcription only 
when in heterodimers with a Rel protein (Gilmore, 2006; Hayden and Ghosh, 2008). No 
DNA-binding or transcriptional regulatory studies have been performed with NF-κB 





prior to the research presented in this thesis. 
The most extensive research on basal NF-κB activity has been done with the NF-
κB protein of the sea anemone N. ventensis (Nv-NF-κB). Curiously, it was found that 
wild populations of these anemones have two major alleles of Nv-NF-κB that differ at 10 
residues, six of which are in the RHD (Sullivan et al., 2009). Two of these variable 
residues are ones that are predicted to contact DNA, and, as a consequence, one of the 
allelic Nv-NF-κB proteins (Nv-NF-κB-C) binds DNA with an approximately two-fold 
higher affinity than the other variant (Nv-NF-κB-S) (Wolesnki et al., 2011). Despite its 
reduced DNA-binding activity, Nv-NF-κB-S activates transcription in reporter gene 
assays in human cells more effectively than Nv-NF-κB-C (Wolenski et al., 2011). 
Overall, the PBM-based binding site profiles of both Nv-NF-κB alleles still largely 
resemble that of mammalian p50 (Ryzhakov et al., 2013; Mansfield et al., 2017). 
Interestingly, the DNA-binding site profiles of Nv-NF-κB-C and Nv-NF-κB-S are as 
different from each other as each is from human p50 (Mansfield et al., 2017), suggesting 
that within a given species (i.e., N. vectensis) there can be considerable flexibility in 
DNA binding site recognition that does not have an obvious effect on the organism’s 
overall developmental phenotype. However, these results do not exclude the possibility 
that anemones harboring distinct NF-κB alleles have differences in other properties, such 
as immunity.  
In the mammalian non-canonical pathway, human p100 is phosphorylated by 
IKKα at a cluster of three serine residues that are located C-terminal to the ANK repeats, 





sequences up to the GRR (Sun, 2011). This cluster of serine residues is conserved in 
many sequenced cnidarian NF-κBs, including those of the corals Pocillopora damicornis, 
Stylophora pistillata, and Acropora millipora, and the sea anemones Actinia tenebrosa, 
Aulactinia veratra, and Aiptasia (Gauthier and Degnan, 2008; Baumgarten et al., 2015; 
Anderson et al., 2016; Mansfield et al., 2017; Voolstra et al., 2017; Cunning et al., 2018; 
Ying et al., 2019). Furthermore, phosphorylation and proteasomal processing of NF-κB 
from a sea anemone (Aiptasia) can be induced by co-expression of human IKKα and 
IKKβ or the single Aiptasia IKK (Mansfield et al, 2017), suggesting that IKK-dependent 
processing of cnidarian NF-κBs can occur in their natural settings. On the other hand, the 
Capsaspora NF-κB protein clearly has C-terminal ANK repeats and a GRR, but it does 
not have any apparent C-terminal IKK target site serine residues and no IKK can be 
found in the Capsaspora genome. Intriguingly, Capsaspora does have at least one 
possible caspase cleavage site similar to what is seen in the Drosophila protein Relish 
(Figure 1.1 and Figure 1.4). Overall, the emergence of IKK proteins appears generally 
coincident with the presence of regulatory serine residues downstream of the ANK repeat 
domains of basal NF-κBs. Of note, the Drosophila Relish protein also lacks C-terminal 
serine residues and a GRR and is processed by a site-specific protease cleavage event 
(Stöven et al., 2003), and in some conditions, shortened human p105 NF-κB proteins can 
be generated by ribosomal stalling (Lin et al., 1998).  
For the N. vectensis NF-κB protein, which lacks C-terminal ANK repeats, it was 
shown that the independent Nv-IκB could directly bind to Nv-NF-κB and that this Nv-





aspects of canonical signaling may also be present in cnidarians.  
Proteasomal-mediated processing has not been directly demonstrated to induce 
nuclear translocation of any basal NF-κB in its natural setting. Furthermore, while the 
ubiquitin-proteasome system is present in basal phyla, regulated processing has not been 
experimentally demonstrated for any protein (Fort et al, 2015). However, in a 
reconstituted mammalian cell system, IKK-induced processing of the anemone Aiptasia 
NF-κB can be blocked by a proteasome inhibitor (Mansfield et al., 2017). In addition, 
when expressed in chicken tissue culture cells, the full-length RHD-ANK protein of the 
anemone Aiptasia is located in the cytoplasm, and deletion of the ANK repeat domains of 
this NF-κB causes it to localize to the nucleus (Mansfield et al., 2017), suggesting that C-
terminal processing would do the same in the host organism. Similarly, in these same 
assays, the naturally truncated anemone Nv-NF-κB protein localizes to the nucleus, but it 
is sequestered in the cytoplasm when Nv-IκB is co-expressed (Wolenski et al., 2011). 
Prior to the research in this thesis, nothing was known about the subcellular localization 
or regulation of sponge or protist NF-κB proteins. Indeed, choanoflagellate NF-κBs lack 
a clear NLS as well as C-terminal ANK repeats. 
Notwithstanding the above-described reconstitution experiments conducted with 
cnidarian NF-κBs in vertebrate cell systems, it is not known whether or how regulated 
processing of basal NF-κBs occurs in any natural setting. Indeed, in the anemone 
Aiptasia (Mansfield et al., 2017), most NF-κB protein is largely processed and nuclear in 
the absence of any known stimulus. Furthermore, certain treatments (e.g., bleaching in 





κB pathway genes rather than C-terminal processing (Mansfield et al., 2017). Prior to this 
thesis, the sea anemone Aiptasia was the only basal organism where this phenomenon 
had been seen, but it was suggested that this may be the case in other organisms 
(Mansfield et al., 2017; Mansfield and Gilmore, 2019). 
 
1.4 Basal NF-κBs likely have roles in development and immunity  
One of the most important questions regarding NF-κB in basal metazoans is what 
biological processes are regulated by this transcription factor. At least in cnidarians and 
sponges, there is evidence that NF-κB has roles in both early development and/or adult 
immunity (Table 1.1).  
1.4.1 Role of NF-κB in sponge and cnidarian development 
In the sponge A. queenslandica and several cnidarians, NF-κB transcripts have 
been shown to be expressed in the early embryo. In A. queenslandica, fluorescent in situ 
staining has shown that NF-κB transcripts are broadly expressed throughout the embryo 
after cleavage, and are particularly strong in granular cells, which eventually become the 
outer layer of the developing embryo (Gauthier and Degnan, 2008). Similarly, some 
cnidarians express NF-κB transcripts in the early embryo and juvenile larvae (Helm et al., 
2013; Tulin et al., 2013; Wolenski et al., 2013; Fischer et al., 2014; Siboni et al., 2014; 
Warner et al., 2018). In the anemone N. vectensis, NF-κB mRNA expression is seen as 
early as one hour post fertilization (hpf) (Helm et al., 2013; Tulin et al., 2013; Fischer et 





late gastrula stage (Wolenski et al., 2013). Morpholino-based knockdown of NF-κB in 
the developing N. vectensis embryo led to a failure to develop cnidocytes at the juvenile 
polyp stage (Wolenski et al., 2013). Cnidocytes are a Cnidaria-specific cell type that is 
involved in a variety of sensing, prey capture, and perhaps defense roles (Babonis and 
Martindale, 2014). In addition, morpholino knockdown of the single NF-κB-inducing 
Toll-like receptor (TLR) transcript also led to an early developmental defect in N. 
vectensis (Brennan et al., 2017). 
1.4.2 Role of NF-κB in juvenile and adult sponges and cnidarians 
NF-κB transcripts and proteins have also been detected in several cell types in 
differentiated sponge tissues. Whole-mount in situ hybridization of juvenile sponge tissue 
showed that NF-κB transcripts are present in flask cells, which are large ciliated cells that 
express a range of genes whose orthologues play roles in eumetazoan neurons (Gauthier 
and Degnan, 2008). Two recent studies (Musser et al., 2019; Sogabe et al., 2019) 
performed single cell sequencing on different adult sponge cell types, and they reported 
that NF-κB transcripts were primarily expressed in two cell types: choanocytes, which 
are cells that reside in the chambers that allow the sponge to filter feed, and archaeocytes, 
which are motile phagocytic cells that are inside the mesohyl (a gelatinous matrix 
between the internal and external layers of sponges). Treatment of two Mediterranean 
species of sponges, Aplysina aerophoba and Dysidea avara with an immunogenic 
cocktail of lipopolysaccharide (LPS, a potent TLR-to-NF-κB inducer in mammals) and 
peptidoglycan led to the upregulation of immune-related receptors involved in signaling 





  Taken together, the above studies suggest that NF-κB plays a role in a select 
number of cells involved in sponge immunity. However, explicit studies on the protein 
level, for example on the processing or activation of sponge NF-κB, have not been 
previously reported. 
Several studies have suggested that NF-κB also has a role in immunity in adult 
cnidarians. In the anemone N. vectensis, cytoplasmic NF-κB and IκB are expressed in a 
subset of cnidocytes in the body column of juvenile and adult anemones (Siboni et al., 
2014). NF-κB protein is also highly expressed in cnidocytes that are present in circulating 
multicellular bodies called nematosomes, which also express high levels of TLR and c-
GAS-STING innate immune signaling components (Babonis and Martindale, 2014; 
Brennan et al., 2017), which are are upstream of NF-κB in vertebrates. Those results, 
along with the ability of nematosomes to take up bacteria (Babonis and Martindale, 2014; 
Brennan et al., 2017), suggest that the nematosome is a primitive circulating immune 
organ in some anemones. 
Aiptasia is a tropical anemone that has been used as a model for cnidarian 
symbiosis with algal dinoflagellates in the family Symbiodiniaceae (Wolfowicz et al., 
2016). Colonization of both larval and adult Aiptasia with algal symbionts of certain 
strains results in down-regulation of NF-κB transcripts, protein, and DNA-binding 
activity (Burns et al., 2017; Mansfield et al., 2017; Mansfield et al., 2019). Conversely, 
induction of loss-of-symbiosis with either chemical or heat treatment results in increased 
levels of NF-κB expression and activity (Mansfield et al., 2017), and Aiptasia lacking 





(Mansfield et al., 2019). These results have led to the hypothesis that suppression of NF-
κB-directed immunity is required for the establishment of algal symbiosis in some 
cnidarians, similar to what has been found in amphibians (Burns et al., 2017). It is 
noteworthy that the symbiont-modulated changes in NF-κB activity in Aiptasia occurred 
primarily at the level of protein and mRNA expression (Mansfield et al., 2017), and not 
by post-translational processing as generally seen in vertebrate systems. That is, both 
symbiotic and aposymbiotic Aiptasia have nuclear NF-κB-staining cells, but the number 
of NF-κB-positive cells is substantially increased in Aiptasia in which symbiont loss has 
occurred (Mansfield et al., 2017). In addition, most NF-κB protein is in its processed 
form in both symbiotic and aposymbiotic Aiptasia (Mansfield et al., 2017). 
The research on NF-κB in Aiptasia is of high interest because corals host the same 
family of algal symbionts and because ocean warming-induced loss of symbiosis 
(“bleaching”), as well as microbial pathogen infections, are causing large-scale loss of 
coral reef health (Wolfowicz et al., 2016). Several studies have also investigated NF-κB 
and NF-κB pathway gene expression in corals, and such studies further suggest a role for 
NF-κB in immunity and symbiosis/dysbiosis (Table 1.1). For example, transcripts 
encoding NF-κB and its signaling components have been identified in transcriptomes 
from bleached O. faveolata (DeSalvo et al., 2010). Furthermore, NF-κB mRNA was 
substantially upregulated in the coral Acropora palmata following extended exposure to 
elevated water temperature (Traylor-Knowles et al., 2017), while another study found 
that NF-κB transcripts were only transiently induced shortly after heat treatment in the 





ways in different cnidarians undergoing heat stress-induced changes. Additionally, one 
study has shown an increase in transcripts encoding members of the NF-κB pathway in 
corals with microbial diseases (Wenger et al., 2014), further suggesting that NF-κB has 
an immune-related role in cnidarians. 
 Several lines of evidence suggest that TLR and TLR-like pathways are upstream 
activators of NF-κB in cnidarians. First, homologs of TLR-to-NF-κB pathway signaling 
are present in most cnidarians (Sullivan et al., 2007; Chapman et al., 2010; Shinzato et 
al., 2011; Wolenski et al., 2011; Gilmore and Wolenski, 2012; Baumgarten et al., 2015; 
Voolstra et al., 2017; Gold et al., 2019). Second, Hydra and N. vectensis TLR-like 
proteins have a conserved ability to activate NF-κB when ectopically expressed in human 
cells (Franzenburg et al., 2012; Brennan et al., 2017). Third, as mentioned above, TLR 
and NF-κB proteins are expressed in many of the same cnidocytes in adult N. vectensis 
(Brennan et al., 2017). Indeed, TLR-to-NF-κB signaling has been proposed to play a role 
in embryonic development (Siboni et al., 2014; Brennan et al., 2017), immunity (DeSalvo 
et al., 2010; Franzenburg et al., 2012; Wenger et al., 2014; Brennan et al., 2017), and 
regeneration (Woznica et al., 2017) in cnidarians. Nevertheless, TLR is not the sole 
receptor that can signal to NF-κB in mammals that is also present in cnidarians. For 
example, cnidarians also possess homologs to tumor necrosis factor (TNF) receptors and 
their downstream components (Sullivan et al., 2007), which are extensively characterized 
activators of NF-κB in vertebrates. However, the ability of cnidarian TNF receptors to 
activate NF-κB in cnidarians has not been investigated. Finally, activation of the cGAS-





of NF-κB in Nematostella (Margolis et al., 2021). 
The biological role of NF-κB in single-celled organisms remains unknown (Table 
1.1). However, one can speculate that biological processes controlled by NF-κB in 
protists are quite different than in multicellular animals, given that protists have no innate 
or adaptive immunity in the traditional sense of specialized immune cells. Thus, if NF-κB 
plays a role in immunity in protists, it may do so in an unexpected manner. Or, in the case 
of Capsaspora, which is a symbiont of the snail B. glabrata, NF-κB may modulate either 
protist or host immunity to facilitate symbiosis, similar to what has been proposed for 
Aiptasia-Symbiodiniaceae symbiosis. Alternatively, NF-κB could play a 
“developmental” role in the solitary vs. colony states seen in many protists, including 
choanoflagellates. Finally, NF-κB may be involved in some protist-specific process. For 
example, one species of choanoflagellate has been shown to be induced to sexually 
reproduce upon stimulation with bacterial components (Brook et al., 2020). 
Currently, little is known about the evolution of immunity, and the most ancient 
roles of conserved transcription factors involved in invertebrate immunity. Therefore, 
understanding how NF-κB operates in the context of basal organisms will likely provide 
insights into our own evolution as well as allowing researchers to uncover molecular 







1.5 Thesis rationale 
This thesis describes the first molecular and biochemical characterization of NF-
κB signaling in four organisms that represent three branches of basal evolution. This 
research describes the first characterization of a TLR-to-NF-κB pathway in an 
endangered coral, and the first characterization of NF-κB in two groups basal to 
cnidarians (sponges and protists). Therefore, this work provides a framework for our 
understanding of the structure, signaling, biology, and evolution of basal NF-κB proteins. 
Studies of NF-κBs in more derived organisms, such as flies and humans, have 
revealed that these NF-κBs have conserved biological roles in immunity and 
development. The primary goal of this research was to explore the evolution of the 
structure, activity and regulation, and biological roles of NF-κB proteins from early 
branching organisms. This thesis describes NF-κBs from an endangered coral Orbicella 
faveolata (Of), an evolutionarily significant sponge Amphimedon queenslandica (Aq), 
and the protists Capsaspora owczarzaki (Co) and Acanthoeca spectabilis (As). It is 
shown that the structure, DNA-binding profiles, and cellular localization of basal NF-κBs 
are most highly conserved to the human NF-κB p100/p105 proteins. Furthermore, the 
regulation of NF-κB processing, at least when reconstituted in human cells, is conserved 
even in the most basal animals, in that Of-NF-κB and Aq-NF-κB can be truncated to their 
nuclear form with IKK-mediated processing through conserved residues. However, this 
method of regulation is not seen outside of animals, as demonstrated in the protists 
characterized here. Finally, evidence is provided into the biological roles in these basal 





organisms, but the level of activation of NF-κB in basal organisms is likely different than 
what is seen in higher organisms. Taken together, this research provides insight into the 
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Figure 1.1 The structures of NF-κBs in organisms basal to Bilateria are most similar 
to human NF-κB proteins rather than Rel proteins.  
The basic domain structures of homologs of NF-κB in Capsaspora, choanoflagellates, 
poriferans (sponges), and cnidarians are compared to the fly and vertebrate NF-κBs 
(Relish, p100/p105), Rels (Dif, Dorsal, RelA, RelB, c-Rel), and IκB (Cactus). Green, Rel 
Homology Domain (RHD); purple, nuclear localization signal (NLS); blue, Glycine-rich 





Domain; SSS/SS, conserved serines important for phosphorylation and degradation of the 
protein (red SSS indicate homology to p100); and orange, N-terminal domains of 







Figure 1.2 Motif analysis of NF-κB and Rel proteins.  
MEME analysis was performed on each sequence to identify shared motifs. Conserved 
motifs are highlighted and two choanoflagellate specific sequences are labeled and shown 










Figure 1.3 Phylogenetic analysis places choanoflagellate NF-κBs as an outgroup of 
vertebrate and fly NF-κBs.  
A) Bayesian analysis of holozoan RHDs, including the recently identified 
choanoflagellate NF-κBs. MEME analysis was performed on each sequence to identify 
shared motifs. NF-κB proteins and Rel proteins cluster separately from each other, and 
choanoflagellate NF-κBs cluster as a single outgroup. B) A multiple sequence alignment 
of important NF-κB subdomains across multicellular metazoans and single-celled pre-
metazoans. Exact amino acid matches to either p100/p105 are highlighted in blue across 
phyla, and residues with conserved functional groups are highlighted in yellow. All 
multicellular metazoans contain a defined start to the Rel Homology Domain (RHD), 
dimerization sequence, and nuclear localization sequence (NLS). Single-celled pre-
metazoans have a less defined RHD start, low homology in the dimerization sequence, 
and no canonical NLS (with the exception of Capsaspora). All metazoans and pre-







Figure 1.4 Alignment of putative caspase cleavage sites.  
The consensus sequence for caspase cleavage is aligned with the known site of DREDD 
cleavage in Drosophila Relish and with a putative caspase site in Capsaspora NF-κB. 






MATERIALS AND METHODS2 
 
2.1  Phylogenetic analyses of conserved genes 
For comparative analysis of Toll-like receptors, the predicted TIR domains of 
Orbicella faveolata (Of) TLR, Nematostella vectensis (Nv) TLR, Drosophila 
melanogaster (Dm) Toll, and an Amphimedon queenslandica (Aq) TLR-like protein 
(Gauthier et al., 2010) were analyzed along with the ten human TLR proteins. The TIR 
domains of Of-TLR, Nv-TLR, and Aq-TLR were identified through MEME analysis 
(Bailey et al., 2006), and sequences were trimmed to contain only the TIR domains based 
on motif prediction and known human TIR domains (Table 2.5). Human TLR and Dm-
Toll amino acid sequences, along with their annotated TIR domains, were obtained from 
the UniProt database. Clustal Omega (Sievers et al., 2011) was then used to align the 
trimmed and culled TIR sequence dataset. The tree was rooted with the Aq-TLR, and 
phylogenetic comparison was performed using neighbor-joining analysis bootstrapped 
1000 times using PAUP* (Swofford, 2001).  
For phylogenetic analysis of the NF-κB and Rel proteins in Chapter 3, the RHD 
sequences of O. faveolata (Of) NF-κB (from NCBI) Aiptasia sp. NF-κB (NCBI), Actinia 
tenebrosa NF-κB (NCBI), N. vectensis NF-κB (UniProt), D. melanogaster Relish, 
Dorsal, and Dif (UniProt), and Homo sapiens p100, p105, RelA, RelB, and c-Rel 
 
2 Adapted from Williams et al., 2018; Williams et al., 2020; Williams et al., 2021; Williams, Aguirre 





(UniProt) were obtained. The tree was rooted with an NF-κB-like protein from 
Capsaspora owczarzaki (NCBI). As described above, conserved motifs from MEME 
analysis (Bailey et al., 2006) were truncated based on motif predictions (Table 2.6), were 
aligned by Clustal Omega (Sievers et al., 2011), and were inputted into PAUP* 
(Swofford, 2001) for maximum likelihood analysis bootstrapped 1000 times.  
For phylogenetic analysis of the NF-κB and Rel proteins in Chapter 4, the RHD 
sequences of NF-κB from A. queenslandica (Aq) (Gauthier and Degnan, 2008) were 
compared phylogenetically to Aiptasia pallida (Ap) NF-κB (AIPGENE8848) from the 
ReefGenomics database, Orbicella faveolata NF-κB (Williams et al., 2018), and N. 
vectensis (Nv), Drosophila Dif, Dorsal, and Relish, and Homo sapiens and Mouse p100, 
p105, RelA, RelB, and c-Rel from the UniProt database. Carcinoscorpius rotundicauda 
(Horseshoe crab) Relish, and Danio rerio, Xenopus laevis, and Strongylocentrotus 
purpuratus NF-κBs were from NCBI (Accession numbers: ABC75034.1, 
NP_001001840.2, NP_001081181.1, and NP_999819.1, respectively). The tree was 
rooted with RHD of Capsaspora owczarzaki NF-κB (from UniProt database). Conserved 
motifs from MEME analysis were truncated based on motif predictions (Table 2.7), were 
aligned by Clustal Omega (Sievers et al., 2011), and were inputted into PAUP* 
(Swofford, 2001) for maximum likelihood analysis bootstrapped 1000 times. 
For phylogenetic analysis of the NF-κB and Rel proteins in Chapter 5, the RHD 
sequences of NF-κB from C. owczarzaki were compared phylogenetically to the NF-κB-
like sequences present in the transcriptomes of sequenced choanoflagellates. Details on 





Clustal Omega (Sievers et al., 2011). A maximum likelihood phylogenetic tree was 
created using PAUP* (Swofford, 2001) and was bootstrapped 1000 times. Bayesian 
phylogenetic analyses showed similar results. 
 
2.2  Codon optimization of cDNA sequences  
The cDNA of Of-, Aq-, Co-NF-κBs and As-NF-κB1-3 were optimized using 
GenScript’s services before synthesizing through GenScript for optimal expression in 
mammalian cells. 
 
2.3  Recombinant DNA techniques 
Molecular cloning techniques were used to create bacterial and mammalian 
plasmids for the expression of full-length and deletion mutants of basal NF-κBs and other 
relevant proteins. 
2.3.1 Identification and synthesis of basal NF-κBs, IKKs, and Of-TLR 
The cDNA for Of-NF-κB, Aq-NF-κB, Of-IKK, Of-TLR and Co-NF-κB were 
identified by BLAST homology on NCBI or through Pinzón et al. (2015) or Gauthier and 
Degnan (2008), and As-NF-κB1-3 were identified from Richter et al. (2018).  The human 
cell codon-optimized cDNA corresponding to the predicted aa sequence of each were 






2.3.2  Digestion of DNA 
DNA was digested with endonucleases and endonuclease buffers (New England 
Biolabs) according to the manufacturer’s protocol. Generally, restriction digestion 
reactions contained 1 μg of DNA, 1 μl of restriction enzyme(s), and 2 μl of the 
appropriate endonuclease buffer in a total volume of 20 μl. Unless specified otherwise, 
samples were incubated for 1 h at 37°C in 1.5-ml microcentrifuge tubes. Digested 
products were analyzed by gel electrophoresis as described previously (Wolenski, 2012).  
2.3.3  Polymerase chain reaction (PCR)  
PCRs contained 10-20 ng of template plasmid DNA, 1.25 μM forward and 
reverse primers, 0.2 μM dNTPs, 0.02 Units/μl Q5 Hot Start DNA polymerase (New 
England Biolabs), and 5 μl of 5X Q5 reaction buffer in a total volume of 25 μl. The PCR 
mixture was mixed by pipetting and subjected to the following thermocycler conditions: 
98°C for 30 sec, 35 cycles of 1) 98°C for 10 sec, 2) 58-65°C for 30 sec (optimized for 
each primer pair), and 3) 72°C for 30 sec (per kilobase of product), followed by a single 
extension at 72°C for 5 min. PCR products were analyzed by gel electrophoresis. When 
introducing multiple sites of mutations into DNA, overlapping PCR was performed as 
previously described (Wolenski, 2012). 
2.3.4 Oligonucleotides 
Oligonucleotides used in this thesis are listed in Table 2.1. Many oligonucleotides 






2.3.5 DNA ligation 
DNA was run on a 1.5% low melt agarose gel at 60 volts (V) and correctly sized 
DNA bands were excised from the gel and placed in 1.5-ml microcentrifuge tubes. 
Excised DNA-gel slices were directly used or purified using phenol and chloroform for 
ligation reactions. Ligation reactions using T4 DNA ligase were performed as described 
previously (Haery, 2016). 
2.3.6 Preparation of chemically competent DH5α cells 
Chemically competent Escherichia coli DH5α cells were used for all cloning 
protocols. The preparation of chemically competent E. coli DH5α bacterial cells was 
performed as previously described (Wolenski, 2012). 
2.3.7 Transformation of plasmid DNA 
Transformation of plasmid DNA was performed essentially as previously 
described (Wolenski, 2012; Haery, 2016). For transformation of DNA fragment 
assemblies using T4 DNA ligase and HiFi Assembly, the entire ligation/DNA assembly 
reaction volume (20-25 μl) was combined with 60 μl of chemically competent E. coli 
DH5α, 170 μl TCM [10 mM Tris-HCl (pH 7.5), 10 mM CaCl2, 10 mM MgCl2], and 
incubated on ice for 1 h in a 1.5-ml microcentrifuge tube. Samples were then heat-
shocked at 42°C in a water bath for 2 min, then supplemented with 1 ml of LB [1% (w/v) 
bacto-tryptone, 0.5% (w/v) yeast extract, 1% (w/v) NaCl, pH 7.4]. After 1 h at 37°C 
shaking at 225 rpm, cells were pelleted at 3,000 rpm for 3 min, resuspended in 100 μl LB 





1% (w/v) NaCl, pH 7.4; 1.5% (w/v) bacto-agar (Difco)] containing 100 μg/ml ampicillin 
and 50 μg/ml chloramphenicol (amp/cam), or 100 μg/ml ampicillin (amp) only. These 
plates were incubated at 37°C overnight. Bacterial colonies were picked the next day to 
inoculate 5 ml of LB-amp or LB-amp/cam for overnight growth at 37°C shaking at 
225 rpm. 
2.3.8 Plasmid constructions  
Details about the source and construction of plasmids used in this thesis are 
described in Table 2.2. 
2.3.9 Small-scale plasmid preparation  
Small-scale preparations (minipreps) of plasmid DNA were performed as 
described previously (Wolenski, 2012; Haery, 2016). 
2.3.10 Large-scale plasmid preparation  
Large-scale plasmid isolation was performed by the cesium preparation method as 
described previously (Wolenski, 2012) or by using the ZymoPURE Midiprep kit (Zymo 
Research) following the manufacturers protocol.  
 
2.4 Cell culture  
Cell lines used in this thesis are listed in Table 2.3. 
2.4.1 Vertebrate cell culture 
DF-1 chicken fibroblasts and human HEK 293 or 293T cells were grown in 





serum (Biologos), 50 units/ml penicillin, and 50 μg/ml streptomycin as described 
previously (Wolenski, 2012). 
2.4.2 Capsaspora cell culture 
Capsaspora cell cultures (strain ATCC ®30864) were grown axenically in 25 cm2 
culture flasks (ThermoScientific Nunclon) with 10 ml ATCC medium 1034 (modified 
PYNFH medium) at 23°C. Cultures for each Capsaspora life stage were generated as 
previously described (Sebé-Pedrós et al., 2013) and as instructed by ATCC. Filopodic 
cells were maintained in an actively dividing adherent state by scraping and passaging 
1/40-1/50 of the cultures every 6-8 days, before floating cells appeared. Floating cystic 
cells were collected from 14-day-old filopodic cultures. Aggregative cells were created 
by actively scraping dividing filopodic cells and seeding them into a 25 cm2 culture flask, 
which was gently agitated at 60 RPM for 4-5 days, and grown axenically at 23°C. 
2.4.3 Polyethylenimine-based cell transfection 
Transfection of cells with expression plasmids was performed using 
polyethylenimine (PEI) (Polysciences, Inc.) essentially as described previously 
(Wolenski, 2012). Briefly, on the day of transfection, cells were incubated with plasmid 
DNA and PEI at a DNA:PEI (1 mg/ml) ratio of 1:6. Media was changed 24 h post-
transfection, and whole-cell lysates were prepared 24 h later. If cells were used for 






Although a method for transfection of Capsaspora cells has been previously been 
described (Parra-Acero et al., 2018), we developed a new PEI-based method for 
transfection of these cells. That is, transfection of Capsaspora cells with expression 
plasmids was performed using polyethylenimine (PEI) (Polysciences, Inc.). Briefly, the 
day before transfection, actively dividing Capsaspora filopodic cells were plated at about 
80-90% confluency. The next day, cells were transfected by incubation with 5 μg of 
plasmid DNA and 25 μl of 1 mg/ml PEI. Media was changed ~20 h post-transfection, and 
Capsaspora cells to be analyzed by immunofluorescence were passaged onto poly-D-
lysine (ThermoFisher)-treated glass coverslips on the day prior to fixation. 
 
2.5  Whole-cell extract preparation  
Whole-cell extracts were prepared, in general, in AT Lysis buffer, as detailed 
below. 
2.5.1  Tissue culture cells 
Non-denaturing whole-cell protein lysates of transfected HEK 293 cells and HEK 
293T cells were made using AT Lysis Buffer (20 mM HEPES, pH 7.9, 150 mM NaCl, 1 
mM EDTA, 1 mM EGTA, 20% wt/vol glycerol, 1% [wt/vol] Triton X-100, 20 mM NaF, 
1 mM Na4P2O7·10H2O, 1 mM dithiothreitol, 1 mM phenylmethylsulfonyl fluoride, 1 
μg/ml leupeptin, 1 μg/ml pepstatin A, 10 μg/ml aprotinin) essentially as described 
previously (Wolenski, 2012). Generally, cells were harvested 48 h post-transfection. 
Tissue culture plates containing HEK 293T cells were scraped with a cell scraper and 
media containing the cells was transferred to 15-ml conical tubes and samples were 





cells were washed once with 4°C phosphate buffered saline (PBS; GIBCO), cells were 
removed by gentle scraping with a rubber scraper, and then transferred to a 1.5-ml 
microcentrifuge tube. For lysis of a 100-mm tissue culture plate, cells were resuspended 
in 160 μl of AT buffer by pipetting. For lysis of a 60-mm tissue culture plate, cells were 
resuspended in 100 μl of AT buffer by pipetting. Cell samples were then passed five 
times through a 27.5- gauge needle to ensure complete lysis. NaCl was then added to a 
final concentration of 150 mM and protein lysates were clarified by centrifugation at 
13,000 rpm for 25 min at 4°C. Supernatants were then transferred to fresh 1.5-ml 
microcentrifuge tubes and stored at -80°C. Protein concentration was determined using 
the Bio-Rad Protein Assay dye reagent (Bio-Rad) as described previously (Wolenski, 
2012). 
2.5.2 Cliona sp. 
Black encrusting sponge tissue was obtained from the Boston University Marine 
Program lab by scraping tissue off a rock substrate, immediately flash freezing the tissue, 
and storing it at -80 °C until use. To prepare a sponge lysate, a piece of tissue 
approximately 2 cm by 2 cm was placed into a glass dounce tissue grinder (Wheaton) 
with 1 ml of AT Lysis Buffer and protease inhibitors (described previously in this 
chapter). Tissue was ground approximately ten times by hand, and then the sample was 
transferred to a 1.5-ml microcentrifuge tube and gently rotated for 1 h at 4 °C. The 






Whole-cell lysates of cells from each life stage were prepared in AT Lysis Buffer 
(20 mM HEPES, pH 7.9, 150 mM NaCl, 1 mM EDTA, 1 mM EGTA, 20% w/v glycerol, 
1% w/v Triton X-100, 20 mM NaF, 1 mM Na4P2O7·10 H2O, 1 mM dithiothreitol, 1 mM 
phenylmethylsulfonyl fluoride, 1 μg/ml leupeptin, 1 μg/ml pepstatin A, 10 μg/ml 
aprotinin). On the day of lysis, cells from five 25 cm2 culture flasks (ThermoScientific 
Nunclon) were washed once with PBS and then scrapped with a rubber scraper with 1 ml 
of PBS for each and transferred into five 1.7-ml microcentrifuge tube. The cells were 
pelleted at 3000 rpm for 5 min at 4°C and then combined and resuspended in 250 ul of 
AT buffer by pipetting. For lysis of a 60-mm tissue culture plate, cells were resuspended 
in 100 μl of AT buffer by pipetting. Cell samples were then passed five times through a 
27.5-gauge needle to ensure complete lysis. NaCl was then added to a final concentration 
of 150 mM and protein lysates were clarified by centrifugation at 13,000 rpm for 25 min 
at 4°C. Supernatants were then transferred to fresh 1.5-ml microcentrifuge tubes and 
stored at -80°C. Protein concentration was determined using the Bio-Rad Protein Assay 
dye reagent (Bio-Rad) as described previously (Wolenski, 2012). 
 
2.6  SDS-Polyacrylamide gel electrophoresis and Western blotting  
Western blotting was performed as described previously (Wolenski et al., 2011; 
Mansfield et al., 2017). Briefly, cell and tissue extracts were first separated on SDS-
polyacrylamide gels. Proteins were then transferred to nitrocellulose at 4°C at 250 mA 





Tris-HCl [pH 7.4], 150 mM NaCl, 0.1% v/v Tween 20) containing 5% powered milk 
(Carnation) for 1 h at room temperature. Filters were incubated at 4°C with primary 
antiserum diluted in 5% milk TBST as follows: FLAG antiserum (1:1000, Cell Signaling 
Technology), α-tubulin antiserum (1: 1000, Cell Signaling Technology) or Ap-NF-κB 
antiserum (1:1000, (Mansfield et al., 2017)) (see Table 2.4 for details on antibodies). 
After extensive washing in TBST, filters were incubated with anti-rabbit horseradish 
peroxidase-linked secondary antibody (1: 4000, Cell Signaling Technology) or anti-
mouse horseradish peroxidase-linked secondary antibody (1:3000, Cell Signaling 
Technology). Immunoreactive proteins were detected with SuperSignal West Dura 
Extended Duration Substrate (Pierce) after exposure to X-ray film, or using a Sapphire 
Biomolecular Imager (Azure Biosystems).  
 
2.7  Electrophoretic mobility shift assay (EMSA) 
EMSAs were performed using a 32P-labeled κB-site probe (GGGAATTCCC, see 
Table 2.1) and 293 whole-cell extracts, as described previously (Wolenski et al., 2011). 
For gel analysis of the EMSA, a 10X TGE buffer was prepared (1.9 M glycine, 250 mM, 
10 mM EDTA pH 8.3) and chilled to 4°C. A 50 ml non-denaturing 5% polyacrylamide 
gel was cast [5% (v/v) polyacrylamide, 2.5% (v/v) glycerol, 400 μl 10% (w/v) APS, and 
80 μl TEMED in 1X TGE] and allowed to polymerize for at least 1 h. The gel was pre-
run for 30 min at 50 mA, then radioactive samples were loaded and the gel was 
electrophoresed at 30 mA for 2-3 h, until the 1X blue dye [6X: 50% (w/v) sucrose, 





was then dried under vacuum and either exposed overnight to a phosphor plate at room 
temperature or X-ray film at -80°C, and developed or imaged on a Sapphire Biomolecular 
Imager (Azure Biosystems). 
  
2.8  GST-tagged protein purification 
Isolation of GST proteins was performed essentially as previously described 
(Wolenski, 2012; Brennan, 2017). Glycerol stocks of BL21 DE3 E. coli containing the 
pGEX vector, BL21 DE3 pLysE E. coli containing the GST-Of-TIR or GST-Nv-TIR 
fusion, were used to inoculate 5 ml of LB-amp or LB-amp/cam, respectively, and were 
grown overnight at 37°C with shaking at 225 rpm. For expression of pGEX vector 
control, one overnight culture was inoculated. For expression of GST-Nv-TIR or GST-
Of-TIR, six or 12 overnight cultures were inoculated, respectively. Approximately 18 h 
later, cultures were spun at 3,000 rpm, the supernatant discarded, and the cell pellets were 
resuspended in 1 ml of fresh LB with the required antibiotics. The resuspended culture 
was then transferred to a 50 ml flask of LB-amp or LB-amp/cam and grown in a shaking 
incubator for 3 h at 37°C. To induce protein expression, 0.1 mM of isopropyl-1-thio-b-D-
galactoside (IPTG; Sigma) was added to each culture and cells were grown for an 
additional 3 h at 37°C in a shaking incubator.  
 Bacteria were then pelleted using a Sorvall SH-3000 rotor in a Sorvall RC-5 
centrifuge at 5,000 rpm for 10 min at 4°C. The cell pellet was washed once with 50 ml 
PBS and centrifuged as described above. The supernatant was discarded, and the bacterial 





1% aprotinin, and 2 μg/ml pepstatin-A). The resuspended pellet was lysed in a 15-ml 
conical tube by sonication using a Sonic Dismembrator 550 for six rounds of 30 sec at 
setting 4, with 2 min on ice in between each round of sonication. The lysate was 
transferred to a 2-ml microcentrifuge tube and each tube was supplemented with 200 μl 
of 10% Triton X-100 and rocked on a nutator for 10 min at 4°C. To clarify the lysate, 
each 2-ml tube was centrifuged at 14,000 rpm for 15 min at 4°C.   
 The GST-Of-TIR or GST-Nv-TIR lysates were combined in a 15-ml conical tube 
and 60 μl of 50% glutathione-agarose bead slurry (Sigma) was added. 60 μl of 50% 
glutathione-agarose bead slurry was also added to the pGEX vector clarified lysate. 
These lysates were rocked on a nutator for 18 at 4°C. Beads were then gently pelleted at 
3,000 rpm for 3 min and washed five times with ice cold PBS to remove unbound 
proteins. After the final PBS wash, the beads were resuspended in 1 ml of PBS with 
protease inhibitors and 5% of the resuspended bead slurry was electrophoresed on an 
SDS-polyacrylamide gel and stained with Coomassie blue to determine the relative 
amounts of expressed GST-tagged proteins as described previously (Wolenski, 2012).  
 
2.9  GST-pull down assays 
GST and GST-TIR domain fusion proteins were expressed in BL21 and BL21 
pLyse bacterial cells, respectively, and were purified from extracts using glutathione 
beads as described previously (Garbati et al., 2010). To assess the amounts and sizes of 
the purified GST proteins 1% of GST and 10% of the GST samples were electrophoresed 





Rad). The remaining portions of the GST proteins on beads were incubated with extracts 
from 293 cells expressing FLAG-MYD88. The beads were then washed four times with 
cold PBS, and were boiled in 2X SDS sample buffer to release proteins from the beads. 
Proteins were electrophoresed on a 7.5% SDS-polyacrylamide gel, and the gel was 
subjected to anti-FLAG Western blotting as described elsewhere (Wolenski et al., 2011) 
and in this chapter. 
 
2.10  Reporter gene assays 
2.10.1  Luciferase reporter assay 
Luciferase reporter gene assays were performed in 293 cells as previously 
described (Sullivan et al., 2009; Wolenski, 2012). For TLR activation luciferase assays, 
the 293 cells were grown in 6-well 35-mm plates to 60% confluence then transfected with 
the following using PEI: 1.5 ug 3x-κB, 1.5 ug RSV-βGAL, and basal NF-κBs or NF-κB 
mutants. The NF-κB-site luciferase reporter contains three copies of the major 
histocompatibility complex (MHC) class IκB element upstream of the gene encoding 
luciferase (Wolenski, 2012). Media was changed 20 h later, and cells were lysed 48 h 
post transfection and analyzed according to the Luciferase Assay System (Promega) 
manufacturer’s instruction.  
Luciferase measurements were first divided by the respective β-galactosidase 
values. If the assay was done in triplicate, the average value (luciferase/β-galactosidase) 
was calculated. All values were normalized to a vector control that was set to 1.0. 





2.10.2 GAL4 reporter assay 
Two separate 3 ml cultures of selective Trp- media were inoculated with two 
independent yeast colonies from GB-plasmids and then grown at 30oC for 24 h. 200 µl of 
cells from each culture was transferred into a 96-well micro plate for subsequent OD595 
measurements; 200 µl of Trp- media was used as a blank control. One mL of each culture 
was then transferred to a 1.5-ml microcentrifuge tube, centrifuged for 1 min, decanted, 
and then resuspended in 90 µl of lysis buffer (100 mM Tris [pH 7.6]; 0.05% Triton X-
100) with vortexing. Samples were freeze/thawed five times by repeated immersion in a 
dry ice/ethanol bath (until frozen) and then a 37oC water bath (until completely thawed). 
To each sample 450 µl of Z/ONPG solution (60 mM Na2HPO4, 40 mM NaH2PO4, 10 
mM KCl, 1 mM MgSO4, 50 mM 2-mercaptoethanol, 0.8 mg/ml orthonitrophenyl-β-D-
galactopyranoside [ONPG], 1 mM DTT, 0.005% SDS, pH 7) was added. All samples 
were incubated at 30°C until appearance of a yellow color (or 35 min elapsed without any 
change in color), at which point the reaction was stopped by addition of 225 µl of 1 M 
Na2CO3 (time of reaction from start to termination was recorded for each sample). 
Samples were centrifuged for 2 min and 200 µl of the supernatant was transferred into a 
96-well plate for measurement of β-galactosidase activity by measuring OD415; as a blank 
control 200 µl of supernatant from a centrifuged sample containing 90 µl yeast lysis 






2.11  In vitro kinase assay 
In vitro kinase assays were performed as described previously (Wolenski et al., 
2011). Briefly, human 293T cells were transfected with pcDNA-FLAG-IKKβ and 
pcDNA-FLAG-Of-IKK constructs, lysed two days later, and the kinases were 
immunoprecipitated with anti-FLAG beads (Sigma). These immunoprecipitates were 
then incubated with approximately 4 μg of GST alone, GST-Of-NF-κB or GST-Of-NF-
κB-3X-Ala C-terminal peptides and 5 μCi [γ-32P]ATP (Perkin Elmer) in kinase reaction 
buffer (25 mM Tris-HCl, pH 7.5, 20 mM β-glycerophosphate, 10 mM NaF, 10 mM 
MgCl2, 2 mM DTT, 500 μM Na3VO4, 50 μM ATP) for 30 min at 30°C. Samples were 
then boiled in 2X SDS sample buffer and electrophoresed on a 10% SDS-polyacrylamide 
gel. The 32P-labeled GST-Of-NF-κB peptides were detected by phosphorimaging. As a 
control for protein input, 4 μg of GST alone, GST-Of-NF-κB or GST-Of-NF-κB-3X-Ala 
was electrophoresed on a 10% SDS-polyacrylamide gel, and proteins were detected by 
staining with Coomassie blue (Bio-Rad).  
In vitro kinase assays were performed as described previously (Wolenski et al., 
2011; Mansfield et al., 2017). Briefly, human 293T cells were transfected with pcDNA-
FLAG-Hu-IKKβ, lysed two days later, and the tagged kinase was immunoprecipitated 
with anti-FLAG beads (Sigma). The immunoprecipitate was then incubated with 
approximately 4 μg of GST alone, GST-Aq-NF-κB, or GST-Aq-NF-κB-ALA C-terminal 
peptides and 5 μCi [γ-32P] ATP (Perkin Elmer) in kinase reaction buffer (25 mM Tris-
HCl, pH 7.5, 20 mM β-glycerophosphate, 10 mM NaF, 10 mM MgCl2, 2 mM DTT, 500 





sample buffer and electrophoresed on a 10% SDS-polyacrylamide gel. The 32P-labeled 
GST-Aq-NF-κB peptides were detected by phosphorimaging. As a control for protein 
input, 4 μg of GST alone, GST-Aq-NF-κB, or GST-Aq-NF-κB-ALA was electrophoresed 
on a 10% SDS-polyacrylamide gel, and these proteins were detected by staining with 
Coomassie blue (Bio-Rad).  
 
2.12  Indirect immunofluorescence  
2.12.1  Indirect immunofluorescence of tissue culture cells 
Indirect immunofluorescence of transfected DF-1 cells was performed to detect 
the subcellular localization of basal NF-κBs and mutants. DF-1 cells were transfected 
with 3 μg of expression vector and were passaged onto UV sterilized coverslips 2 days 
post-transfection. Immunofluorescence of transfected DF-1 cells was performed as 
described previously (Wolenski et al. 2011; Wolenski, 2012). Information about 
antibodies used for immunofluorescence of DF-1 cells is included in Table 2.4.  
2.12.2  Indirect immunofluorescence of sectioned Cliona sp. tissue   
Flash-frozen black encrusting sponge tissue was placed into ice-cold 4% 
paraformaldehyde in full-strength filtered artificial sea water (ASW) (Instant Ocean) to 
fix overnight at 4 °C. Fixed tissue was then washed three times with filtered ASW, and 
then dehydrated in 30% (w/v) sucrose in ASW at 4 °C overnight. Samples were then 
embedded in Optimal Cutting Temperature Compound (Sakura Tissue-Tek), 
cryosectioned on a microtome into 45 µm slices, placed onto Superfrost Plus Microscope 





immunofluorescence. Tissue slices were rehydrated with room temperature PBS, and the 
tissue slices were placed in individual wells of a 48-well plate using forceps. Tissue slices 
were then washed with agitation three times with 1X PBS, and then blocked and 
permeabilized with 0.3% Triton X-100 + 5% goat serum (Gibco) in PBS for 1 h at room 
temperature. Slices were then incubated with anti-Ap-NF-κB antibody (Mansfield et al., 
2017) (1:5000) diluted in PBS containing 0.3% Triton X-100 plus 5% goat serum for an 
overnight period at 4°C in a humidified chamber, with rotation. Slides were then washed 
with agitation three times in PBS containing 0.3% Triton X-100, and were incubated with 
secondary antibody (goat-anti-rabbit Alexa Fluor 488 (1:500) diluted in 5% goat 
serum/0.3% Triton X-100 in PBS. Slices were then washed three times with PBS/0.3% 
Triton X-100, and on the last wash Hoechst (1:5000 of 20 µM) was added for 10 min. 
Slices were then washed three more times with PBS/0.3% Triton X-100, and then 
mounted onto Superfrost Plus Microscope Slides (Fisher Scientific) with Prolong Gold 
(Molecular Probes by Life Technologies) with coverslips. Samples were imaged on a 
confocal microscope (Nikon C2 Si).  
 
2.12.3  Indirect immunofluorescence of Capsaspora owczarzaki cells 
Coverslips were treated by pipetting approximately 500 μl of Poly-L-lysine 
(Sigma P4707-50mL) onto coverslips and placing in 37°C incubator for 2 h or overnight. 
Lysine was washed from coverslips three times with PBS. Coverslips were then placed in 
35-mm tissue culture dish and UV sterilized by putting each coverslip in the open dish 
for about 40-45 min in the tissue culture hood. Approximately 24-30 h after fluid 





treated coverslips. Cells were allowed to grow another 24 h and then subjected to indirect 
immunofluorescence exactly like tissue culture cells (described in this chapter), except 
cells were fixed using 4% paraformaldehyde.   
 
2.13  Treatment with LPS  
2.13.1  Treatment of Orbicella faveolata tissue with LPS 
Collected O. faveolata were exposed to lipopolysaccharide (LPS) from 
Escherichia coli 0127:B8 (Sigma) at a final concentration of 10 μg/ml for 30 min, and 
samples were then aerated with seawater for 4 h before being removed and frozen in 
liquid nitrogen. Samples were lysed in a 50 mM Tris-base, pH 7.8, with 0.05 mM 
dithiothreitol, and then RNA was extracted, made into cDNA, and sequenced.  
2.13.2  Treatment of Cliona sp. tissue with LPS 
Black encrusting sponge tissue of approximately 1 cm x 1 cm was obtained from 
the Boston University Marine Program lab by collecting tissue off a rock substrate, 
transferring it immediately into a glass dish with ASW, and allowing it to acclimate at 
25°C with light provided by Sylvania Gro-Lux (GRO/Aq/RP) fluorescent bulbs at 
approximately 20 μmol photons/m2/sec for 1 h. The sample was then cut in half with an 
70% ethanol- cleaned razor and each piece was placed into a 6-well plate with 10 ml of 
ASW and lipopolysaccharide (LPS) from Escherichia coli 0111:B4 (Sigma) at a final 
concentration of 5 μg/ml (or an equal volume of sterile distilled H2O, in which the LPS 
was dissolved). The LPS or water was applied directly above the surface of the tissue, 





placed into AT buffer and lysed as described above, before being subjected to Western 
blotting or EMSA.  
 
2.14  Immunoprecipitations 
HEK 293T cells were transfected with MYC-As-NF-κB2 and either a pcDNA 
FLAG empty vector, FLAG-As-NF-κB1, or FLAG-As-NF-κB3 as above (See 
“Vertebrate cell culture and transfection”). Lysates were prepared 48 h later and were 
incubated with 50 μl of a 1X PBS-washed anti-FLAG bead slurry (Sigma) overnight at 4 
°C with gentle rocking. The next day, the beads were washed three times with 1X PBS. 
The pellet was then boiled in 2X SDS sample buffer, and the supernatant was 
electrophoresed on a 7.5% SDS-polyacrylamide gel, as above (see “Western blotting”). 
The membrane was then probed with a rabbit anti-MYC (Cell Signaling Technologies, 
1:1000) antiserum, then with anti-rabbit horseradish peroxidase-linked secondary 
antiserum (1: 4000, Cell Signaling Technology), and reacted with SuperSignal West Dura 
substrate (Pierce). An image was then obtained on a Sapphire Biomolecular Imager 
(Azure Biosystems). The membrane was stripped and probed with rabbit anti-FLAG 
antiserum as above. These same transfection and IP experiments were repeated with 
MYC-As-NF-κB3 and either pcDNA FLAG empty vector, FLAG-As-NF-κB1, or FLAG-
As-NF-κB2. 
 
2.15  Cliona sp. taxon identification by CO1 gene analysis 





Total RNA Isolation Kit (ThermoFisher) protocol for extracting total nucleic acid. Total 
genomic DNA was assessed on an agarose gel. To sequence the mitochondrial 
cytochrome oxidase subunit 1 (CO1) gene, we used CO1 degenerate primers (see Table 
S2) and the PCR conditions from Vargas et al. (2012) with slight modifications. Briefly, 
we used standard three-step PCR conditions with an initial denaturation step of 3 min at 
94 °C, followed by 35 cycles of 30 s at 94 °C, 30 s at 40 °C, and 1 min at 72 °C, and a 
final extension step of 5 min at 72 °C. PCR products were visualized on 1.7% agarose 
gels and then purified with the Qiagen MinElute PCR purification kit (Qiagen). Purified 
PCR products were sent for Next-Generation Sequencing using the Complete Amplicon 
Sequencing method at the Massachusetts General Hospital Center for Computational & 
Integrative Biology DNA Core (https://dnacore.mgh.harvard.edu/new-cgi-
bin/site/pages/index.jsp). To identify poriferan sequences, the sequencing results were 
compared by BLAST analysis to the NCBI database. 
 
2.16  Capsaspora owczarzaki RNA-seq analysis 
RNA-sequencing data from each life stage of Capsaspora was obtained from 
Sebé-Pedrós et al. (2013). To identify potential target genes of NF-κB, we sorted all 
sequencing data with genes that were differentially expressed in the same manner as NF-
κB for each life stage (lowest expression in aggregative, medium expression in filopodic, 
highest expression in cystic). We discarded genes if they were not expressed at a given 
life stage (i.e., had an RPKM of 0). Of the 8674 total genes, 1348 genes were 





had annotated homologs, and 305 had human homologs (Table 5.2). We then performed 
GO analysis (http://pantherdb.org) by entering the UniProt ID of each gene and selecting 
Homo sapiens. We then created and analyzed the Biological Processes that were present 
in this gene list.  
To identify genes with potential upstream NF-κB binding sites among these 1348 
genes, we also extracted the 500 base pair sequence upstream of each gene. We then 
imported these 1348 upstream regions into MEME-FIMO and scanned the sequences for 
NF-κB motifs (but not Rel motifs) extracted from JASPAR (http://jaspar.genereg.net) 





Table 2.1 Oligonucleotides used in this thesis 
Primers used for subcloning 
Primer 



















































































































RHD-1  5’-GGTACCATGGACTACAAGGACG -3' 
F-Gib-
Cterm-2 5’- CCGTTTTCACGACCCCACCAGAATC -3’ 
R-Gib-












































































5’- TCGAGAGGTCGGGGAATTCCCCCCCCG -3’  
  5’- TCGACGGGGGGGGAATTCCCCGACCTC -3’ 
  
  










Table 2.2 Plasmids used in this thesis  
 
Plasmid Name Plasmid Description 
pcDNA-FLAG pcDNA with a 5’ FLAG Tag (Sullivan et al., 2009). 
pcDNA-FLAG-Nv-NF-κB Wolenski et al., 2011 
pcDNA-FLAG-Aq-NF-κB 
BamHI-BamHI fragment containing amino acids 
2-1096 of Aq-NF-κB was PCR-amplified from 
pMD5-Aq-NF-κB and subcloned into Bam HI-
digested pcDNA-FLAG (Mansfield et al., 2017).  
pcDNA-FLAG-Aq-NF-κB-ALA 
EcoRV-Aq-NF-κB-1037-1082-ALA and Aq-NF-
κB-1066-1096-ALA-NotI PCR fragments were 
used as a template for assembly PCR of an 
EcoRV-NotI fragment containing full-length 
pcDNA-FLAG-Aq-NF-κB. Primers used for 




BamHI-PstI digested pcDNA-FLAG-Aq-NF-κB 
PCR product containing codons 2-511 and PstI-
BamHI digested pcDNA-FLAG-Aq-NF-κB 
product containing codons 681-1096 were used as 
a template for assembly PCR of the two PCR 
products. Primers used for amplification were 
pcDNA-FLAG-Aq-RHD-F, pcDNA-FLAG-Aq-
Cterm-R, Aq-NF-κB-DEL-F, Aq-NF-κB-DEL-R 
pcDNA-FLAG-Aq-NF-κB-ΔALA 
BamHI-PstI digested pcDNA-FLAG-Aq-NF-κB-
ALA PCR product containing codons 2-511 and 
PstI-BamHI digested pcDNA-FLAG-Aq-NF-κB-
ALA product containing codons 681-1096 were 
used as a template for assembly PCR of the two 
PCR products. Primers used for amplification 
were Aq-NF-κB-ALA-F-1, Aq-NF-κB-ALA-F-2, 
Aq-NF-κB-ALA-R-3, Aq-NF-κB-ALA-R-4. 
pcDNA-FLAG-Aq-RHD 
BamHI-XhoI digested Aq-RHD PCR product 
containing codons 2-452 was subcloned into 
BamHI-XhoI digested pcDNA-FLAG. Primers: 
pcDNA-FLAG-Aq-RHD-F and pcDNA-FLAG-







EcoRI-BamHI digested Aq-Cterm PCR product 
containing codons 442-1095 was subcloned into 
EcoRI-BamHI digested pcDNA-FLAG. Primers: 
pcDNA-FLAG-Aq-Cterm-F and pcDNA-FLAG-
Aq-Cterm-R. PCR- amplified from pcDNA-
FLAG-Aq-NF-κB.  
pcDNA-FLAG-Ap-IKK Mansfield et al., 2017 
pcDNA-FLAG-Aq-TBK 
BamHI-BamHI fragment containing Aq-TBK 
(codons 2-759) was excised from pUC57-Aq-
TBK and subcloned into BamHI digested 
pcDNA-FLAG. The cloned vector was then cut 
with HindIII to ensure correct orientation into 
pcDNA-FLAG vector. 
HA-IKKβ-SS-EE Starczynowski et al., 2007 
pUC57-Aq-TBK 
pUC57-Simple with Aq-TBK cDNA codon-
optimized for expression in human cells. Has a 5’ 
BamHI site and 3’ BamHI site for excision. 
Synthesized by GenScript.  
pGBT9 Wolenski et al., 2011 
pGB-Nv-NF-κB Wolenski et al., 2011 
pGB-Aq-RHD 
BamHI-XhoI digested Aq-RHD PCR product 
containing codons 2-452 was subcloned into 
BamHI-XhoI digested pGBT9. Primers: GB-Aq-
RHD-F and GB-Aq-RHD-R. PCR-amplified from 
pcDNA-FLAG-Aq-NF-κB.  
pGB-Aq-Cterm 
EcoRI-BamHI digested Aq-Cterm PCR product 
containing codons 442-1095 was subcloned into 
EcoRI-BamHI digested pGBT9. Primers: GB-Aq-
Cterm-F and GB-Aq-Cterm-R. PCR- amplified 
from pcDNA-FLAG-Aq-NF-κB.  
pcDNA-FLAG-Aq-NF-κB-
Aiptasia serine mutant 
EcoRV-Aq-NF-κB-1037-1082-SER and Aq-NF-
κB-1066-1096-SER-NotI PCR fragments were 
used as a template for assembly PCR of an 
EcoRV-NotI fragment containing full-length 
pcDNA-FLAG-Ap-NF-κB. Primers used for 
amplification were Aq-NF-κB-ALA-F-1, Aq-NF-
κB-SER-F-2, Aq-NF-κB-SER-R-3, Aq-NF-κB-
ALA-R-4. 






EcoRI-XhoI fragment containing Aq-NF-κB 
codons 1048-1086 was subcloned into EcoRI-
XhoI digested pGEX-KG. Primers GST-Aq-NF-
κB-Cterm-F and GST-Aq-NF-κB-Cterm-R were 
used to PCR amplify the fragment from pcDNA-
FLAG-Aq-NF-κB. 
pGEX-KG-Aq-Cterm-ALA 
EcoRI-XhoI fragment containing Aq-NF-κB-
ALA codons 1048-1086 was subcloned into 
EcoRI-XhoI digested pGEX-KG. Primers GST-
Aq-NF-κB-Cterm-F and GST-Aq-NF-κB-Cterm-
R were used to PCR- amplify the fragment from 
pcDNA-FLAG-Aq-NF-κB-ALA. 
pcDNA-FLAG-Co-NF-κB 
EcoRI-XhoI fragment containing amino acids 2-
1224 of Co-NF-κB was excised from pUC57-Co-
NF-κB and subcloned into EcoRI-XhoI digested 
pcDNA-FLAG.  
pcDNA-FLAG-Co-NF-κB-ALA 
Gibson primers were used to amplify off pcDNA 
FLAG-Co-NF-κB and pcDNA FLAG Aiptasia 
NF-κB-AAA (Mansfield et al., 2017) to create 
three fragments which were assembled using the 
Gibson Assembly Cloning Kit (New England 
BioLabs). Primers F-Gib-RHD-1 and R-Gib-
RHD-1 were used to create a fragment that 
contained the FLAG-tag and Co-NF-κB aa 2-889; 
Primers F-Gib-Cterm-2 and R-Gib-Cterm-2 were 
used to create a fragment that contained the C-
terminus of pcDNA FLAG Aiptasia NF-κB-SSS; 
Primers F-Gib-FLAG-3 and R-Gib-FLAG-3 were 
used to create the pcDNA FLAG backbone. 
pcDNA-FLAG-Co-NF-κB-SER 
Gibson primers were used to amplify off pcDNA 
FLAG-Co-NF-κB and pcDNA FLAG Aiptasia 
NF-κB (Mansfield et al., 2017) to create three 
fragments which were assembled using the 
Gibson Assembly Cloning Kit (New England 
BioLabs). Primers F-Gib-RHD-1 and R-Gib-
RHD-1 were used to create a fragment that 
contained the FLAG-tag and Co-NF-κB aa 2-889; 
Primers F-Gib-Cterm-2 and R-Gib-Cterm-2 were 
used to create a fragment that contained the C-
terminus of pcDNA FLAG Aiptasia NF-κB; 
Primers F-Gib-FLAG-3 and R-Gib-FLAG-3 were 






EcoRI-XhoI digested Co-RHD PCR product 
containing aa 2-582 was subcloned into EcoRI-
XhoI digested pcDNA-FLAG. Primers: F-FLAG-
Co-NF-κB and R-FLAG-Co-RHD. PCR-
amplified from pcDNA-FLAG-Co-NF-κB.  
pcDNA-FLAG-Co-Cterm 
EcoRI-XhoI digested Co-Cterm PCR product 
containing aa 542-1224 was subcloned into 
EcoRI-XhoI digested pcDNA-FLAG. Primers: F-
FLAG-Co-ANK and R-FLAG-Co-NF-κB. PCR-
amplified from pcDNA-FLAG-Co-NF-κB.  
pUC57-Co-NF-κB 
pUC57-Simple with Co-NF-κB cDNA codon-
optimized for expression in human cells. Has a 5’ 
EcoRI site and 3’ XhoI site for excision. 
Synthesized by GenScript.  
pcDNA-FLAG-Ap-IKK Mansfield et al., 2017 
pcDNA-FLAG-IKKβ-SS-EE Mansfield et al., 2017 
HA-NIK Mansfield et al., 2017 
pGB-Co-NF-κB  
EcoRI-XhoI digested Co-NF-κB PCR product 
containing codons 2-1224 was subcloned into 
EcoRI-SalI digested pGBT9 vector. Primers: F-
GBT9-Co-NF-κB and R-GBT9-Co-NF-κB. PCR-
amplified from pcDNA-FLAG-Co-NF-κB.  
pGB-Co-RHD 
EcoRI-XhoI digested Co-RHD PCR product 
containing codons 2-582 was subcloned into 
EcoRI-SalI digested pGBT9 vector. Primers: F-
GBT9-Co-NF-κB and R-GBT9-Co-RHD. PCR-
amplified from pcDNA-FLAG-Co-NF-κB.  
pGB-Co-Cterm 
EcoRI-XhoI digested Co-Cterm PCR product 
containing codons 542-1224 was subcloned into 
EcoRI-SalI digested pGBT9 vector. Primers: F-
GBT9-Co-Cterm and R-GBT9-Aq-NF-κB. PCR-
amplified from pcDNA-FLAG-Co-NF-κB.  
pUC57-As-NF-κB1 
pUC57-Simple with As-NF-κB1 cDNA codon-
optimized for expression in human cells. Has a 5’ 
BamHI site and 3’ BamHI site for excision. 
Synthesized by GenScript.  
pUC57-As-NF-κB2 
pUC57-Simple with As-NF-κB2 cDNA codon-
optimized for expression in human cells. Has a 5’ 
EcoRI site and 3’ EcoRI site for excision. 
Synthesized by GenScript.  





EcoRI site and 3’ EcoRI site for excision. 
Synthesized by GenScript.  
pcDNA FLAG-As-NF-κB1 
BamHI-BamHI fragment containing amino acids 
2-409 of As-NF-κB1 was excised from pUC57-
As-NF-κB1 and subcloned into BamHI-digested 
pcDNA-FLAG.  
pcDNA FLAG-As-NF-κB2 
EcoRI-EcoRI fragment containing amino acids 2-
502 of As-NF-κB2 was excised from pUC57-As-
NF-κB2 and subcloned into EcoRI-digested 
pcDNA-FLAG.  
pcDNA FLAG-As-NF-κB3 
EcoRI-EcoRI fragment containing amino acids 2-
412 of Co-NF-κB was excised from pUC57-As-
NF-κB3 and subcloned into EcoRI-digested 
pcDNA-FLAG.  
pGB-As-NF-κB1 
EcoRI-SalI digested As-NF-κB1 PCR product 
containing codons 2-409 was subcloned into 
EcoRI-SalI digested pGBT9 vector. Primers: F-
GBT9-As-NF-κB1-EcoRI and R-GBT9-As-NF-
κB1-SalI. PCR- amplified from pcDNA-FLAG-
As-NF-κB1.  
pGB-As-NF-κB2 
EcoRI-SalI digested As-NF-κB2 PCR product 
containing codons 2-502 was subcloned into 
EcoRI-SalI digested pGBT9 vector. Primers: F-
GBT9-As-NF-κB2-EcoRI and R-GBT9-As-NF-
κB2-SalI. PCR- amplified from pcDNA-FLAG-
As-NF-κB2.  
pGB-As-NF-κB3 
EcoRI-SalI digested As-NF-κB3 PCR product 
containing codons 2-412 was subcloned into 
EcoRI-SalI digested pGBT9 vector. Primers: F-
GBT9-As-NF-κB3-EcoRI and R-GBT9-As-NF-
κB3-SalI. PCR- amplified from pcDNA-FLAG-
As-NF-κB3.  
pcDNA MYC vector Wolenski et al., 2011 
pMYC-As-NF-κB2 
EcoRI-XbaI fragment containing amino acids 2-
502 of As-NF-κB2 was PCR-amplified from 
pcDNA FLAG-As-NF-κB2 using primers F-
MYC-As-NF-κB2-EcoRI and R-MYC-As-NF-
κB2-XbaI and subcloned into EcoRI-XbaI 
digested pcDNA-MYC vector. 





pcDNA FLAG-As-NF-κB3 and subcloned into 
EcoRI-XbaI digested pcDNA-MYC vector. 
pcDNA-FLAG-Of-NF-κB EcoRI-NotI fragment containing full-length Of-
NF-κB was excised from pUC57-Of-NF-κB and 
subcloned into EcoRI-NotI digested pcDNA-
FLAG.  
pcDNA-FLAG-Of-NF-κB-3X-Ala SgrAI-Of-NF-κB-1434-2607-3X-Ser-Ala and Of-
NF-κB- 2581-2763-3x-Ser-Ala-NotI PCR 
fragments were used as a template for assembly 
PCR of an SgrAI-NotI fragment containing full-
length Ap-NF-κB-3x-Ser-Ala. Primers used for 
amplification were Of-NF-κB-3X-Ala-F-1, Of-
NF-κB-3X-Ala-F-2, Of-NF-κB-3X-Ala-R-3, Of-
NF-κB-3X-Ala-R-4. 
pcDNA-FLAG-Of-RHD EcoRI-NotI digested Of-RHD PCR product 
containing codons 2-425 was subcloned into 
EcoRI-NotI digested pcDNA-FLAG. Primers: 
pcDNA-FLAG-Of-RHD-F and pcDNA-FLAG-
Of-RHD-R. PCR- amplified from pUC57-Of-NF-
κB.  
pcDNA-FLAG-Of-Cterm EcoRI-NotI digested Of-Cterm PCR product 
containing codons 389-920 was subcloned into 
EcoRI-NotI digested pcDNA-FLAG. Primers: 
pcDNA-FLAG-Of-Cterm-F and pcDNA-FLAG-
Of-Cterm-R. PCR-amplified from pUC57-Of-
NF-κB.  
pcDNA-FLAG-IKKα Starczynowski et al., 2007  
pcDNA-FLAG-IKKβ Starczynowski et al., 2007 
pcDNA-FLAG-Of-IKK BamHI fragment containing Of-IKK (codons 2-
728) was excised from pUC57-Of-IKK and 
subcloned into BamHI digested pcDNA-FLAG. 
The cloned vector was then cute with BamHI and 
EcoRI to ensure correct orientation into pcDNA-
FLAG vector. 
pUC57-Of-IKK pUC57-Simple with Of-IKK cDNA codon-
optimized for expression in human cells. Has a 5’ 
BamHI site and 3’ BamHI site for excision. 
Synthesized by GenScript.  
pUC57-Of-NF-κB pUC57-Simple with Of-NF-κB cDNA codon-
optimized for expression in human cells. Has a 5’ 
EcoRI site and 3’ NotI site for excision. 





pUC57-Of-TLR pUC57-Simple with Of-TLR cDNA codon-
optimized for expression in human cells. Has a 5’ 
EcoRI site and 3’ EcoRI site for excision. 
Synthesized by GenScript. 
pGB-Of-RHD EcoRI-SalI digested Of-RHD PCR product 
containing codons 2-425 was subcloned into 
EcoRI-SalI digested pGBT9. Primers: GB-Of-
RHD-F and GB-Of-RHD-R. PCR- amplified 
from pUC57-Of-NF-κB.  
pGB-Of-Cterm EcoRI-SalI digested Of-Cterm PCR product 
containing codons 389-920 was subcloned into 
EcoRI-SalI digested pGBT9. Primers: GB-Of-
Cterm-F and GB-Of-Cterm-R. PCR-amplified 
from pUC57-Of-NF-κB.  
pGEX-KG Expression plasmid containing a 5' GST tag. 
pGEX-KG-Of-NF-κB-Cterm EcoRI-XhoI fragment containing Of-NF-κB 
codons 843-874 was subcloned into EcoRI-XhoI 
digested pGEX-KG. Primers Of-NF-κB-F-C-term 
and Of-NF-κB-R-C-term were used to PCR- 




EcoRI-XhoI fragment containing Of-NF-κB-3X-
Ala codons 843-874 was subcloned into EcoRI-
XhoI digested pGEX-KG. Primers Of-NF-κB-F-
C-term and Of-NF-κB-R-C-term were used to 
PCR-amplify the fragment from pcDNA-FLAG-
Of-NF-κB-3X-Ala.  
pGEX-KG-Of-TIR EcoRI-XhoI fragment containing the predicted 
intermembrane and TIR domain of Of-TLR were 
subcloned into EcoRI-XhoI digested pGEX-KG. 
Primers Of-TLR-F-TIR and Of-TLR-R-TIR were 






Table 2.3 Vertebrate cell lines used in this thesis 
Cell line Description/cell type Culture media 
A293 Human embryonic kidney DMEM-10 
A293T Human embryonic kidney expressing the SV40 
large T-antigen 
DMEM-10 









Table 2.4 Antibodies used in this thesis 




FLAG WB R 1:1000 CST 
#2368 




FLAG IF R 1:50 CST 
#2368 







IF R 1:50 Abcam 
#ab9110 




Ap-NF-κB  WB R 1:1000 Pierce 
(Custom) 







IF  R 1:50 Peirce  
(Custom) 




MYC-Tag WB M 1:1000 CST 
#2276 





488-α-R IF G 1:160 TF 
#A11008 








IF G 1:80 TF 
#A11008 






WB G 1:4000 CST 
#7074S 






WB H 1:3000 CST 
#7076S 




Table is adapted from Wolenski (2012).  
1Antisera conjugations: FITC, fluorescein isothiocyanate; 488, Alexa fluor 488; TR, 
Texas red; HRP, horseradish peroxidase.  






3Antibody host animal: G, goat; GP, guinea pig; H, horse; M, mouse; R, Rabbit.  
4Antibody source: CST, Cell Signaling Technology; TF, ThermoFisher; VL, Vector Labs. 
Corresponding catalog number is listed below company number, except for custom 
antibodies Ap-NF-κB (Mansfield et al., 2017). 
5Blocking buffer used to block nitrocellulose membrane or cells/tissues and dilute 
primary and secondary antisera. TBS, Tris-buffered saline; PBS, phosphate-buffered 
saline; BSA, bovine serum albumen; NGS, normal goat serum; Tw, Tween-20; Tx, 
Triton-X-100. All concentrations are measured in v/v except for milk and BSA (w/v).  
6Duration of primary antisera incubation: h, hours; RT, room temperature. Blocking was 















Table 2.5 TLR TIR Domain sequences for Chapter 3 phylogenetic analysis. 
 
Taxa: protein Full-length TLR sequence with TIR domain in bold



















Supplemental Table 1 













































































































































































































































































Full-length amino acid sequences of TLR proteins from the organisms used for MEME 
analysis to identify the conserved motifs. TLR sequences from Orbicella faveolata was 
obtained from the NCBI database; Amphimedon queenslandica TLR was obtained from 
(Gauthier et al., 2010); and Nematostella vectensis Drosophila, and Homo sapiens TLRs 
were obtained from UniProt database. All sequences were truncated to their predicted (or 












































domains were based on MEME predictions and by comparison to known Homo sapiens 
TIR domains. The truncated and culled TIR sequence dataset allowed Clustal Omega to 
successfully align TIR sequences to be input into PAUP* for neighbor-joining 











Taxa: protein Full-lenth NF-κB with truncated RHD domain in bold




















































































































































































































































































































Full-length amino acid sequences of NF-κB proteins from the organisms used as input for 
MEME analysis to identify conserved motifs. NF-κB sequences for Orbicella faveolata 
and Actinia tenebrosa were obtained through a BLASTp on NCBI using Aiptasia pallida 
NF-κB (from NCBI); Capsaspora owczarzaki and Nematostella vectensis NF-κB, Homo 
sapiens p100, p105, RelA, RelB, c-Rel, and Drosophila Relish, Dorsal, and Dif were 
obtained from UniProt database. All sequences were truncated to the Rel Homology 
Domain using MEME analysis and are shown in bold. The start of the RHD was highly 
conserved in all taxa and was predicted using the start of the known Homo sapiens RHD 
for both the NF-κB and Rel proteins. The end of the RHD was highly conserved in all 
taxa and was predicted by using the MEME identified motif immediately before the 
predicted glycine-rich region. The trimmed and culled RHD sequence dataset allowed 
Clustal Omega to successfully align RHD sequences to be input into PAUP* for 






Table 2.7 NF-κB Rel Homology Domain sequences for Chapter 4 phylogenetic 
analysis. 




































































































































































































































































































































































































































































Full-length amino acid sequences of NF-κB proteins from the organisms used as input for 
MEME analysis to identify conserved motifs. NF-κB sequences from A. queenslandica 
(Aq) (Gauthier and Degnan, 2008) were compared phylogenetically to Aiptasia pallida 
(Ap) NF-κB (AIPGENE8848) from the ReefGenomics database, Orbicella faveolata NF-
κB (Williams et al., 2018), and N. vectensis (Nv), Drosophila Dif, Dorsal, and Relish, 
and Homo sapiens and Mouse p100, p105, RelA, RelB, and c-Rel from the UniProt 
database. Carcinoscorpius rotundicauda (Horseshoe crab) Relish, and Danio rerio, 
Xenopus laevis, and Strongylocentrotus purpuratus NF-κBs were from NCBI (Accession 
numbers: ABC75034.1, NP_001001840.2, NP_001081181.1, and NP_999819.1, 
respectively). All sequences were truncated to the Rel Homology Domain using MEME 
analysis and are shown in bold. The start of the RHD was highly conserved in all taxa 
and was predicted using the start of the known Homo sapiens RHD for both the NF-κB 
and Rel proteins. The end of the RHD was highly conserved in all taxa and was predicted 
by using the MEME identified motif immediately before the predicted glycine-rich 
region. The trimmed and culled RHD sequence dataset allowed Clustal Omega to 
successfully align RHD sequences to be input into PAUP* for 






Table 2.8 Organisms RHD sequences used for Chapter 5 phylogenetic analysis. 

































































































































































































































































































Amino acid sequences of NF-κB-like proteins from the organisms used as input for 
MEME analysis to identify conserved motifs. The species used (first column), predicted 
RHD sequences from these organisms from MEME analysis (middle column), and where 
the sequence came from (last column) are shown.The trimmed and culled RHD sequence 
dataset allowed Clustal Omega to successfully align RHD sequences to be input into 







THE ENDANGERED CORAL ORBICELLA FAVEOLATA HAS A CONSERVED 
TOLL-LIKE RECEPTOR-TO-NF-κB SIGNALING PATHWAY 3 
3.1 Introduction  
The Toll-Like Receptor (TLR)-to-NF-κB signaling pathway is a prominent innate 
immune pathway in higher metazoans. Specific pathogen-associated molecular patterns 
(PAMPs) are detected by membrane-bound TLRs, which then initiate intracellular 
signaling cascades. One main TLR pathway leads to activation of transcription factor NF-
κB to induce changes in the expression of genes encoding innate immune effector 
molecules such as cytokines and anti-microbial peptides, (Akira et al., 2006; Kawai and 
Akira, 2007). TLR-to-NF-κB pathways have been intensively studied for their roles in 
immunity in many model systems from flies to humans (Aderem and Ulevitch, 2000; 
Silverman and Maniatis, 2001; Vasselon and Detmers, 2002; Minakhina and Steward, 
2006; Kawai and Akira, 2007). Recently, genome and transcriptome sequencing has 
revealed that many basal metazoans and some pre-metazoans also have homologs of the 
TLR-to-NF-κB pathway (Gilmore and Wolenski, 2012). However, the biological roles of 
TLR and NF-κB in these basal organisms are not well understood (Bosch et al., 2009).  
In mammals, TLRs are single-pass transmembrane proteins with an N-terminal 
extracellular leucine-rich repeat domain (LRR), a central transmembrane domain (TM), 
and a C-terminal intracellular Toll/interleukin-1 receptor (TIR) domain. Ligand 
 





recognition by the LRR domain promotes engagement of the intracellular TIR domain 
with other TIR domain-containing adapter proteins, which initiates downstream signaling 
cascades (Kawai and Akira, 2007). These adapter proteins include myeloid differentiation 
primary response protein 88 (MYD88), TIR domain-containing adapter protein 
(TIRAP/MAL), TIR domain-containing adapter inducing IFNβ (TRIF), and Trif-related 
adapter protein (TRAM) (Aderem and Ulevitch, 2000; Kawai and Akira, 2007). The 
number of TLRs varies widely among organisms, with ten TLRs in humans, 13 in mice, 
nine in fruit flies, and over 200 in sea urchins (Vasselon and Detmers, 2002; Valanne et 
al., 2011; Buckley and Rast, 2012). In more basal organisms, such as sponges and 
cnidarians (which include hydras, jellyfish, sea anemones, and corals), there are two 
types of TLR-like proteins. Most often, these basal TLR-like proteins contain only a TM 
domain and a TIR domain; however, some basal animals have genes encoding full-length 
TLRs with LRR, TM, and TIR domains, similar to mammalian TLRs. Within the phylum 
Cnidaria, there are animals having no complete TLRs (Aiptasia pallida, Hydra vulgaris), 
ones having one complete TLR (Nematostella vectensis), and ones having multiple 
complete TLR and TLR-like proteins (Acropora digitifera) (Miller et al., 2007; Shinzato 
et al., 2011; Poole and Weis, 2014).   
In insects and mammals, the NF-κB superfamily comprises multiple related 
transcription factors that bind distinct DNA sequences known as κB sites (Hayden and 
Ghosh, 2004). Based on DNA binding-site preference and sequence similarity, the NF-κB 
RHDs are more related to each other than to the RHDs of Rel proteins (Siggers et al., 





cnidarians, sponges, pre-metazoans) have single NF-κB family proteins, which are 
phylogenetically most similar to the vertebrate and insect NF-κB subclass (Finnerty and 
Gilmore, 2015). In the mammalian non-canonical NF-κB signaling pathway, IκB kinase 
(IKK)-mediated phosphorylation of p100 at three serine residues located C-terminal to 
the ANK repeats promotes its processing to p52 by the proteasome (Sun, 2011). On the 
other hand, the Drosophila melanogaster NF-κB protein Relish is activated by a discrete 
caspase-mediated proteolytic event that removes the C-terminal ANK repeat domain 
(Stöven et al., 2003; Valanne et al., 2011). Overall, it is not known how NF-κB proteins 
are regulated and activated in organisms basal to Drosophila.  
The mountainous star coral Orbicella faveolata (Of), previously known as 
Montastraea faveolata, is an endangered reef-building coral found in the Caribbean Sea 
and the Gulf of Mexico. O. faveolata forms a symbiotic relationship with a dinoflagellate 
of the genus Symbiodinium (Steele et al., 2011; Davy et al., 2012). Like most reef-
building corals, O. faveolata is susceptible to an environmentally induced loss of 
symbiosis, commonly referred to as “bleaching” because this process gives the coral 
tissue a white appearance (Gleason and Wellington, 1993; Brown, 1997; Hoegh-
Guldberg et al., 2007; Hughes et al., 2017; Weis, 2008). Bleaching often causes coral 
death, but in some cases, corals can recover from a bleaching event and re-establish a 
symbiotic relationship with Symbiodinium. Nevertheless, recovered corals often show 
increased susceptibility to microbial diseases such as yellow band disease, black band 
disease, and plague (Kushmaro et al., 1996; Pinzón et al., 2015).  





bleached and pathogen-infected corals have suggested that the cnidarian innate immune 
system plays a role in coral diseases (Pinzón et al., 2015; Anderson et al., 2016; Fuess et 
al., 2016, 2017; Zhou et al., 2017). To gain deeper insights into molecular processes 
important for coral immunity and health, we have had an ongoing interest in 
characterizing cnidarian homologs of mammalian immunoregulatory molecules and 
pathways (Wolenski et al., 2011, 2013). In this chapter, we use phylogenetic, 
biochemical, and cell-based assays to characterize the structure, activity, and regulation 
of TLR and NF-κB proteins from O. faveolata. We also show that lipopolysaccharide 
(LPS) treatment of O. faveolata tissue can induce a gene expression profile consistent 
with induction of the NF-κB pathway. These results represent the first characterization of 
proteins in the conserved immunoregulatory TLR-to-NF-κB pathway of a critically 
endangered coral.  
 
3.2 Conservation of Toll-like Receptor (TLR) pathway in Orbicella faveolata 
To determine whether proteins in the vertebrate TLR-to-NF-κB innate immune 
pathway (Silverman and Maniatis, 2001) are present in the coral O. faveolata, we 
scanned transcriptomic data (Pinzón et al., 2015). Homologous transcripts of many of the 
receptor and downstream signaling components of the mammalian TLR pathway were 
present in O. faveolata (Figure 3.1). Nevertheless, in many cases, there were reduced 
numbers of signaling components in each family (Table 3.1). For example, there are five 
NF-κB/Rel proteins in humans, but there was a single NF-κB-like protein in O. faveolata. 





single predicted full-length TLR (Figure 3.2) and four TLR-like proteins containing only 
TM and TIR domains. 
 
3.3 A predicted TLR-to-NF-κB pathway in Orbicella faveolata 
From transcriptomic analysis, the single full-length Of-TLR is predicted to 
contain bona fide LRR, TM, and TIR domains. By phylogenetic analysis using the 
neighbor-joining method, the TIR domain of Of-TLR was most closely related to the TIR 
domains of the single characterized N. vectensis (Nv) TLR (Brennan et al., 2017) and to 
the D. melanogaster Toll protein. Among the human TLRs, Of-TLR appeared to be most 
similar to the TIR domain of human TLR4 (Figure 3.3A).  
Since the TIR domain of human TLR4 interacts with the intracellular adapter 
protein MYD88 as an early step in signaling to NF-κB (O’Neill et al., 2003), we sought 
to determine whether the TIR domain of Of-TLR (Of-TIR) could also interact with 
human MYD88. We incubated bacterially expressed GST-Of-TIR with 293 cell extracts 
overexpressing FLAG-MYD88, and then performed a pull-down assay (Figure 3.3B). As 
shown in Figure 3.3C, MYD88 was detected by Western blotting in pull-down fractions 
containing GST-Of-TIR, but MYD88 was not seen with GST alone. As a positive 
control, we showed that MYD88 also interacted with GST-Nv-TIR, which we have 
recently shown can interact with human MYD88 (Brennan et al., 2017). Thus, the 
phylogenetic similarity of Of-TLR and human TLR4 proteins was reinforced functionally 
by Of-TLR’s ability to interact with the human TLR4 adapter protein MYD88. 





determine whether O. faveolata tissue would elicit a response to gram-negative 
lipopolysaccharide (LPS), an activator of the mammalian TLR4-to-NF-κB pathway. 
Therefore, we treated O. faveolata tissue for 30 min with LPS, and followed that 
treatment with a 4-h washout period with seawater. RNA was then extracted from treated 
tissues and subjected to RNA-seq analysis. Ingenuity Pathway Analysis (IPA) of the 
RNA-seq data identified 39 pathways in O. faveolata that were significantly activated (as 
compared to control tissue), and 13 of these pathways had numerical z-scores. Of these 
13 pathways, NF-κB signaling was the most significantly activated pathway (IPA: z-
score = 1.8, p = 0.03) (Fuess et al., 2017). A total of 16 genes in the NF-κB signaling 
pathway were expressed in our samples, resulting in a 9.3E-02 pathway ratio (Table 3.2). 
Among the NF-κB pathway components activated by LPS treatment were the following: 
TLR1- and 2-like proteins; members of the tumor necrosis factor receptor associated 
factor family (TRAF2, 3, 5), which are proteins involved with regulation of the pathway; 
kinases including RIPK1, MAP3K3, and PIK3R4; and the adapter protein MYD88. 
Nearly all genes in the NF-κB signaling pathway were up- or down-regulated in a manner 
that was consistent with activation of the pathway as it known in mammalian systems 
(Table 3.2). 
 
3.4 The structure and phylogenetic analysis of the O. faveolata NF-κB protein 
indicates that it is more similar to mammalian NF-κB proteins than to Rel proteins 
 Because IPA predicted that LPS could activate the NF-κB pathway in O. 





O. faveolata transcriptomic database (Pinzón et al., 2015), we identified transcripts 
encoding a single NF-κB-like protein, but no Rel-like protein. The amino acid sequence 
of the Of-NF-κB protein (Figure 3.4) indicated that it had an overall domain structure that 
was most similar to mammalian NF-κB proteins, i.e., with an N-terminal RHD, followed 
by a glycine-rich region, and then a series of ANK repeats (Figure 3.5A). A maximum-
likelihood analysis of Of-NF-κB also indicated that it was most similar to other 
invertebrate NF-κB proteins, most notably those from sea anemones (N. vectensis, 
Aiptasia sp., and A. tenebrosa) (Figure 3.5B). Moreover, Of-NF-κB clustered with NF-
κB proteins from D. melanogaster (Relish) and humans (p100 and p105), and was 
distinct from the Rel proteins. This result is similar to the clustering of Nv-NF-κB with 
NF-κB proteins, but distinct from Rel proteins, as reported by Sullivan et al. (2007).   
 
3.5 C-terminal truncation of the O. faveolata NF-κB protein is required for 
nuclear localization, DNA binding, and transactivation  
The mammalian NF-κB proteins p100 and p105 require removal of their C-
terminal ANK repeat domain in order to become active transcription factors. Due to the 
structural similarity of Of-NF-κB to human NF-κB p100 and p105, we sought to 
determine whether C-terminal truncation of Of-NF-κB would unveil active transcription 
factor properties. Therefore, we created expression vectors for FLAG-tagged codon-
optimized versions of full-length Of-NF-κB, an N-terminal form (Of-RHD), and a protein 
containing only the C-terminal glycine-rich and ANK repeat domain (Of-Cterm) (Figure 





NF-κB protein (Nv-NF-κB), which we have characterized previously as an active NF-κB 
protein (Wolenski et al., 2011). Each of the Of-NF-κB constructs directed the expression 
of an appropriately sized protein when transfected into HEK 293 cells (Figure 3.6B). 
To determine the subcellular localization of the Of-NF-κB proteins, we 
transfected the plasmids into chicken fibroblasts and later performed anti-FLAG indirect 
immunofluorescence. We found that full-length Of-NF-κB and Of-Cterm were present in 
the cytoplasm of transfected chicken fibroblasts, whereas Of-RHD and the control Nv-
NF-κB protein were both located in the nucleus of these cells (Figure 3.6C).  
We next analyzed the DNA-binding and transactivation properties of the full-
length and truncated Of-NF-κB proteins. To measure DNA-binding activity, 293 cells 
were transfected with the Of-NF-κB expression plasmids, and extracts were analyzed for 
DNA-binding activity by an electrophoretic mobility shift assay (EMSA) using a κB-site 
probe that we have previously shown can be avidly bound by Nv-NF-κB (Wolenski et al., 
2011). Lysates from cells transfected with expression plasmids for Of-RHD and the 
positive control Nv-NF-κB both contained proteins that strongly bound to the κB-site 
probe (Figure 3.6D). In contrast, extracts from cells transfected with the empty vector 
control, Of-NF-κB or Of-Cterm showed only low or background κB-site DNA-binding 
activity (Figure 3.6D). In addition, Of-RHD and Nv-NF-κB both activated transcription 
of an NF-κB-responsive luciferase reporter plasmid when overexpressed in 293 cells as 
compared to empty vector control-transfected cells (Figure 3.6E). As expected, full-
length Of-NF-κB and Of-Cterm did not activate the reporter above vector control levels 





repeat domain sequences of Of-NF-κB enabled the protein to enter the nucleus, bind to 
DNA, and activate transcription in vertebrate cells.  
To further demonstrate that Of-NF-κB was a functional transcriptional activator, 
we assessed its ability to activate transcription in yeast, which do not have endogenous 
NF-κB proteins. To accomplish this, we fused the Of-RHD to the GAL4 DNA-binding 
domain (GAL4-Of-RHD) and expressed this protein in yeast cells, which contain an 
integrated GAL4-site LacZ reporter locus. In these cells, GAL4-Of-RHD activated 
transcription of the GAL4-site reporter substantially (~135-fold) above control (GAL4 
alone) levels. However, the GAL4-Cterm fusion protein did not activate transcription of 
the reporter in yeast (Figure 3.6F). As we have shown previously (Alshanbayeva et al., 
2015; Wolenski et al., 2011), a GAL4-Nv-NF-κB fusion protein strongly (~240-fold) 
activated transcription in yeast as compared to the GAL4 alone control. Therefore, the 
ability of the Of-RHD sequences to activate transcription appeared to be conserved from 
yeast to human cells, and appeared to be an intrinsic property of sequences within the N-
terminal half of the protein. 
 
3.6 C-terminal truncation of Of-NF-κB can be induced by an IKK-dependent 
mechanism in human cells 
Upon activation, the human NF-κB p100 protein is converted to its active p52 
form by proteasomal processing of C-terminal sequences up to the glycine-rich region 
(Sun, 2011). This processing is initiated by IKK-dependent phosphorylation of a cluster 





Of-NF-κB protein contains three serine residues with similar spacing and flanking 
sequences to the IKK target serines in human p100 and in an NF-κB protein from the sea 
anemone A. pallida (Figure 3.7A). In an in vitro kinase assay (Figure 3.7B), a 
constitutively active form of human IKKβ and the predicted Of-IKK protein (Figure 3.8) 
could each phosphorylate a bacterially expressed GST-fusion peptide containing the C-
terminal serine residues of Of-NF-κB (amino acids 843-874); however, neither of these 
IKKs phosphorylated the analogous GST-fusion protein containing alanine substitutions 
for the three serine residues or GST alone (Figure 3.7B).  
To determine whether IKK-dependent phosphorylation could induce processing 
of Of-NF-κB, we transfected human 293T cells with expression vectors for FLAG-Of-
NF-κB and either FLAG-Of-IKK or HA-Hu-IKKβ, which we have recently shown can 
induce processing of the sea anemone A. pallida NF-κB protein in similar experiments 
(Mansfield et al., 2017). As shown in Figure 3.7C, co-transfection of 293T cells with 
FLAG-Of-NF-κB and either FLAG-Of-IKK or HA-Hu-IKKβ resulted in the appearance 
of an Of-NF-κB band of approximately 50 kDa. No such smaller band was seen when the 
Of-NF-κB-3X-Ala mutant was co-transfected with FLAG-Of-IKK or HA-Hu-IKKβ. 
Together, these results indicate that Of-NF-κB can undergo IKK-induced processing in 







3.7 Chapter 3 summary 
The endangered, reef-building coral, O. faveolata expresses homologs to a 
conserved TLR-to-NF-κB signaling pathway. Tissue exposed to LPS, a potent vertebrate 
activator of NF-κB, expresses a gene expression profile consistent with activation of the 
NF-κB pathway. Furthermore, the structure and phylogenetic relationships of Of-TLR 
suggest it is most homologous to Hu-TLR4, and structure and phylogenetic analyses Of-
NF-κB suggest it is most related to the NF-κB proteins rather than the Rel proteins. Pull-
down assays of Of-TIR domain reveal that it can bind MYD88 in vitro. Cellular and 
molecular analyses of Of-NF-κB suggest that it is most homologous to human p100 
protein, in that it requires C-terminal truncation to enter the nucleus, bind DNA, and 
activate transcription, and that this truncation can be induced by IKK-mediated 
processing of conserved C-terminal residues. These results suggest that O. faveolata 














Contig ID in O. faveolata transcriptome 
(Pinzón et al., 2015) 
A20 TLR/TNF + comp268115_c0_seq1  
Akt TNF -   
CD40 TNF -   
cIAP1/2 TNF -   
Cot TNF -   
CYLD TNF + 
comp268162_c0_seq1 
comp268162_c0_seq2 
BR3 TNF -   
ECSIT TLR + comp253068_c0_seq1  
HOIL TNF -   
HOIP TNF -   
IκB𝛼 TLR/TNF -   




IKK𝜸/NEMO TLR/TNF -   
IRAK-1 TLR -   
IRAK-4 TLR -   
IRAK-M TLR -   
ITCH TNF -   
LT𝛃R TNF -   
MyD88 TLR + comp261294_c0_seq1  














NIK TNF + 
comp268939_c0_seq3 
comp268939_c0_seq5 
PDK1 TNF + comp256479_c0_seq1 
PI3K TNF -   




RNF11 TNF + comp263654_c0_seq1  
SHARPIN TNF -   
TAB1 TLR + comp253554_c0_seq1  
TAB2 TNF -   
TAB3 TNF -   
TAK1 TLR -   
TAX1BP1 TNF -   
TIRAP TLR -   
TLR1 TLR + comp265379_c0_seq1  


















TLR4 TLR  + comp267159_c0_seq1 
TLR5 TLR + comp249146_c0_seq2  









TLR11 TLR -   






TOLLIP TLR + comp267143_c1_seq4  
TRADD TNF -   
TRAF2 TNF + comp263023_c0_seq1  





















TRAF5 TNF + comp262923_c1_seq1  































































TRAM TLR -   
TRIF TLR -   
Ubc13 TLR/TNF -   






An overview of human proteins that have homologs based on the O. faveolata 
transcriptome from Pinzón et al. (2015). Listed are contig IDs for each sequence 
matching the corresponding protein, which can be searched in the supplemental material 
from Pinzón et al. (2015). Full reads can be found on the National Center for 






Table 3.2 NF-κB pathway genes differentially expressed following LPS 
treatment on O. faveolata. 







TRAF2 1 2.7 N/A Enzyme Consistent 
RIPK1 1 2.6 N/A Kinase Consistent 
FGFRL1 1 1.8 N/A Transmembrane receptor Consistent 
FGFR4 1 1.4 N/A Kinase Consistent 
TRAF3 8 0.8 0.43 Enzyme Consistent 
TLR2-like 4 0.6 1.00 Transmembrane receptor 
Not 
predicted 
TRAF5 9 0.5 0.30 Transporter Consistent 
FGFR1 3 0.4 0.01 Kinase Consistent 
MAP3K3 3 0.4 0.51 Kinase Consistent 
BMP2 2 0.3 0.87 Growth factor Consistent 
MALT1 3 0.2 0.53 Peptidase Consistent 
IGF2R 1 −0.3 N/A Transmembrane receptor 
Not 
predicted 
TLR1-like 2 −0.6 0.97 Transmembrane receptor 
Not 
predicted 
TDP2 2 −0.7 0.60 Transcription regulator Inconsistent 
MYD88 2 −0.7 0.24 Other Inconsistent 
PIK3R4 2 −1.4 1.08 Kinase Consistent 
 
O. faveolata tissue was exposed to E. coli LPS for 30 min and then returned to seawater 
for 4 h. RNA-seq was performed to identify transcripts whose expression was affected by 
this treatment, and Ingenuity Pathway Analysis was then used to identify pathways 
whose gene expression patterns were significantly changed by LPS treatment. The “NF-
κB pathway” was found to be the most significantly activated pathway overall. Listed are 
16 O. faveolata genes with homologs in the NF-κB pathway whose expression was 
affected by LPS treatment. Average Log2-Fold Change is indicated as well as associated 
error, encoded protein function from IPA analysis (Function), and consistency with 














Figure 3.1 Homologs of proteins in the mammalian Toll-Like Receptor-to-NF-κB 
pathway are present in Orbicella faveolata.  
Transcriptomic data of O. faveolata from Pinzón et al., (2015) were mined and found to 
contain RNAs encoding many receptor and downstream signaling components of the 
mammalian TLR-to-NF-κB pathway. TLR signaling components that are only found in 





in O. faveolata are in yellow. TLR1, 2, 5, and 6 homologs in O. faveolata are TIR 






Original Sequence Codon Optimized Amino Acid Sequence
ATGTTTGTGAAATCACAAACAGCACTAATTCAATCAAATCTACACATCTTGGTCCTTGATCAACGTCACACAGTC
--------T---AGT--G--G--T--T--C--G--T-----G--T---C-------G------A-A--T--T---
M  F  V  K  S  Q  T  A  L  I  Q  S  N  L  H  I  L  V  L  D  Q  R  H  T  V 
CTGCTCGCCACATCTCTTGTGTTCGACACGAAAGGCTCTCTGATTATATTCAGCTGCTTGGTTCTCTTTGCGATC
--CT-G--G--G--A--C--C--T--T-----G--------C--A--C--------------A--T-----A--T
L  L  A  T  S  L  V  F  D  T  K  G  S  L  I  I  F  S  C  L  V  L  F  A  I 
GAGGCTACTGGACAACAACGCAGAAGGTTTCTACACTGCGGTGCATCTTTCTGCCTGTTGAAAAGGTCTATGTCG
-----G--G--C-----G---C--C----CT-G--T--T--C--GAG---T-----C-----GC--AG----AGT
E  A  T  G  Q  Q  R  R  R  F  L  H  C  G  A  S  F  C  L  L  K  R  S  M  S 
TCCTTCTTCGAAACAGGCAATGGTACTCTTATCAAAGAGCAAGCGGTAATATGTGTCTTGAAAAGCGACAAGGTT
--------T--G-----A-----A--C--C--T--G--A-----T--T--C-----AC-C--G--T--T------
S  F  F  E  T  G  N  G  T  L  I  K  E  Q  A  V  I  C  V  L  K  S  D  K  V 
CGCGACCGATGTGTCGTGGACATCAGTCTGATATTGAAAACGATAACAACGCCTCAAGATGTCGTATTGCATTTT
A-G--T--G--C--G--A--T--ATCCT----TC-------C--C--T--A--------C--T---C--------
R  D  R  C  V  V  D  I  S  L  I  L  K  T  I  T  T  P  Q  D  V  V  L  H  F 
GCTGCCGTGTGTTTAACCCCGATGGAAATTGCCTTCTACAACTCTTTAAACGCCACAAAGAAAAACGCCATATTT
--C--A--A-----G--A--C-----G--C--A--T-----T-----G--T--A--------------G------
A  A  V  C  L  T  P  M  E  I  A F  Y  N  S  L  N  A  T  K  K  N  A  I  F 
TACTTGCAAATCAAGGGACACTGCAGCTTTTCAGCCGATGGCATCTCTCACTGGGGAAAAGCTACAGACTTTCGG
--TC-C--G-----------T--TTC---C--C--G--C--G-----C--T-----C--G--C--C-----C---
Y  L  Q  I  K  G  H  C  S  F  S  A  D  G  I  S  H  W  G  K  A  T  D  F  R 
GTTTTCTATCTCATGGAAAACTCGACTTTACTAGAAGGAAATAAAACGCTGGCAAACAACTCTCGTCGAGCATTG
--A--------T--------TAGC---C-T--G--------C--------T--C--T---AG---G-----T---
V  F  Y  L  M  E  N  S  T  L  L  E  G  N  K  T  L  A  N  N  S  R  R  A  L 
GAAAACATTGGCACTCTTATGATAGACAAATCTAAACTACGAACTCTTCCAAAAATGTTTAGTAGTACTAAAGTG
--G-----A--G---T-G-----C--T--GAGC-----T-----A--C--G--G-----CTC-TCC--G--G--C
E  N  I  G  T  L  M  I  D  K  S  K  L  R  T  L  P  K  M  F  S  S  T  K  V 
TGGCCAAGAATGGCCGAGGTAGTATTCTCCAAATTACAACTCACATCGATACCTCCGGAGCTCAATACGACGATG
-----CC-G-----A-----C--C---------C-T--G--G---AGC-----A--C-----T--C--C--T---
W  P  R  M  A  E  V  V  F  S  K  L  Q  L  T  S  I  P  P  E  L  N  T  T  M 
CCGTTCTTGCAGTCGCTTGAGCTTGCTAACAATAAACTAACAACACCACCTCCGTTTCCATGGTGTAAAGCTACG
--C--TC-C-----CT-G-----C--C--T--C--G--C--C--T--G--A--A-----------C--G------
P  F  L  Q  S  L  E  L  A  N  N  K  L  T  T  P  P  P  F  P  W  C  K  A  T 
CTCAAACTGCCAAGAGGACTGCAAAGAACTCCAACAGGAAATCATCACTACCAATTCGGCACTAACGTGCGTCCA
T-G---T----CC-G--C-----GC-------T--C--C--------T--T--G-----T-----T--T--G---









N  I  Y  R  R  F  L  D  L  S  Y  N  N  I  E  D  L  S  T  H  N  F  R  G  F 
CTGAACAAGTTGACTCTCGAGGGAAACGGCCTAAAAGTCATTGGAACATCGTGTTTTCGCAACTTGAAAGGAATA
--T--T---C-C--A--G-----C------T-G-----G-----T--GAGC-----C------C-C-----T--T
L  N  K  L  T  L  E  G  N  G  L  K  V  I  G  T  S  C  F  R  N  L  K  G  I 
CATGTGATCTCCCTCAGCAAAAACAAGTTGAAAAGTTTACCATCAGAGCTGTTCCAAGGACAAGATAGTTTACTA
--C-----------T--T--------AC-C---TC-C-C--C-----A-----T-----C--G--CTCA--G--G
H  V  I  S  L  S  K  N  K  L  K  S  L  P  S  E  L  F  Q  G  Q  D  S  L  L 
GAATTACGACTTGACCACAATAACATTTCGATAATACCAAACGATCTCTTCAAAACAGTGACCCAAATCAAAAGA
-----G---T-G--T--T--C-----AAGT-----C--G--T--C--T--T--G-----A--A-----A--GC--
E  L  R  L  D  H  N  N  I  S  I  I  P  N  D  L  F  K  T  V  T  Q  I  K  R 
ATTGACTTGCATAGCAACAAACTGAGCTGTATTCCACAAGAATTGTTCAGCAAGTTAAAAAATATCAAAATTCTA
--A--TC-------------G--C-----C--C--G-----------TTCT--AC-G--------T--G-----G
I  D  L  H  S  N  K  L  S  C  I  P  Q  E  L  F  S  K  L  K  N  I  K  I  L 
CATTTAGAAGACAACCACATCACGCAAGTACACGACAAAGCTTTCTCCATAGATTCAAGTTCATTACAAAACATT
---C-T--G--T--T--T-----A-----G--T-----G--A--T--T------AGCTCAAGCC-C-----T---
H  L  E  D  N  H  I  T  Q  V  H  D  K  A  F  S  I  D  S  S  S  L  Q  N  I 
TATCTCCAAAAGAACAAAATAAGCCGCATTCCATTAACATTACTACTGCAACGGCACGCTGTTAAAATTGATTTG
-----G-----A--------TTC---------TC-T--TC-CT-G-----G--A--T--G--C--G--A--CC--
Y  L  Q  K  N  K  I  S  R  I  P  L  T  L  L  L  Q  R  H  A  V  K  I  D  L 
TCTTTTAATCAGTTGACGTTTCAAGACTTTAACAGGCTGATACAAGAATTAGACTTGGAGACATTTCTGTATCAC
--A--------AC----A--C-----------TC--T----C--G--GC-T--TC-------T--C--C-----T
S  F  N  Q  L  T  F  Q  D  F  N  R  L  I  Q  E  L  D  L  E  T  F  L  Y  H 
CATCGCCATACGGCGAGCTCTTCTCAAATGAGACTGCAAGAAAGTTTAAAGTCTATCAGCTTCGCTCACAACAAG
---A-G--------C--TAGC--C--G---C--T----G---TCCC-C-----C--T--T--T--G--T------
H  R  H  T  A  S  S  S  Q  M  R  L  Q  E  S  L  K  S  I  S  F  A  H  N  K 
TTCACCACGATCAACATAGAAGCATTCAACAGAACAGAGGAACTAACGTTCGAGTATCTTCTGCGGGTTTACGAG
-----T-----A--T--T--G--T------C----C--A--G--G--A--------C--C--TA----A--T---
F  T  T  I  N  I  E  A  F  N  R  T  E  E  L  T  F  E  Y  L  L  R  V  Y  E 
ATAGACATGTCGGGGAATCTCCTCCTATGCGACTGCAAGATTCTGCTTCTGAGTCGCTGGCTTCGAGCTTTAGTT
--T--T-----T--T------T-GT-G--T-----------A-----------CA-G-----GA-----C-C--C
I  D  M  S  G  N  L  L  L  C  D  C  K  I  L  L  L  S  R  W  L  R  A  L  V 
CAAAGGCACACGCGCATCCGAAATGAACAGTTTCAAACTTGGAAATGCGCCGCTCCGACTGAACTCAAAGGGAAA
---C-C------A-G-----C--C-----------G--G--------T--A-----C-----G--T--G--A---
Q  R  H  T  R  I  R  N  E  Q  F  Q  T  W  K  C  A  A  P  T  E  L  K  G  K 
CCGATCCTATCCGTGGACGAAAATCGATTTAAATGCCAGAGAAATCTAGAAAACTGCCCCCACGGATGCTTGTGT
------T-G--T------------A----C--G--T--A--G---T-G--G-----T--T--T------------








L  V  R  A  L  D  G  T  V  V  I  D  C  K  G  R  N  L  T  A  I  P  P  K  V 
CCAAGCGGTCGCATAGAGCTTAAGTTAGAGGACAACAACATCCGGGAGATTCCACCATATCCTTATATGGAAAAT
--CTCT-----A-----A-----AC-T--A--T--T-----A--C--A--A--------C--A--C---------
P  S  G  R  I  E  L  K  L  E  D  N  N  I  R  E  I  P  P  Y  P  Y  M  E  N 
GTGACGGCTCTGTACTTAACGCATAACAAGATACAAGTATTAAACAAGTCCACGGTACGAAGGTTTACGCGAATT
--T--T--G--C-----G--A-----T--A--C--G--C--G--T--AAGT-----GA-G-----C-----C---
V  T  A  L  Y  L  T  H  N  K  I  Q  V  L  N  K  S  T  V  R  R  F  T  R  I 
AAAGTTTTGTTCATCGATTCGAACAAACTCACCTATTTGCCTAAGAATATCGAAAATTTAAACTTTACGAGTCTT
-----CC-C-----T---AGT-----G--G--G--------A--A--C-----------G--T------TCA--C
K  V  L  F  I  D  S  N  K  L  T  Y  L  P  K  N  I  E  N  L  N  F  T  S  L 
GCGTTACACCACAATTTCTTCAAATGCGACTGTACGACATTATGGATAAAGCACTGGCTACAGAGAAAACAAAGT
---C-C--------C-----T--G--T-----C--C--CC-G-----C-----T-----G--A--G--G--GTCC
A  L  H  H  N  F  F  K  C  D  C  T  T  L  W  I  K  H  W  L  Q  R  K  Q  S 
AAAATATTACACATTAAAAATGTTCTTTGCAACTCCGAGGGAAGTACGCAGGGAAAAGCAATTTACACTCTGCCA
--G---C-T-----A--G--C-----G--T-----------C-----C--A--G--G-----C--T--AT----T
K  I  L  H  I  K  N  V  L  C  N  S  E  G  S  T  Q  G  K  A  I  Y  T  L  P 
AATGAAGAATTTGTTTGCAAAAAGAATAAGAAAGACATCCCTACTACACAATCTATAACAAAGGACAAGACTTTC
--------------C-----G--------A-----T-----C--A--G--GAGC--T--G--A--T--A--A--T
N  E  E  F  V  C  K  K  N  K  K  D  I  P  T  T  Q  S  I  T  K  D  K  T  F 
AAAATAATCGCGTTGACTCTTGGAGGCGCGCTGGTTTTGACTTTCATCGCTTTTATCGTGGCTTACAAATACCGC
--G-----A--AC----A--C--C--G--T--C---C-T-----------C--C-----C--------G--T---
K  I  I  A L  T  L  G  G  A  L  V  L  T  F  I  A F  I  V  A  Y  K  Y  R 
GGAGAAATGAAAGTCCTCATGTACACTCATTTTAACTGGCACCCATTTGACCGTGTAGATGACTCGGATCCAAGA
--T-----------TT-G--------G--C-----------T-----C--T--C-----------C--C--TC-C
G  E  M  K  V  L  M  Y  T  H  F  N  W  H  P  F  D  R  V  D  D  S  D  P  R 
AAAATATACGACGCGTTCGTATCGTACAGCGGGAGTGATCACCAGTGGGTTGTCAACACCTTGCAAGAGCGACTC
-----T--T-----T--T--CAGC--TTC---ATC---C--T--A-----C--G--T--TC-T--G--A--G---
K  I  Y  D  A  F  V  S  Y  S  G  S  D  H  Q  W  V  V  N  T  L  Q  E  R  L 
GAACATCACGACCCCCCTTACAAATTGTGCATTCACCACCGCGACTTCGTAGTGGGTGCACCAATCCAGGAAAAC
--------T-----T--A--T--GC-C-----C--------G--------G--A--A--C-----T--A--G---
E  H  H  D  P  P  Y  K  L  C  I  H  H  R  D  F  V  V  G  A  P  I  Q  E  N 
ATTCTGAACAGCGTTGACCAAAGTAAGCGCATGCTCATGGTGCTCTCTCGCAACTTTTTAAAGAGCGAATGGTGC
--A-----T--T-----------C--A------T-G-----C--T--AA-A--T-----G---TC---G------
I  L  N  S  V  D  Q  S  K  R  M  L  M  V  L  S  R  N  F  L  K  S  E  W  C 
TTGTTGGAGTTTCGCGCGGCACATCGTAAAGTGCTAGAAGATCGCATGAATTATCTGATAATTATTCTGTTTGAT
-----------C-----T--G--C--C-----C--T--------A-----C--C--T--C-----CT-------C






Figure 3.2 Human codon optimization for Of-TLR.  
Original cDNA sequence (top line, red), nucleotide changes made in the human codon-




G  I  N  M  D  E  L  D  D  E  M  K  L  Y  M  R  T  N  T  Y  L  S  V  S  Y 
AAGTGGTTCTGGGAGAAGTTGTATTACGCGATGCCACAGAGTACTGACAGGCAGTTTAGAGCGAGAGATCTCTCA
--------T-----A--AC-------T--T-----G--ATCA--C--TC----------G--T--G--CT-G---
K  W  F  W  E  K  L  Y  Y  A  M  P  Q  S  T  D  R  Q  F  R  A  R  D  L  S 
AGCATTTCCTCAAATGCTGGCATGCAATATTCCACTGAGACAGTGTTCAAGAATGAAGCATACCTCAAAGTCACT
TC---AAGTAGC-----G--A-----G-----T--C-----C--C--T-----------T---T-G-----T--G
S  I  S  S  N  A  G  M  Q  Y  S  T  E  T  V  F  K  N  E  A  Y  L  K  V  T 
GATATTCTGGAGTGA
--C---T--------






Figure 3.3 Similarity of Of-TLR to human TLR4.  
(A) Phylogenetic analysis of the TIR domains of the indicated TLR proteins was 
performed using neighbor-joining tree analysis bootstrapped 1000 times. The phylogeny 
was rooted with the TIR domain of a TLR-like protein of the sponge A. queenslandica. 
Branches indicate bootstrap support values. Of, O. faveolata; Nv, N, vectensis; 
Aq, A. queenslandica. TLR1-10 are the human TLR proteins. (B) Schematic structures of 





pull-down assays. Highlighted are conserved structural components shared with other 
TLR and adapter proteins: LRR, leucine-rich region; TM, transmembrane domain; TIR, 
Toll/interleukin-1 receptor; DD, death domain, IM, intermediary domain. (C) Pull-down 
assays with GST and GST-TIR, and FLAG-tagged MYD88. The top panel shows an anti-
FLAG Western blot of pull-downs using GST, GST-Nv-TIR or GST-Of-TIR. The input 
lane contains 0.7% of the FLAG-MYD88 293 cell lysate used in the pull-downs. 
Expression of bacterially expressed GST proteins was confirmed by SDS-PAGE 
followed by Coomassie blue staining (bottom). Dashed line represents the merge of 
Western blot lanes from a single gel. (Note: so that the amounts of GST proteins analyzed 
in the pull-downs were more similar, one-half of the sample from the GST alone pull-






Original Sequence Codon Optimized  Amino Acid Sequence
ATGGCCACCAACAGCGAGAGGCAGATCGGCGAGACCCTGACCGACAGCCTGCTGATGGACATCATGACCCCCGGC
-----T--A-----T-----A-----T--T--A---T----A---TC------------T--T--------T---
M  A  T  N  S  E  R  Q  I  G  E  T  L  T  D  S  L  L  M  D  I  M  T  P  G
TACCTGCCCGACATCAGCGCCCTGCAGGTGCCCACCGCCACCTACAGCGGCCCCTACATGGAGATCCTGGAGCAG
---T----------ATC---A--------T-----------T--TTCA--T--A--------A------------
Y  L  P  D  I  S  A  L  Q  V  P  T  A  T  Y  S  G  P  Y  M  E  I  L  E  Q
CCCAAGCAGAGGGGCTTCAGGTTCAGGTACCCCTGCGAGGGCCCCAGCCACGGCGGCCTGCCCGGCCAGTACAGC
-----A--A--A--T--T--A-----A-----A--T-----T--T-----T--T--------A--------TTCT
P  K  Q  R  G  F  R  F  R  Y  P  C  E  G  P  S  H  G  G  L  P  G  Q  Y  S
GAGAAGGGCAAGAAGAGCTACCCCAGCGTGCAGCTGTGCAACTACCACGGCCCCGCCAGGATCGTGGTGAGCCTG
--A--------A---TCA-----T--------A--------T--T--------------A--------TTC-T--
E  K  G  K  K  S  Y  P  S  V  Q  L  C  N  Y  H  G  P  A  R  I  V  V  S  L
GTGACCGTGGACGAGCCCCCCATGCCCCACGCCCACAGCCTGATCGGCAAGAACAGCAACAACGGCGCCGTGACC
--------T--T-----A--T-----T--T--A---TCT--------T--A--TTCT--------T--------A
V  T  V  D  E  P  P  M  P  H  A  H  S  L  I  G  K  N  S  N  N  G  A  V  T
GTGCAGATCGGCCCCGAGCACGGCATGACCGCCAGCTTCCCCAACCTGGGCATCCAGCACGTGACCAAGAAGAGC
--T--A-----T-----A--T-----------T-----T--A-----------T-----------T--A---TCT
V  Q  I  G  P  E  H  G  M  T  A  S  F  P  N  L  G  I  Q  H  V  T  K  K  S
GTGGGCAAGGTGCTGATGGAGAGGTACATCAAGATGCAGACCCTGCACACCGCCACCCTGCACGCCCTGACCGCC
-----A--A--T-----------A--T-----------A--TT----T--A--A-----------AT----A---
V  G  K  V  L  M  E  R  Y  I  K  M  Q  T  L  H  T  A  T  L  H  A  L  T  A
GACAGCAAGGGCTTCGACATGGAGCTGGTGGGCGACCAGGCCCTGGCCGACGGCGAGACCGCCACCTTCAACAGG
--TTCT-----T--T--------A-----T-----T------T----T-----A-----T-----A-----T--A
D  S  K  G  F  D  M  E  L  V  G  D  Q  A  L  A  D  G  E  T  A  T  F  N  R
ACCATGGCCGAGGCCGTGGCCGCCGAGGAGAGCCAGAAGGTGAGGCAGATGGTGGAGGACCAGAAGCAGAGCATG
--T-----A--A-----------T--A---TC------A-----A--A-----T--A--T--------ATCA---
T  M  A  E  A  V  A  A  E  E  S  Q  K  V  R  Q  M  V  E  D  Q  K  Q  S  M
AACCTGAACGCCGTGAGGCTGTGCTTCCAGGCCTACCTGCCCGACGACGGCGGCTGCTTCACCAAGGCCCTGCCC
--T--------A--T--AT----T--T--------------A--T-----A--T--T-----T--A---T-----
N  L  N  A  V  R  L  C  F  Q  A  Y  L  P  D  D  G  G  C  F  T  K  A  L  P
CCCTGCATCAGCAACCCCGTGTACGACAGCAAGGCCCCCAGCGCCAGCAACCTGAAGATCTGCAGGATGGACAGG
--A-----TTCA-----T-----T--T-----A--T--------ATCT--T-----------T--A--------A









N  S  G  C  V  T  G  G  D  E  V  Y  L  L  C  D  K  V  Q  K  E  D  I  D  V
ATGTTCTACGAGATCGACGTGGAGACCGGCAAGAAGACCTGGGAGGCCGGCGGCGTGTTCGCCCCCACCGACGTG
--------T--------------A--A-----A--------------A--T--------T--------A--T--T
M  F  Y  E  I  D  V  E  T  G  K  K  T  W  E  A  G  G  V  F  A  P  T  D  V
CACAGGCAGGTGGCCATCGTGTTCAAGACCCCCGCCTACTGGAACATCGCCACCGAGAGGCCCGTGAAGGTGCAC
--T--A-----------T--T--------A--A--T--------------A--------A--T-----A--T---
H  R  Q  V  A  I  V  F  K  T  P  A  Y  W  N  I  A T  E  R  P  V  K  V  H
CTGGAGCTGAGGAGGAAGAGCGACCAGGAGACCAGCGAGCCCGTGGAGTTCACCTACCAGCCCCAGCTGTTCGAC
-----AT----A--A---T-T--T--A--A---TC------A--T-----T--T--------T--A---------
L  E  L  R  R  K  S  D  Q  E  T  S  E  P  V  E  F  T  Y  Q  P  Q  L  F  D
AAGGAGCAGATCGGCGCCAAGAGGAGGAAGAAGATCCCCCACTTCAGCGACTACTTCAGCGGCGGCGGCGGCGGC
--A--A--------T--T-----A--A-----A--T--A--T---TCT--T------TC---A--T-----A--T
K  E  Q  I  G  A  K  R  R  K  K  I  P  H  F  S  D  Y  F  S  G  G  G  G  G
GGCGGCCCCCCCGGCATGGGCGGCGCCGGCGCCGGCGGCGGCGGCTTCGGCACCTTCGCCCCCCTGGGCCTGCTG
-----A--T-----A-----T-----T--T--A--A--T-----A--T--A--A-----T--A------------
G  G  P  P  G  M  G  G  A  G  A  G  G  G  G  F  G  T  F  A  P  L  G  L  L
GGCAGCGCCCTGTGGTTCGCCAACCCCGGCACCAGCCAGAGCAACAACCAGGGCGGCAGCGGCGGCGCCGGCACC
--A-----TT-------T--A--T--T--T--ATC----TCA--T-----A--T---TCT--A--T--A------
G  S  A  L  W  F  A  N  P  G  T  S  Q  S  N  N  Q  G  G  S  G  G  A  G  T
AGCCAGCAGGGCCAGAGCCACAGCAGCGGCCAGAGCCAGGCCAGCGGCCAGAGCCACCAGGCCGACCTGAGCGAG
TCA-----A--A--A-----TTCTTC-------TCT--A--TTC---A---TCA-----A--A--T---------
S  Q  Q  G  Q  S  H  S  S  G  Q  S  Q  A  S  G  Q  S  H  Q  A  D  L  S  E
CTGGCCTGGAACCTGGCCGAGAAGAGCGCCGCCGCCATGAGGGACTACGCCGCCACCGGCGACATGAGGTACCTG
T----------------T--A--ATCT--A-----T-----A--T-----A-----------------A--T---
L  A  W  N  L  A  E  K  S  A  A  A  M  R  D  Y  A  A  T  G  D  M  R  Y  L
CTGGCCGCCCAGAGGCACCTGACCGCCGTGCAGGACGACAGCGGCGACACCGCCCTGCACCTGGCCGTGATCAAC
T----T--A-----A--T-----T-----T--A--T---TC---A-----A--A------T----------T--T
L  A  A  Q  R  H  L  T  A  V  Q  D  D  S  G  D  T  A  L  H  L  A  V  I  N
AGCCAGCAGGAGGTGGTGCAGTGCCTGATCGACATCATGGCCGGCCTGCCCGAGAGCTACATCAGCGAGTACAAC
TCA-----A--A-----T-----T-----T--T--------T---T----T--------T--TTCT--A------
S  Q  Q  E  V  V  Q  C  L  I  D  I  M  A  G  L  P  E  S  Y  I  S  E  Y  N
TTCCTGAGGCAGAGCCCCCTGCACCTGGCCGCCATCACCAAGCAGCCCAGGATGCTGGACTGCCTGCTGAGGGCC
--------A---TCT--------TT-------T-----------A--A--A---T----T------T----A---








S  A  N  V  R  S  R  D  R  H  G  N  T  A  V  H  I  A C  M  H  G  D  A  V
TGCCTGAAGGCCCTGCTGAACTACAACGTGAGCAAGACCGTGCTGAACTGGCAGAACTACCAGGGCGTGACCCCC
--------A--T---T----T---------TC---------TT----T-----------T--A--A-----T--T
C  L  K  A  L  L  N  Y  N  V  S  K  T  V  L  N  W  Q  N  Y  Q  G  V  T  P
GTGCACCTGGCCGTGCTGGCCGGCAGCAAGGACGTGCTGAAGCTGCTGAACAGCGCCGGCGCCAACATGAGCGCC
--T--T--------TT----T--TTCA--A--T------------------TCT--A--T---------TC---T
V  H  L  A  V  L  A  G  S  K  D  V  L  K  L  L  N  S  A  G  A  N  M  S  A
CAGGACGGCACCAGCGGCAAGACCCCCCTGCACCACGCCGTGGAGCAGGACAACCTGGCCGTGGCCGGCTTCCTG
-----T--T--TTCA-----A--A--------T-----A--T-----A-----TT----T-----A--T--T---
Q  D  G  T  S  G  K  T  P  L  H  H  A  V  E  Q  D  N  L  A  V  A  G  F  L
ATCCTGGAGGCCAACTGCGACGTGGACGCCACCACCTTCGACGGCAACACCCCCCTGCACATCGCCGCCGCCAGC
--TT----A--T--T--T--T--T-----A--T--A--------------T--A-----------A-----T---
I  L  E  A  N  C  D  V  D  A  T  T  F  D  G  N  T  P  L  H  I  A A  A  S
GGCCTGAAGGGCCAGACCGCCCTGCTGGTGGCCGCCGGCGCCGACACCACCCTGCAGAACAGCGACGAGGAGACC
--AT-------T-----A------T-------A--------T--T-----T-----A--TTCT--T--A------
G  L  K  G  Q  T  A  L  L  V  A  A  G  A  D  T  T  L  Q  N  S  D  E  E  T
GCCTTCGACCTGGCCAACGTGGCCGAGGTGCAGGAGATCCTGGACGAGGACGAGGCCCTGAGCACCGACCCCAGC
-----T---T----A--------------T-----A--T-----T--A---------T--TCA--------A---
A  F  D  L  A  N  V  A  E  V  Q  E  I  L  D  E  D  E  A  L  S  T  D  P  S
CAGGACGACGAGCTGACCGCCGGCCTGACCGGCCTGACCCTGGGCCAGGGCGACATGGACAAGCTGGACCCCTAC
--A--T-----A-----T--T---T-------A-----TT----------A--T--------A-----T--T---
Q  D  D  E  L  T  A  G  L  T  G  L  T  L  G  Q  G  D  M  D  K  L  D  P  Y
GTGAGGAGGAAGATGGCCCAGAGGCTGGACCCCAGCATCGGCGCCGACTGGAGGGAGCTGGCCAAGAGGCTGGGC
--T--A--A-----------A--AT----T---TC---T--TG----------A--------T--A--A-----T
V  R  R  K  M  A  Q  R  L  D  P  S  I  G  A  D  W  R  E  L  A  K  R  L  G
CTGGGCACCCTGGAGAGCGCCTTCGCCATCCACAGCAGCCCCACCACCCAGGTGCTGGCCCAGTACGAGGCCGCC
T-------AT----ATCA-----T--T-----TTCA-----T--A--------------T--A--T-----T--A
L  G  T  L  E  S  A  F  A  I  H  S  S  P  T  T  Q  V  L  A  Q  Y  E  A  A
GACGGCAGCATCAAGACCCTGAGGCAGGTGCTGAGGGACATGAGGAGGGGCGACGTGCTGGAGATCCTGGACGGC
-----TTCT--T-----T-----A-----TT----A--T-----A--A--T-----------A---T----T---
D  G  S  I  K  T  L  R  Q  V  L  R  D  M  R  R  G  D  V  L  E  I  L  D  G
AGGAAGAGCCCCCTGAGCCACGACAGCGGCTTCGACAGCGGCCTGGGCAGCCAGAGCCTGAGCGCCTACAGGAGC
--A---TC---T---TCA-----T------------TCA--A-----T-----ATCTT--TC---T-----ATCA






Figure 3.4 Human codon optimization of Of-NF-κB.  
Original cDNA sequence (top line, red), nucleotide changes made in the human codon-




E  E  L  A  S  Y  E  A  G  S  S  S  V  P  S  S  S  S  L  Q  K  G  T  T  S
CTGGAGAGCACCAGGAAGGCCGGCGGCTACAGGCCCATCAGGCAGCACCAGGACGTGTTC
T----ATCT--A-----A--A--A--A-----A--A--A--A-----------T------TAATGA






Figure 3.5 Of-NF-κB is most similar to other NF-κB proteins and not to Rel 
proteins.  
(A) Schematic linear structure of the Of-NF-κB protein (920 amino acids). Highlighted 
are functional domains shared with mammalian NF-κB proteins: RHD, Rel Homology 
Domain; NLS, Nuclear Localization Sequence; Gly, glycine-rich region; S, 





indicated NF-κB and Rel proteins using maximum-likelihood analysis bootstrapped 1000 
times. The phylogeny was rooted with the NF-κB protein of the single-celled 
eukaryote Capsaspora owczarzaki. Branches indicate bootstrap support values. 
Co, Capsaspora owczarzaki; Of, Orbicella faveolata; Nv, Nematostella vectensis; Ap, 










Figure 3.6 Characterization of the activity of the O. faveolata NF-κB protein in cell-
based assays.  
(A) FLAG-tagged expression vectors used in these experiments. Shown from top to 
bottom are generalized structures of the naturally shortened Nv-NF-κB, full-length Of-
NF-κB, a C-terminal truncation mutant of Of-NF-κB (Of-RHD), and an N-terminal 
deletion mutant of Of-NF-κB possessing only the glycine-rich region and the Ankyrin 
repeats  (Of-Cterm). (B) An anti-FLAG Western blot of lysates from 293 cells transfected 
with the indicated plasmid expression vectors. (C) Chicken DF-1 fibroblasts were 
transfected with pcDNA-FLAG vectors containing the indicated proteins, and three days 
later cells were analyzed by anti-FLAG (αFLAG) indirect immunofluorescence (left, 
green) and DAPI staining (middle, blue). Merged images are shown in the right panels. 
Scale bar = 10 μm. (D) Top: A κB-site EMSA using lysates from 293 cells expressing the 
indicated FLAG-tagged proteins, as shown in (B). Arrows indicate the free probe and the 
shifted NF-κB-DNA complex. (E) A κB-site luciferase reporter gene assay was 
performed with the indicated proteins in 293 cells. Luciferase activity is relative (Rel.) to 
that seen with the empty vector control (1.0), and values are the averages of three assays 
performed with triplicate samples with standard error. (F) A GAL4-site LacZ reporter 
gene assay was performed in yeast Y190 cells. β-galacotisidase (β-gal) reporter gene 
activity is relative (Rel.) to the GAL4 (aa 1-147) control (1.0), and values are the 










Figure 3.7 IKK can phosphorylate conserved serines in Of-NF-κB in vitro and 
induce processing of Of-NF-κB in human cells.  
(A) An alignment of relevant regions of NF-κB from human p100, the sea anemone 
A. pallida, and O. faveolata. Conserved serine residues are boxed in red. (B) In vitro 
kinase assay (top) using a constitutively active FLAG-Hu-IKKβ protein and FLAG-Of-
IKK with bacterially expressed substrates of GST alone or GST fusion 
proteins containing the wild-type (WT) serine residues of Of-NF-κB (amino acids 843-
874), or the same C-terminal residues with conserved serines mutated to alanines (3X-
Ala). The GST proteins were electrophoresed on an SDS-polyacrylamide gel and stained 
with Coomassie blue (bottom). Dashed lines indicate the respective Coomassie blue stain 
for each protein. (C) A Western blot of lysates from 293T cells co-transfected with Of-
NF-κB wild-type (WT) or 3X-Ala and with HA-Hu-IKKβ (top two panels) or FLAG-Of-
IKK (bottom panel). Full-length and processed forms of Of-NF-κB are indicated. Shown 
also are the HA-Hu-IKKβ (middle panel) and FLAG-Of-IKK proteins (bottom panel) 






Original Sequence Codon Optimized Amino Acid Sequence
ATGGAATATGGAAGAGAAAGGAAAAAATCAAGGGAGGGGTGGGTGGAGGAAAGATGTATTGGGTCCGGTGGTTTT     
--------C--C--G--G--A--G--GAGC--A--A--C--------A--G--G--C--C-----A-----C--C
M  E  Y  G  R  E  R  K  K  S  R  E  G  W  V  E  E  R  C  I  G  S  G  G  F
GGAACAGTTACACTGTATGAGAACAAGATTACCAAGCAACAGATTGCCCTTAAGAGATGTCGCATGGATTTAAAT
--G-----G--CT-------A-----A--C--G--A-----A--A-----G--AC----C---------C-T--C
G  T  V  T  L  Y  E  N  K  I  T  K  Q  Q  I  A L  K  R  C  R  M  D  L  N
GCTCAAAACAAGAAGCTATGGCGACAGGAAGTTGACATAATGAAGAGACTGGATCACCCAAACCTTGTGTCAGCT
--G--G-----A--A--C---A-G--A-----A--T--C--------G-----C--T--C--T--C--T-----G
A  Q  N  K  K  L  W  R  Q  E  V  D  I  M  K  R  L  D  H  P  N  L  V  S  A
AAAGATGTTCCAGCACCACTGGATGTCAGTGTTGATGAACTTCCTCTGTTGGCCATGGAGTTTTGCTCTGGAGGA
--------G--G------T----C--TTCA--------------A--TC----------A--C--T--C--G--G
K  D  V  P  A  P  L  D  V  S  V  D  E  L  P  L  L  A  M  E  F  C  S  G  G
GACTTGAGAAAGGTACTAAACTCCCCAGAAAGTTGCTGTGGGCTGAAAGAAAAGACAGTTTTGAAGATTGCCTCA
--T--------A--C--C-----T-----GTC---T--C--C-----G--G--A--G---C-T--------G--C
D  L  R  K  V  L  N  S  P  E  S  C  C  G  L  K  E  K  T  V  L  K  I  A S
GATGTTGCTGCTGCAGTGGAATTTCTTCATGGCCACCGCATCATTCACAGAGATCTAAAACCTGAAAACATTGTT
-----G--A--G-----T-----C--C--C--T--T--A--T--C--------C--C--G--C--------A---
D  V  A  A  A  V  E  F  L  H  G  H  R  I  I  H  R  D  L  K  P  E  N  I  V  
ATAAGTCATGTGGATAATAAGGTAGTTTACAAACTGATAGATCTTGGCTATGCAAAAGAACTGGATCAAGGAAGT
---T-C--C--------C-----G--C--T--G--T------T-G--G--C--C-----GT-------G--GTCC
I  S  H  V  D  N  K  V  V  Y  K  L  I  D  L  G  Y  A  K  E  L  D  Q  G  S  
CTGGCTACCACTTTTGTCGGGACTCTAAAATATCTGGCCCCTGAACTGCTTGACAAGGTGCAATACACAAAAACG
T----C--------C--A--C-----G-----C--C---------T----C--T--A-----------------A
L  A  T  T  F  V  G  T  L  K  Y  L  A  P  E  L  L  D  K  V  Q  Y  T  K  T
GTGGATTATTGGAGTTTTGGCACACTCTTGTTTGAATGCATTACTGGAATGCGGCCTTTTCTTACCGAACTATCT
--A-----C-----C--C-----G--TC----C--------C-----C--------G--C--C--------G---
V  D  Y  W  S  F  G  T  L  L  F  E  C  I  T  G  M  R  P  F  L  T  E  L  S
CCAGTCCAGTGGTATAATAAAGTTCGCAGCAAAGGACCGGATGACATCTGTGCCTACTTTGATCTAAAAGAGGAA
--C--A-----------C-----CA-GTC---G--T--C--C--T-----C--T-----------T--G------
P  V  Q  W  Y  N  K  V  R  S  K  G  P  D  D  I  C  A  Y  F  D  L  K  E  E
ATACAGTTCTCTTCTGTTCTGCCGACTCCCAATTCCCTCTGTAGGCAACTTCAAGACAAGTTTGTTGCCCTTCTT
--T--A------AGC--------C--C--G--CAG------CC-A--GT-G--G--T-----C--A--A--C--G
I  Q  F  S  S  V  L  P  T  P  N  S  L  C  R  Q  L  Q  D  K  F  V  A  L  L  








R  L  L  L  L  W  D  P  Q  A  R  G  G  S  I  L  E  S  G  K  K  E  C  F  D
GTGCTTGAAAAGATCATCAATACTGTGATAGTCCGTGTATTCTTAGTCAGCTCAGCAGTGGCGATTCCATTTGAA
--C-----------T--T--C--G--C--C--T--G--T-----G--ATC------C--T--C-----G--C--G
V  L  E  K  I  I  N  T  V  I  V  R  V  F  L  V  S  S  A  V  A  I  P  F  E
GTATTACCAAGTGAAACGATAGAGGATCTGCAAGTTAAATTATCTGAGGCAACTGGAGTCGATGTTAAGGAGCAG
--TC-T--TTCC--G--C--------CT----G--A---C-G--------T--------A-----G--A------
V  L  P  S  E  T  I  E  D  L  Q  V  K  L  S  E  A  T  G  V  D  V  K  E  Q
GAATTGTTGTTGGCTTCAGGGCAGGCTGTTAAGCCAAATACACTTGTCATGGATTGCATCAAGGATGATCAGATT
---C--C-TC-T--------T-----C--G--A--G-----------A--------T--------C-----A---
E  L  L  L  A  S  G  Q  A  V  K  P  N  T  L  V  M  D  C  I  K  D  D  Q  I
GGAGATGATTGCGCTCTGTTCCTTTTGCCAACAAGTGTTGAACCAAAATCCACACGGCCATTGTACACTTTGCCA
--T--------------C-----GC----C--G--C--C-----G-----T--TA-A--GC-C--T--AC-C--C
G  D  D  C  A  L  F  L  L  P  T  S  V  E  P  K  S  T  R  P  L  Y  T  L  P  
CCTACAGTTCAAGGAATGGTCACTGAGCAGAAAACGCTGATGTCGTACGAGGAATTGAAAAGGGCCTTTGCTCAG
--C--T--A--G--C-----T--A-----------A--------A-----A---C----GC-C--------C--A
P  T  V  Q  G  M  V  T  E  Q  K  T  L  M  S  Y  E  E  L  K  R  A  F  A  Q  
GGCGTGAACTTTTGCCGTGAACAGACAAAGATAAATCAGCTGCTGATTGAAGGCTTTAGGGCGGCACAGATTTCA
--G--A--T------A-G--------C--------C--A--TT----C-----T--C--A--C--T--A------
G  V  N  F  C  R  E  Q  T  K  I  N  Q  L  L  I  E  G  F  R  A  A  Q  I  S
TTGTTAGTTCTTAATTCCAAACTTGGACAGCTCAAGTCTGAACTTCTAACTGAATCCAACAAACTGGAGGCAAAA
---C-T--G--G---AG-------------T-G--A--A--G--C--G--C--G--T--T-----T--A--T---
L  L  V  L  N  S  K  L  G  Q  L  K  S  E  L  L  T  E  S  N  K  L  E  A  K
ATAGACTTTTTCAACTCCAGTTTACAGACTGATTTAGAAATTTATGCTGATAATATCAACCTTGTAAAAAATGAT
-----------T--T------C-C--A--A--CC-C--G-----C--C--------T-----C--G---------
I  D  F  F  N  S  S  L  Q  T  D  L  E  I  Y  A  D  N  I  N  L  V  K  N  D  
AAACTGCTCAGAAACTGGAAACGGGCGCAGAAAAAGGTGGAGTCGTTTCAGAATAATGATGTAACACAACTGAAA
--G---T-GC-G--T-----G--C--T--A--------A--AAGC-----------------T--G-----C---
K  L  L  R  N  W  K  R  A  Q  K  K  V  E  S  F  Q  N  N  D  V  T  Q  L  K
GAGTTCACAGCAGCAGTACAGACTAAAGTTGTTGAGCTGCAGAAGAGTCCATACACAAGTGGAACGCAATCGAAA
-----------T--T--T--------G--C--G-----T-----ATCC--G--T--G--C--T--T-----C--G
E  F  T  A  A  V  Q  T  K  V  V  E  L  Q  K  S  P  Y  T  S  G  T  Q  S  K
TCTAAACCTGATGGAATGAGGTACGACTGTGCTGTCAAACTTTACGAGAAGCTGAAACAAAGCGACAGACGACCC
AG---G--A--C------C-------T--C--A--T--G-----------A--T--G--GTCT--TC-CA-G--A






Figure 3.8 Human codon optimization for Of-IKK.  
Original cDNA sequence (top line, red), nucleotide changes made in the human codon-






A  D  S  Q  P  M  A  T  I  I  L  Q  I  L  A  Q  R  E  K  L  H  R  D  I  C
ACTCAGTTAAGTGAAGTGATGTCCTGCAGAAGAGAGATCCGCAAACTCATGTATCGTGTTATACAGGTCAAGGAG
--A--AC-GTCC-----C-----T---C-G-----A-----A-----G-----C--G-----------G------
T  Q  L  S  E  V  M  S  C  R  R  E  I  R  K  L  M  Y  R  V  I  Q  V  K  E
AAACTTATCACCAGAGCAGATGAGCTCACAGAGATGCAGAAGCAAAGACAAGTTGACCTGTGGAGACTTCTCCAA
--G--C-----AC----T--C-----------A-----A-----G-----G--G--------------C--T---
K  L  I  T  R  A  D  E  L  T  E  M  Q  K  Q  R  Q  V  D  L  W  R  L  L  Q  
TCAAAGAGGCAAAGAGAACAGAATCGTTCGTCAAGCAGTCCACATACATCAATTTCTTCGCTCACAACTTCTTGT
AGT---C----GC----G--A-----C--TAGTTC---C-----C--G--T------AGCT-G--G--C------
S  K  R  Q  R  E  Q  N  R  S  S  S  S  P  H  T  S  I  S  S  L  T  T  S  C  
CTCAGTACACAATCCGTTGTTCTAATTGAGGAGAGCTCTAGATCCTTTGAAAAGTTTGCCGGATTGATAAACAAA
--------G--G--T--C--G--C--C--A---TCAAG-C-GAG------G-----------GC----T-----G
L  S  T  Q  S  V  V  L  I  E  E  S  S  R  S  F  E  K  F  A  G  L  I  N  K  
TTGAAGATCGATCAGATCAGTGAGACGGAGAATTTCGACTGGGAATTCCTTGAGGAAGAAAATAGCTCAACTGAC
C-C-----A--------------A--T--A--C-----T-----G--T-----A--------CTCTAGC--A---
L  K  I  D  Q  I  S  E  T  E  N  F  D  W  E  F  L  E  E  E  N  S  S  T  D  
CAAGAGAGCGTT
--G--ATCT--CTGA






PORIFERAN TRANSCRIPTION FACTOR NF-κB HAS CONSERVED AND 
UNIQUE SEQUENCES, ACTIVITIES, AND REGULATION 4 
4.1 Introduction 
Sponges are the sole members of the phylum Porifera, with about 8,500 known 
extant species (Van Soest et al., 2012). Poriferans are widely considered the sister group to 
all other multicellular animals (Simion et al., 2017). Sponges are estimated to have first 
appeared approximately 600 million years ago, prior to the Cambrian explosion (Yin et al., 
2015). Sponges are found in a variety of aquatic habitats throughout the world, with the 
majority of species living in marine environments (Van Soest et al., 2012).  
Sponges have simple body plans that resemble a sac of cells with an extracellular 
matrix and pores. Nevertheless, the simplicity of the sponge body plan belies the complex 
mechanisms that must be coordinated to allow for their existence. Indeed, due to their water 
filtration system and body plan, sponges have an extremely high exposure to a diverse array 
of microorganisms as compared to other multicellular organisms (Wiens et al., 2005). 
Therefore, it is not surprising that sponges have a robust innate immune system to monitor 
and counteract their continuous exposure to microbes. As with more advanced metazoans, 
the immune system of sponges has the ability to distinguish between friendly and foreign 
matter, such as the recognition of cells from heterologous sponges, the uptake of bacteria 
by phagocytosis through macrophage-like cells (Wehrl et al., 2007), the production of 
 





secondary metabolites for defense (Proksch, 1994), and the recognition of bacterial cell 
wall-derived lipopolysaccharide (LPS) (Böhm et al., 2001). The molecular mechanisms by 
which these defense processes are regulated are largely unknown; however, the presence 
of homologs to higher metazoan innate immune molecules in sponges suggests a conserved 
and complex level of immune defense and regulation (Müller and Müller, 2003).  
Because of their phylogenetic position as the earliest lineage of living animals, 
sponges are useful for addressing questions regarding the origin of metazoan-specific gene 
families and their evolution (Riesgo et al., 2014). The Great Barrier Reef demosponge 
Amphimedon queenslandica (Aq) is perhaps the most extensively studied poriferan at the 
cellular and molecular level, including having its genome sequenced and being the subject 
several studies focused on investigating the evolution of metazoan development and 
multicellularity ( Larroux et al., 2006; Adamska et al., 2007; Tompkins-MacDonald et al., 
2009; Srivastava et al., 2010).  
One of the most prominent proteins involved in the regulation of immunity in 
complex metazoans is transcription factor NF-κB, whose activity is regulated by many 
upstream factors (Gilmore, 2006). Many homologs of the NF-κB pathway are conserved 
across diverse phyla, from vertebrates to the single-celled holozoan Capsaspora 
owczarzaki (Gilmore and Wolenski, 2012). NF-κB pathway components and 
transcriptional responses have been intensively studied in vertebrates and flies for their 
involvement in immunity, development, and disease. However, this pathway and genes 
regulated by NF-κB are, for the most part, less well-characterized in more evolutionarily 





Overall, the amino acid (aa) sequence and structural organization of the single NF-
κB proteins that have been identified in cnidarians (Wolenski et al., 2011; Gilmore and 
Wolenski, 2012; Mansfield et al., 2017; Williams et al., 2018), poriferans (Gauthier and 
Degnan, 2008), the protist Capsaspora owczarzaki (Sebé-Pedrós et al., 2011), and some 
choanoflagellates (Richter et al., 2018) more closely resemble the NF-κB subfamily of 
proteins found in vertebrates and flies.    
Activation of NF-κB pathways can be initiated by various upstream ligands that 
bind to their specific receptors (e.g., Toll-like receptors (TLRs), Interleukin-1 receptors 
(IL-1Rs), tumor necrosis factor receptors (TNFRs)), which then direct appropriate 
downstream effects. In some cases in humans, Tank- binding Kinase (TBK) acts with other 
signaling complexes that feed into a NIK-IKK cascade, which leads to non-canonical NF-
κB activation (Pomerantz and Baltimore, 1999). Ultimately, non-canonical processing of 
p100 leads to generation of the RHD-only protein p52 in a heterodimer with the Rel-like 
protein RelB, and the p52-RelB heterodimer can then translocate to the nucleus, bind DNA, 
and activate target genes (Gilmore, 2006).  
 Transcriptomic and genomic sequencing has revealed that NF-κB and homologs of 
many of its upstream regulators are present in most eukaryotes from protists to vertebrates 
(Gilmore and Wolenski, 2012). However, the numbers and structures of these signaling 
proteins vary across species, and generally become more complex and numerous through 
evolutionary time.  
In this chapter, we use phylogenetic, biochemical, and cell- and tissue-based 





results indicate that sponge NF-κB has many of the same properties as other metazoan NF-
κB proteins, but also has sequences and methods of regulation that may be specific to 
poriferans. 
 
4.2 A. queenslandica NF-κB resembles other metazoan NF-κB proteins both 
structurally and phylogenetically  
Gauthier and Degnan (2008) reported that the sole NF-κB protein in the 
demosponge sole A. queenslandica (Aq-NF-κB) has an overall structure (RHD-ANK 
repeat domain) and aa sequence phylogeny that are more closely related to mammalian 
NF-κB proteins (p100/105) than Rel proteins (RelA, RelB, c-Rel). That is, Aq-NF-κB 
contains an N-terminal RHD, a nuclear localization sequence (NLS), a glycine-rich 
region (GRR), and ANK repeats (Figure 4.1A). However, Aq-NF-κB has an additional 
171-aa sequence between the GRR and the ANK repeats (Figure 4.1A, grey domain) that 
is not found in any other NF-κB protein and has no sequence similarity to any other 
protein in BLAST databases. Nevertheless, the general structure of Aq-NF-κB resembles 
other basal NF-κBs discovered to date, such as those in cnidarians like Aiptasia NF-κB 
and Nematostella NF-κB  (Wolenski et al., 2011; Mansfield et al., 2017; Williams et al., 
2018) and Capsaspora owczarzaki (Sebé-Pedrós et al., 2011) (Figure 4.1B). Our own 
phylogenetic comparison of RHD sequences confirmed that the Aq-RHD is more similar 
to the RHDs of other NF-κB proteins as compared to Rel proteins across phyla, and that 
the Aq-RHD sequences are most closely related to NF-κB-like proteins in Cnidaria, the 





results are consistent with other studies indicating that NF-κB proteins are more ancient 
than Rel proteins (Wolenski et al., 2011; Gilmore and Wolenski, 2012; Mansfield et al., 
2017; Williams et al., 2018). 
 
4.3 Aq-NF-κB can bind DNA and activate transcription    
To investigate the overall DNA binding-site specificity of Aq-NF-κB, we assessed 
the DNA-binding profile of bacterially expressed, affinity purified RHD sequences of Aq-
NF-κB in a protein binding microarray (PBM) consisting of 2592 κB sites and 1159 
random background sequences (for array probe sequences, see Mansfield et al., 2017). We 
(Siggers et al., 2011; Mansfield et al., 2017) and others (Ryzhakov et al., 2013) have 
previously used this type of analysis on both mammalian and cnidarian NF-κB proteins. 
By analysis of z-scores of binding to DNA sites on the PBM, the DNA-binding profile of 
Aq-NF-κB is similar to NF-κB from the sea anemone N. vectensis and human NF-κB p52, 
but is distinct from human c-Rel and RelA (Figure 4.2A).  
In mammals and cnidarians, NF-κB proteins require post-translational processing 
for nuclear translocation, active DNA binding, and transcriptional activation activity (Sun, 
2011; Mansfield et al., 2017; Williams et al., 2018). To investigate corresponding 
properties of Aq-NF-κB, we first created FLAG-tagged expression vectors for full-length 
Aq-NF-κB, a mutant containing the RHD and GRR, and a mutant containing only the 
sequences C-terminal to the RHD (Aq-Cterm, i.e., primarily the ANK repeat domain) 
(Figure 4.2B). As a control, we used an expression vector for the sea anemone N. vectensis 





truncated NF-κB protein (Wolenski et al., 2011). As shown by anti-FLAG Western blotting 
(Figure 4.2C), each construct expressed a protein of the appropriate size when transfected 
into HEK 293T cells. 
To analyze the transactivation properties of full-length and truncated Aq-NF-κB 
proteins, we performed an NF-κB-site luciferase reporter assay in 293 cells. Aq-RHD and 
Nv-NF-κB both activated transcription of the reporter gene (4.8-fold and 21.9-fold, 
respectively) as compared to the empty vector control and to full-length Aq-NF-κB (Figure 
4.2D). Furthermore, a GAL4-Aq-NF-κB RHD fusion protein activated transcription 
approximately 15-fold above control levels in a GAL4-site reporter assay in yeast (Figure 
4.2E). As we have shown previously (Wolenski et al., 2011; Alshanbayeva et al., 2015; 
Williams et al., 2018), a GAL4-Nv-NF-κB fusion protein strongly activated transcription 
in yeast (approximately 600-fold) as compared to the GAL4 DNA-binding domain alone 
control. Therefore, the ability of the Aq-RHD sequences to activate transcription appears 
to be an intrinsic property of sequences within the N-terminal half of the protein, and the 
ability of the Aq-RHD sequences to activate κB site-dependent transcription in cells is not 
seen with the full-length Aq-NF-κB protein. 
To assess the DNA-binding ability of Aq-NF-κB, whole-cell detergent extracts 
from 293T cells transfected with the Aq-NF-κB expression plasmids were analyzed in an 
electrophoretic mobility shift assay (EMSA) using a κB-site probe, which we have 
previously shown can be avidly bound by cnidarian NF-κB proteins (Wolenski et al., 2011; 
Mansfield et al., 2017; Williams et al., 2018). Lysates from cells transfected with 





activity that strongly bound to the κB-site probe (Figure 4.2F). As expected, lysates from 
cells transfected with the empty vector or the Aq-Cterm had little basal DNA-binding 
activity. Somewhat surprisingly, full-length Aq-NF-κB bound the κB-site probe to 
approximately the same extent as the Aq-RHD protein, and showed two prominent DNA-
protein complexes that migrated more slowly than the Aq-RHD-DNA complex.  
Taken together, these results demonstrate that removal of C-terminal ANK repeat 
domain sequences of Aq-NF-κB enables the protein to activate transcription in vertebrate 
cells, but the presence of C-terminal sequences of Aq-NF-κB does not substantially inhibit 
its DNA-binding activity when Aq-NF-κB is expressed in human cells. 
 
4.4 C-terminal truncation of Aq-NF-κB enables it to translocate to the nucleus 
and can be induced by an IKK-dependent mechanism in vertebrate cells  
 In non-canonical NF-κB pathway activation, the human NF-κB p100 protein is 
converted to an active form by proteasomal processing of C-terminal sequences up to the 
GRR, which allows for the shortened p52 protein to translocate to the nucleus (Sun, 
2011). To investigate the subcellular localization properties of Aq-NF-κB, we expressed 
the above-described FLAG-tagged Aq-NF-κB proteins in DF-1 chicken fibroblast cells 
and assessed their subcellular localization by anti-FLAG indirect immunofluorescence 
(Figure 4.3A). Full-length Aq-NF-κB showed cytoplasmic staining, whereas the C-
terminally truncated Aq-RHD protein was located exclusively in the nucleus (as judged 
by overlap with DAPI staining of the nucleus). The N-terminally deleted Aq-Cterm 





staining. Consistent with our previous results (Wolenski et al., 2011), the naturally 
shortened N. vectensis Nv-NF-κB protein localized to the nucleus in these cells. 
We have previously shown that two cnidarian NF-κB proteins (from the sea anemone 
Aiptasia and the coral Orbicella faveolata) can be induced to undergo C-terminal 
processing in human 293T cells by overexpression of human and cnidarian IKKs 
(Mansfield et al., 2017; Williams et al., 2018). Furthermore, IKK-induced processing of 
these cnidarian NF-κBs requires a cluster of C-terminal serine residues with similar 
sequence and spacing to ones found in human NF-κB p100 (Sun, 2011; Mansfield et al., 
2017; Williams et al., 2018). Previously, results from our lab indicated that co-
transfection of IKKs with Aq-NF-κB did not induce its C-terminal processing (Mansfield 
et al., 2017). This lack of processing was proposed to be due to the absence of obvious 
sequence homology of sites of IKK phosphorylation in the C-terminal sequences of Aq-
NF-κB as compared to human p100 and Aiptasia NF-κB. Based on that previous result, 
we hypothesized that the native spacing of serines near the C terminus of Aq-NF-κB was 
not allowing IKK-induced C-terminal processing of the protein. Therefore, in initial 
experiments, we created a FLAG-tagged Aq-NF-κB mutant that had the same spacing 
and number of serines as Aiptasia NF-κB (Figure 4.4). WT Aq-NF-κB and the Aq-NF-κB 
mutant containing the Aiptasia-like serine cluster were then co-transfected with vectors 
for expression of Hu-IKKβ or Ap-IKK, or the corresponding empty vector. In these 
experiments, WT Aq-NF-κB and the Aq-NF-κB-Aiptasia serine mutant were both 
processed when co-expressed with the IKKs, but neither was processed in cells 





and Figure 4.4B). This result demonstrated that the WT Aq-NF-κB can indeed be 
processed in 293T cells by co-expression of these IKKs, and that there was likely an error 
in analysis in the previous (Mansfield et al., 2017) experiments. We believe that the 
previously published Western blot (Mansfield et al., 2017) was run too long and the 
lower processed band was run off the gel or that the blot was not exposed long enough to 
detect processing of Aq-NF-κB.  
With this new information, we sought to identify sequences important for IKK-
induced C-terminal processing of Aq-NF-κB. In a re-analysis, we found that Aq-NF-κB 
contains a cluster of serine residues that are somewhat similar to the serines required for 
processing of human p100 and the sea anemone Aiptasia NF-κB protein (Figure 4.4A, 
serines in red). Additionally, the initial discovery of Aq-NF-κB identified extra sequences 
after the GRR (aa 511-681) (Gauthier and Degnan, 2008) that contained several serines, 
but the function of this region is not known (Figure 4.1A). To determine which sequences 
were required for processing of Aq-NF-κB, we created three mutants: 1) with five C-
terminal serine residues (Figure 4.4A serines in red) changed to phospho-resistant 
alanines (ALA), 2) with a deletion of the additional region between the GRR and the 
ANK repeats (D), and 3) a double mutant (DALA) that had both the serine-to-alanine 
mutations and the deletion of aa 511-681 region. The Aq-NF-κB-ALA mutant showed 
substantially reduced IKK-induced processing as compared to wild-type Aq-NF-κB in 
293T cells (Figure 4.3C, top and bottom, lanes 3 and 4). The Aq-NF-κBD mutant showed 
a level of IKK-induced processing similar to WT Aq-NF-κB (Figure 4.3C, top and 





processing as compared to the Aq-NF-κBD mutant (Figure 4.3C, top and bottom, lanes 7 
and 8). Overall, these results demonstrate that IKK-induced C-terminal processing can 
also occur with Aq-NF-κB, and that this processing requires a cluster of C-terminal serine 
residues but does not require the additional sequences (aa 511-681) in Aq-NF-κB. 
To determine whether these Aq-NF-κB serine residues could be directly 
phosphorylated by human IKKβ, we first generated bacterially expressed GST-fusion 
peptides containing either the wild-type or phospho-resistant alanine sequences (aa 1048-
1086) near the C terminus of Aq-NF-κB. These GST-fusion proteins were then incubated 
with FLAG-Hu-IKKβ in a radioactive in vitro kinase assay. As shown in Figure 4.3D, the 
GST-tagged peptides containing the wild-type Aq-NF-κB serine residues, but not the Ala 
residues, were phosphorylated by IKKβ. 
 
4.5 Sponge tissue expresses putative NF-κB proteins and contains NF-κB site 
DNA-binding activity that increases following treatment with bacterial 
lipopolysaccharide (LPS)  
To determine whether sponge tissue expresses active NF-κB, we acquired tissue 
from an aquarium grown black encrusting demosponge from the Caribbean that is likely 
of the genus Cliona (Figure 4.5A, and Figure 4.6). This sponge was chosen because of the 
difficulty of growing A. queenslandica in captivity (Degnan et al., 2008) and because 
preliminary experiments showed that our anti-sea anemone Aiptasia (Ap) NF-κB antiserum 
(Mansfield et al., 2017) cross-reacted with our aquarium sponge NF-κB protein but not 





encrusting sponge tissue detected one high (~130 kDa) and one lower (~65 kDa) molecular 
weight band, with the majority of the protein being in the lower band (Figure 4.5B). As 
expected, the anti-Aiptasia NF-κB antibody detected two bands of appropriate sizes in a 
293T cell extract containing overexpressed Aiptasia NF-κB (Figure 4.5B).  
When this same sponge tissue lysate was analyzed by an EMSA using an NF-κB-
site probe, a band was detected that migrated similar to the prominent band seen with 
extracts from 293T cells overexpressing FLAG-Aq-RHD (Figure 4.5C).  
To analyze the organismal pattern of NF-κB expression, we performed anti-NF-κB 
immunofluorescence on cryosections of black encrusting sponge tissue. A subset of cells 
expressed immunoreactive proteins that closely coincided with Hoechst-stained nuclei in 
the tissue (Figure 4.5D, for quantitation, Table 4.1). 
Overall, the results in this section indicate that the black encrusting sponge tissue 
has proteins that are similar to full-length and processed NF-κB proteins from other 
species, contains NF-κB-site binding activity, and expresses NF-κB in the nucleus of some 
but not all cells.  
To determine whether a known activator of mammalian NF-κB could affect sponge 
NF-κB, we treated black encrusting sponge tissue with E. coli lipopolysaccharide (LPS) 
for 30 min and then analyzed the tissue by Western blotting or EMSA. After treatment with 
LPS, the amount of processed protein (lower band, Figure 4.7A) increased by 
approximately 15% and the amount of unprocessed protein decreased by approximately 
10% (normalized to the α-tubulin loading control, Figure 4.8). Additionally, LPS treatment 





Overall, these results demonstrate that treatment of the isolated sponge tissue with E. coli-
derived LPS results in an increase in NF-κB processing and DNA-binding activity. 
 
4.6 Chapter 4 summary 
In this chapter, it is demonstrated that at least two sponges have active NF-κB 
proteins. First, it is shown that the A. queenslandica NF-κB protein is phylogenetically 
and structurally similar to other metazoan NF-κB proteins, and that its DNA-binding 
profile, transactivation properties, and subcellular regulation by C-terminal sequences are 
similar to NF-κB proteins found in other species. It is also demonstrated that a black 
encrusting demosponge contains a protein that can bind a conserved κB site in an EMSA 
and two proteins that can be detected by an anti-NF-κB antibody in Western blots and 
tissue immunofluorescence. Furthermore, treatment of this sponge tissue with LPS leads 
to further activation of its putative NF-κB protein, as shown by both increased processing 
and increased DNA binding. Finally, it is shown that A. queenslandica contains 
homologs to many components of a TLR-to-NF-κB pathway (Figure 4.9 and Table 4.2). 
Taken together, these results suggest that sponges have a highly conserved NF-κB 








Table 4.1 Quantification of NF-κB positive nuclei in DF-1 cells and sponge tissue  
Sponge Tissue    
Number of nuclei 
counted 
Number of NF-




233 111 44%  
    
    
    
DF-1 cells 
Localization of the FLAG-tagged protein (NF-κB positive/ 
total cells counted) 
Transfected 
Plasmid Nucleus Cytoplasm Cytoplasm/Nucleus 
FLAG-Nv-NF-κB  79/79 (100%) 0 0 
FLAG-Aq-NF-κB  0 238/238 (100%) 0 
FLAG-Aq-RHD 449/452 (99.3%) 0 3/452 (0.7%) 


















Number of A. 
queenslandica 
Homolog 




TLR NP_003254.2 – 
   
IL-1R 
 




MYD88 NP_002459.3 + NP_001266224.1 1 
 
IRAK NP_066961.2 + XP_019855709.1 
XP_019855710.1 
2 Only has Kinase 
domain (missing 
death domains) 













13 Most have ring 
domains and 
MATH domains, 







   
IKKα NP_001269.3 – 
   
IKKβ NP_001547.1 – 
   
TBK/IK
Kε 














+ NP_001266238.1 1 
 
RelB NP_006500.2 – 
  
  
Listed are select proteins in the TLR–NF–κB pathway (see Figure 4.9) and their 
Accession numbers on NCBI. “Blast Accession Number” indicates the protein sequence 
used to identify the A. queenslandica homolog. Comments provide details of domain 










Figure 4.1 The A. queenslandica NF-κB protein resembles other metazoan NF-κB 
proteins both structurally and phylogenetically.  
(A) Schematic of Aq–NF–κB domains: Rel Homology Domain (RHD, blue), Nuclear 
Localization Sequence (NLS, orange), Glycine-Rich Region (GRR, yellow), extra 
sequences after GRR (grey), Ankyrin Repeats (ANK, red), and conserved C-terminal 
serines (SSS). (B) Schematic comparing domain structures of Aq–NF–κB (1096 amino 
acids), the previously characterized sea anemone Aiptasia NF-κB protein (Ap–NF–κB), 
human p100, and the naturally truncated N. vectensis NF-κB (Nv–NF–κB). Functional 
domains shared between these proteins are marked by colors, as in (A). (C) Phylogenetic 
analysis of RHD sequences of the indicated NF-κB proteins was performed using 
Maximum Likelihood analysis. The phylogeny was rooted with the predicted RHD of the 





Figure 4.2 Aq–NF–κB contains sequences that can bind to DNA and activate 
transcription.  
(A) Comparison of the DNA-binding profile of Aq–NF–κB in a protein binding 
microarray (PBM) to the N. vectensis (Nv) NF-κB (cysteine (Cys) allele) (top, left), 
human c-Rel (top, right), p52 (bottom, left), and RelA (bottom, right). Red dots represent 
random background sequences and blue dots represent κB binding sites. Z-scores are 
compared. (B) FLAG-tagged expression vectors used in these experiments. From top to 
bottom, the drawings depict the naturally shortened Nv–NF–κB, full-length Aq–NF–κB, 





C-terminal-only mutant containing the ANK repeats and other C-terminal sequences (Aq-
Cterm). (C) Anti-FLAG Western blot of 293T cell lysates transfected with the indicated 
expression vectors. (D) A κB-site luciferase reporter gene assay was performed with the 
indicated proteins in 293 cells. Luciferase activity is relative (Rel.) to that seen with the 
empty vector control (1.0), and values are averages of three assays performed with 
triplicate samples with standard error. (E) A GAL4-site LacZ reporter gene assay was 
performed in yeast Y190 cells. β-galactosidase (β-gal) reporter gene activity is relative 
(Rel.) to the GAL4 (aa 1–147) control (1.0) and is presented on a log-scale. Values are 
averages of seven assays performed with duplicate samples with standard error. (F) A 
κB-site electromobility shift assay (EMSA) using each of the indicated lysates, as in (C). 








Figure 4.3 C-terminal sequences of Aq–NF–κB inhibit nuclear translocation and can 
undergo IKK-dependent degradation and phosphorylation.  
(A) DF-1 chicken fibroblasts were transfected with the indicated FLAG vectors and 
subjected to anti-FLAG indirect immunofluorescence. Anti-FLAG, green (left); DAPI-
stained nuclei, blue (middle); and merged images (right). For quantitation of staining see 
Table 4.1 (B). An alignment of relevant sequences of NF-κB from human p100, the sea 
anemone Aiptasia, and A. queenslandica. Conserved serine residues are indicated in red. 





(WT), C-terminal alanine mutant (ALA), aa 511–681 deletion mutant (Δ), or double 
mutant (ΔALA) and with empty vector (−), FLAG-Hu-IKKβ (+, top) or FLAG-Ap-IKK 
(+, bottom). Full-length and processed forms of Aq–NF–κB, and FLAG-Hu-IKKβ are 
indicated. Lanes are numbered at the bottom. (D) In vitro kinase assay (top) using FLAG-
Hu-IKKβ protein with bacterially expressed substrates of GST alone or GST fusion 
proteins containing the wild-type (WT) serine residues of Aq–NF–κB (aa 1048–1086), or 
the same C-terminal residues with conserved serines mutated to alanines (ALA). The 
GST proteins were electrophoresed on an SDS-polyacrylamide gel and stained with 
Coomassie blue (bottom). (E) Anti-FLAG Western blot of 293T cells co-transfected with 
FLAG-Aq–NF–κB and with empty vector (−), HA-NIK, or HA-IKKβ SS/EE. The full-
length and processed forms of Aq–NF–κB are indicated (top). The same membrane was 
stripped and probed using an anti-HA antiserum to detect NIK and IKKβ SS/EE 
(bottom). (F) Anti-FLAG Western blot of 293T cells co-transfected with FLAG-Aq–NF–
κB and either empty vector (−) or FLAG-Hu-IKKβ. Cells were untreated (−) or pre-







Figure 4.4 IKKs can induce processing of both WT Aq-NF-κB and Aq-NF-κB-
Aiptasia serine mutant.  
(A) Amino acid (aa) sequences for IKK-induced phosphorylation and processing in Ap-
NF-κB (top) aligned with Aq-NF-κB aa sequence (middle). Aq-NF-κB-Aiptasia serine 
mutant (bottom) was created by changing Aq-NF-κB aa 1068-1077 to aa 799-808 from 
Ap-NF-κB. Shown in red are relevant serines. (B) Western blot of lysates from 293T 
cells co-transfected with Aq-NF-κB wild-type (WT) or Aq-NF-κB-Aiptasia serine mutant 
and with empty vector (-) or HA-Hu-IKKβ or FLAG-Ap-IKK (bottom). Full-length and 






Figure 4.5 Demosponge tissue extract contains an NF-κB-like protein that has DNA-
binding activity and localizes to the nucleus.  
(A) Black encrusting demosponge (Cliona sp.) tissue under a light microscope. (B) Anti-
Ap–NF–κB Western blot of lysates from 293T cells transfected with either empty vector 
(first lane) or FLAG-Ap–NF–κB (middle lane), and a lysate from black encrusting 
sponge tissue (third lane). Molecular weight markers are indicated to the left of the blot in 





empty vector (−) or FLAG-Aq-RHD, or with tissue extracts from black encrusting 
sponge tissue (Sponge). The shifted protein-DNA complexes and free probes are 
indicated. (D) Confocal microscopy of cryosectioned sponge tissue identifies cells that 
express NF-κB, which is primarily localized to the nucleus. NF-κB is in green (left 
panel), Hoechst-stained nuclei are shown in blue (middle panel), and a merged image 






Figure 4.6 The black encrusting sponge most closely resembles a demosponge of the 
genus Cliona.  
(A) The top five BLAST hits from the black encrusting sponge CO1 PCR product (see 
text and Materials and Methods). (B) A comparison of the morphologies and 
geographical locations of three of the top five BLAST hits from the black encrusting 





databases, our black encrusting sponge is most likely this sponge based on color, 









Figure 4.7 Treatment of sponge tissue with LPS results in increased NF-κB protein 
processing and activity.  
Black encrusting sponge tissue was treated with control water (mock) or E. coli-derived 
lipopolysaccharide (LPS) for 30 min. Lysates were then prepared and analyzed by anti–
NF–κB Western blotting (A) or EMSA (B). (A) The left-most two lanes contain lysates 
from 293T cells transfected with empty vector (−) or FLAG-Ap–NF–κB, respectively. 
Lanes three and four contain black encrusting sponge tissue extracts that were from either 
control treated (mock) or LPS-treated (LPS) tissue. α-tubulin Western blotting is shown 
below for normalization purposes. (B) A κB-site EMSA with a 293T cell lysate 
expressing FLAG-Aq-RHD (first lane), or with extracts from mock-treated or LPS-
treated black encrusting sponge tissue (third and fourth lanes, respectively). The NF-κB-






Figure 4.8 NF-κB processing is induced upon LPS stimulation in black encrusting 
sponge tissue.  
The amount of NF-κB protein as compared to α-tubulin protein, as a percentage of 








Figure 4.9 NF-κB pathway proteins and upstream receptors identified in A. 
queenslandica.  
NF-κB pathway members that are present in humans are colored in blue, and homologs 







DIVERSIFICATION OF TRANSCRIPTION FACTOR NF-κB IN PROTISTS5  
5.1 Introduction 
Transcription factor NF-κB (Nuclear Factor-κB) has been extensively studied for 
its roles in development and immunity in animals from sponges to humans (Gilmore, 
2006; Ghosh and Hayden, 2012; Williams and Gilmore, 2020). Only within the last few 
years has it been discovered that the appearance of NF-κB pre-dates metazoan life; that 
is, that certain single-cell eukaryotes--namely some choanoflagellates and the holozoan 
Capsaspora owczarzaki--also contain genes encoding NF-κB-like proteins (Suga et al., 
2013; Richter et al., 2018). In this chapter, the first functional characterization of this 
important transcription factor in single-celled protists is presented. 
Protists comprise a large group of eukaryotes that are either unicellular or 
multicellular with poorly differentiated tissue, and they make up one of the six major 
Kingdoms (Archibald et al., 2017). Presumably, protists have a common ancestor, but 
they are now known to be an extensively diverse collection of organisms with several 
major supergroups. Two protists that have been studied reasonably well are Capsaspora 
and the taxonomic class of choanoflagellates, both of which are in the Opisthokonta 
subgroup.  
Capsaspora is a single-celled eukaryote that is thought to be among the closest 
unicellular relatives to animals (i.e., basal to sponges) and is the sister group to the 
Filozoa (the clade comprising metazoans and choanoflagellates) (Ferrer-Bonet and Ruiz- 
 





Trillo, 2017). Capsaspora was originally discovered as an amoeba-like symbiont in the 
hemolymph of the fresh-water snail Biomphalaria glabrata. Capsaspora kills sporocysts 
of the flatworm Schistosoma mansoli, the causative agent of schistosomiasis in humans, 
which also inhabits B. glabrata (Stibbs et al., 1979). More recently, the life cycle of 
Capsaspora has been shown to contain three different cell configurations (Stibbs et al., 
1979). Under in vitro culture conditions, Capsaspora grow primarily as filopodial cells, 
which attach to the substrate and undergo active replication until the end of the 
exponential growth phase. Then, cells start to detach, retracting their branching filopodia 
and encysting. During this cystic phase, cell division is stopped. Alternatively, filopodia 
cells can form a multicellular aggregative structure by secreting an unstructured 
extracellular matrix that promotes aggregation but prevents direct cell-cell contact (Sebé-
Pedrós et al., 2013). The genome of Capsaspora contains many genes involved in 
metazoan multicellular processes including integrins, protein tyrosine kinases, and 
transcription factors, including NF-κB (Suga et al., 2013). Furthermore, RNA-sequencing 
has revealed that each life stage contains distinct transcriptomic profiles (Sebé-Pedrós et 
al., 2013). However, the details of how these life-stage processes and transitions are 
carried out on the molecular level in a unicellular organismal context remain unclear.   
A second class of protists of interest for evolutionary biologists includes the 
choanoflagellates. These flagellated eukaryotes comprise over 125 species of free-living 
unicellular and colonial organisms distributed in nearly every aquatic environment (King, 
2005). Choanoflagellates are also widely regarded as being close living relatives to the 





feeding of choanoflagellates on bacteria provides a critical ecological role within the 
global carbon cycle by linking trophic levels. Until somewhat recently, little was known 
about the genomic diversity of choanoflagellates, with only two published genomes of 
Monosiga brevicollis and Salpingoeca rosetta (King et al., 2008; Fairclough et al., 2013). 
Neither genome of these species contains homologs to NF-κB, and it was thought for 
nearly a decade that this transcription factor had been lost in the evolutionary branch 
containing choanoflagellates. However, in 2018, Richter et al. (2018) reported the 
transcriptomes of 19 additional choanoflagellates.  Of these 19 species of 
choanoflagellates, 12 expressed one-to-three NF-κB-like transcripts. Amazingly, 
sequence comparisons have revealed that choanoflagellates are generally as genetically 
distant from each other as a mouse is from a sea sponge, a testimony to the modern-day 
diversity among these taxa (Richter et al., 2018). Among basal organisms -including 
cnidarians, poriferans, and some protists- only NF-κB-like proteins have been found 
(Williams and Gilmore, 2020). Indeed, no Rel proteins have been identified in any 
organism basal to flies.  
Transcriptomic and genomic sequencing has revealed that NF-κB and homologs 
of many of its upstream regulators are present in most eukaryotes from protists to 
vertebrates (Wolenski and Gilmore, 2012; Williams and Gilmore, 2020). However, the 
numbers and structures of these signaling proteins vary across species, and generally 
become more complex and numerous through evolutionary time (Wolenski and Gilmore, 
2012). Furthermore, in the most basal groups of metazoans (cnidarians and sponges), 






In this chapter, the molecular functions of transcription factor NF-κB in two 
unicellular protists are characterized using phylogenetic, cellular, and biochemical 
techniques. As with the human p100 protein, it is shown that some unicellular NF-κB 
proteins require removal of C-terminal ANK repeats to enter the nucleus and bind DNA. 
However, Co-NF-κB does not undergo IKK-mediated processing, and homologs to IKK 
do not exist in Capsaspora or choanoflagellates. Furthermore, it is shown that the 
multiple NF-κBs of a single choanoflagellate can form heterodimers, a first finding in an 
organism outside of the kingdom Animalia, suggesting that choanoflagellates contain 
their own subclasses of NF-κBs, much like in vertebrates and flies. These results are the 
first functional characterization of NF-κB in a taxonomic kingdom outside Animalia.  
 
5.2 Protist NF-κB proteins vary in domain structure and choanoflagellates show 
evidence of gene duplication  
Suga et al. (2013) reported the presence of a single gene encoding an NF-κB-like 
protein in C. owczarzaki (Co). The overall protein structure of Co-NF-κB is similar to 
most other basal NF-κB proteins known to date, in that it has an N-terminal RHD, 
followed by a glycine-rich region (GRR), and five C-terminal ANK repeats (Wolenski et 
al., 2013; Mansfield et al., 2017; Williams et al., 2018; Williams et al., 2020). However, 
Co-NF-κB is larger than other NF-κB homologs, due primarily to additional residues C-
terminal to the ANK repeats (Figure 5.1A), Recently, Richter et al. (2018) showed that 





κB-like genes are not present in two commonly studied choanoflagellates (M. brevicollis 
and S. rosetta) (King et al., 2008; Fairclough et al., 2013). Overall, 12 of the 21 
choanoflagellates are now known to contain NF-κB-like genes, and among those 12, 
there are one, two, or three NF-κB transcripts present.  
A phylogenetic comparison suggests that many of the choanoflagellate NF-κBs 
arose from gene duplications within a given species because the multiple NF-κBs from a 
given species often cluster closely to each other (for example, Diaphanoeca grandis and 
Salpingoeca helianthica) (Figure 5.1B, Table 5.1). Nevertheless, there are some 
choanoflagellates that have multiple NF-κBs that cluster separately with the NF-κBs of 
other choanoflagellate (e.g., Acanthoeca spectabilis and Savillea parva).  
In contrast to what is seen in most basal metazoans, these choanoflagellates 
express transcripts that primarily encode RHD sequences, with no C-terminal GRRs or 
ANK repeats. However, some choanoflagellate NF-κBs do contain extended N termini 
with homology to sequences not normally associated with NF-κBs in vertebrates (Figure 
5.1A, pink bar). 
 
5.3 DNA binding, nuclear translocation, and transactivation by Co-NF-κB  
To investigate the overall DNA binding-site specificity of Co-NF-κB, we first 
characterized the activity of a bacterially expressed Co-NF-κB RHD-only protein by 
protein binding microarray (PBM) analysis on an array containing 2592 κB-like sites and 
1159 random background sequences (for complete array probe sequences, see Mansfield 





DNA-binding profile of Co-NF-κB is most similar to NF-κBs from the sea anemone N. 
vectensis and human p52, and it is distinct from human c-Rel and RelA (Figure 5.2A). 
 To investigate properties of Co-NF-κB in cells, we created pcDNA-FLAG vectors 
for full-length Co-NF-κB and two truncation mutants, one (FLAG-Co-RHD) containing 
the N-terminal RHD sequences including the NLS and the GRR, and a second (FLAG-
Co-Cterm) consisting of the C-terminal ANK repeat sequences and downstream residues 
(Figure 5.2B). As a control, we used the active, naturally truncated N. vectensis (Nv) 
FLAG-tagged Nv-NF-κB protein that we have characterized previously (Wolenski et al., 
2011) (Figure 5.2B). As shown by anti-FLAG Western blotting, each plasmid expressed 
a protein of the appropriate size when transfected into HEK 293T cells (Figure 5.2C). 
 In sponge and some cnidarian NF-κBs, removal of C-terminal ANK-repeat 
sequences are required for nuclear localization in vertebrate cell-based assays (Mansfield 
et al., 2017; Williams et al., 2018; Williams et al., 2020). Based on those results, we next 
transfected each FLAG expression plasmid into DF-1 chicken fibroblast cells and 
performed indirect immunofluorescence using anti-FLAG antiserum (Figure 5.2D; Table 
5.1). Full-length Co-NF-κB and Co-Cterm were both located primarily in the cytoplasm 
of these cells (99.9% and 94%, respectively). In contrast, the Co-RHD and control Nv-
NF-κB proteins were both primarily nuclear, as evidenced by co-localization with the 
Hoechst-stained nuclei (Figure 5.2D; Table 5.1). Thus, the removal of the ANK repeats 
allows Co-NF-κB to enter the nucleus, consistent with what is seen with other metazoan 
RHD-ANK bipartite NF-κB proteins. 





extracts from 293T cells transfected with each of the FLAG constructs were analyzed in 
an electrophoretic mobility shift assay (EMSA) using a high affinity κB-site probe. 
Extracts containing overexpressed Nv-NF-κB and Co-RHD bound the κB site avidly, 
whereas extracts containing full-length Co-NF-κB and Co-Cterm showed essentially no 
κB site-binding activity (Figure 5.2E).  
 We also assessed the ability of Co-NF-κB proteins to activate transcription in 
reporter gene assays in HEK 293 cells using a κB-site reporter. Co-RHD and Nv-NF-κB 
activated transcription well above control levels (i.e., Co-RHD was ~60-fold above the 
negative control; Figure 5.2F). In contrast, full-length or Cterm Co-NF-κB proteins 
showed little to no ability to activate transcription. From these data, the ability to activate 
transcription of a κB site gene locus appears to be a property of sequences within the N-
terminal half of Co-NF-κB. We also assessed the ability of Co-RHD to activate 
transcription in reporter gene assays in yeast cells using a GAL4-site reporter. Indeed, the 
N-terminal half (RHD) of Co-NF-κB activated transcription strongly, nearly 1000-fold 
above the GAL4 (aa 1-147) alone negative control. The transactivation ability of the 
GAL4-RHD sequences of Co-NF-κB in yeast suggests that this is an intrinsic property of 
these sequences.  
  Taken together, the results in this section show that Co-RHD can bind DNA, 
activate transcription, and localizes primarily to the nucleus, unlike the inactive full-
length Co-NF-κB protein, consistent with findings with most NF-κBs from sponges to 
humans when assayed in vertebrate cells (Wolenski et al., 2011; Mansfield et al., 2017; 





5.4 IKK-mediated processing of NF-κB appears to have evolved with the rise of 
multicellularity  
 As is described above for Co-NF-κB, vertebrate NF-κB p100 requires the removal 
of its C-terminal ANK repeats to enter the nucleus and activate transcription (Sun, 2011). 
This proteasome-mediated processing of p100 is initiated by phosphorylation of a C-
terminal cluster of serine residues by an IκB kinase (IKK) (Sun, 2011). We have 
previously shown that some basal organisms, including NF-κB proteins from two 
cnidarians and one sponge, contain homologous C-terminal serines that can be 
phosphorylated by IKKs to initiate proteasome-mediated processing in human cell culture 
assays (Mansfield et al., 2017; Williams et al., 2018; Williams et al., 2020). Examination 
of the C-terminal sequences of Co-NF-κB failed to identify any C-terminal serine clusters 
similar to other NF-κBs that undergo IKK-initiated processing. Nevertheless, we 
performed a series of experiments that examined the ability of IKK to induce processing 
of Co-NF-κB by co-transfecting HEK 293T cells with Co-NF-κB and several IKK 
proteins, including two from humans and one from a sea anemone (Mansfield et al., 
2017; Williams et al., 2018; Williams et al., 2020). In all cases, co-expression of the IKK 
did not induce processing of Co-NF-κB (Figure 5.3A), beyond the small amount of 
constitutive processing of Co-NF-κB that occurs even in the absence of IKK (Figure 5.3A 
and Figure 5.2C). Of note, the lower Co-NF-κB band seen in these extracts was roughly 
the same size as the predicted RHD (Figure 5.2C), and incubation of transfected cells 
with the proteasome inhibitor MG132 reduced the appearance of the lower band, 





To determine whether Co-NF-κB could be processed by an IKK-dependent 
mechanism, we created a mutant in which we replaced C-terminal sequences Co-NF-κB 
(downstream of the ANK repeats) with C-terminal sequences of the sea anemone 
Aiptasia (Ap)-NF-κB that contain conserved serines which can facilitate IKK-induced 
processing of Ap-NF-κB (Mansfield et al., 2017). We termed this mutant Co-NF-κB-
SER, and also created the analogous protein (Co-NF-κB-ALA) in which the relevant 
serines were replaced by alanines. Co-expression of Co-NF-κB-SER with constitutively 
active human IKKb (IKKb SS/EE) resulted in increased amounts of the lower band, 
which was not seen with Co-NF-κB-ALA (Figure 5.3B). Thus, the Co-NF-κB protein 
(consisting of the RHD, GRR, and ANK repeats) can undergo IKK-induced processing if 
supplied with a C terminus containing the IKK target serine residues. However, the 
native Co-NF-κB protein does not appear to be susceptible to IKK-induced processing, 
which is also consistent with the lack of any IKK sequences in the genome of 
Capsaspora. 
 
5.5 Exogenously expressed full-length and truncated versions of Co-NF-κB localize 
primarily to the nucleus in Capsaspora cells 
We were next interested in examining the subcellular localization of NF-κB in 
Capsaspora cells. For these experiments, we transfected Capsaspora cells with our 
FLAG-tagged Co-NF-κB constructs (Co-NF-κB, mutant Co-RHD, and mutant Co-Cterm, 
see Figure 5.2D) and then performed anti-FLAG indirect immunofluorescence. 





RHD and FLAG-Co-Cterm localize to the nucleus and cytoplasm, respectively (Figure 
5.5, middle and bottom rows). Surprisingly, full-length FLAG-Co-NF-κB also appeared 
to be fully nuclear, as judged by its co-localization with the Hoechst-stained nuclei 
(Figure 5.5, top row, and Figure 5.6). We noted that the FLAG-tagged RHD and full-
length Co-NF-κB appeared as puncta within the nucleus of transfected Capsaspora cells, 
which may be indicative of active transcriptional sites (Brasch and Ochs, 1992). 
 
5.6 Co-NF-κB mRNA levels and DNA-binding activity vary coordinately across 
different life stages and the identification of putative NF-κB target genes 
Capsaspora has been shown to have three different life stages: aggregative, 
filopodia, and cystic, and RNA-Seq of each life stage has been reported (Sebé-Pedrós et 
al., 2013). We were interested in determining whether Capsaspora NF-κB protein was 
active at different levels in these three life stages and whether we could use the previous 
RNA-Seq data to identify genes whose expression may be controlled by NF-κB. We first 
examined previous mRNA expression data (Sebé-Pedrós et al., 2013) for NF-κB mRNA, 
and found that NF-κB was expressed at the lowest level in the aggregative stage and 2.3- 
and 5-fold higher in the filopodic and cystic stages, respectively (Figure 5.7A). We next 
generated cultures of Capsaspora at each life stage (Figure 5.7A), made protein extracts, 
and performed an EMSA using the κB-site probe that we showed can be bound by Co-
NF-κB expressed in HEK 293T cells (Figure 5.2E) and by bacterially expressed Co-RHD 
in our PBM assays (see Mansfield et al., 2017 for details on PBM arrays). Consistent 





aggregative, filopodic, and cystic stages (Figure 5.7B). To determine whether the EMSA 
band indeed included Co-NF-κB, we incubated our protein extracts with 10- and 25-fold 
excesses of unlabeled κB-site probe, and we saw a substantial decrease in binding in the 
putative NF-κB band. In contrast, incubation with a 25-fold excess of an unlabeled IRF-
site probe did not decrease the putative Co-NF-κB complex, indicating that the binding 
was specific for the κB-site probe. 
 We next sought to identify genes that might be influenced by the expression of 
NF-κB in order to gain insight into potential functional roles for NF-κB in these life 
stages. We examined the existing RNA-Seq data (Sebé-Pedrós et al., 2013), which 
contains the mRNA expression of 8674 genes of Capsaspora during its three life stages. 
We first narrowed our gene list to those genes that were differentially expressed in a 
manner similar to NF-κB mRNA levels and DNA-binding activity during each life stage 
(i.e., progressively increased in expression from aggregative, filopodic, and cystic 
stages). From this analysis, we identified 1348 mRNAs that were expressed at low levels 
in the aggregative stage, and progressively higher levels in the filopodic and cystic 
stages.  
          Of the 1348 genes that we identified with life-stage expression patterns similar to 
Co-NF-κB, 389 genes were annotated (which is consistent with approximately 1/4 of 
Capsaspora’s total predicted protein-encoding genes being annotated, Table 5.2), and 
305 of these 389 annotated genes had human homologs (Table 5.2). We then performed 
GO analysis to look at Biological Processes overrepresented in these 305 genes. That 





biological processes, including 14 genes that encode proteins associated with 
developmental and immune system processes (Figure 5.7C), which are biological 
processes regulated by NF-κB in many more complex organisms and suggested to be 
regulated by NF-κB in several basal organisms (Steward, 1987; Roth et al, 1989; Kappler 
et al., 1993; Reichhart et al., 1993; Mansfield et al., 2017; Williams et al., 2018; Williams 
et al., 2020). Although 14 genes may seem low, the total database for human GO analysis 
of immune system and developmental processes genes is approximately 2200 genes, but 
the number of annotated homologs that exist in Capsaspora in these two GO categories is 
only 66 genes (Table 5.3). Thus, about 20% (14/66) of the Capsaspora genes in the GO 
category for the developmental and immune processes subset are among the 305 
homologous genes coordinately regulated with NF-κB. Other broad categories 
overrepresented in these 305 genes included Signaling, Metabolic Process, and 
Locomotion (Figure 5.8).  
We then looked for NF-κB binding sites within 500 bp upstream of the 
transcription start sites (TSS) for each of the 1348 genes with expression profiles that 
were similar to NF-κB. 192 of these 1348 gene upstream regions contained one, two or 
three κB sites within 500 bp of the TSS, with the majority of these genes containing 1 κB 
site (Table 5.4). Two of the 14 genes that encode protein homologs associated with GO 
developmental and immune system processes contained a κB site within the 500 bp 
upstream of their TSS (Figure 5.7C). Of the 192 genes with κB sites, 60 are annotated. 
The GO terms within these 60 genes include similar processes, including Development 





5.7 Choanoflagellate NF-κBs can form heterodimers and have different abilities to 
bind DNA and activate transcription  
Richter et al. (2018) sequenced the transcriptomes of 19 choanoflagellates and 
identified RHD-containing NF-κB-related proteins in 12 of these species. We chose to 
characterize the NF-κB proteins from Acanthoeca spectabilis (As) because it has three 
NF-κB-like proteins, which separated into multiple branches when phylogenetically 
compared to all choanoflagellate NF-κBs (Figure 5.1B). These three As-NF-κB proteins 
contained ostensibly complete DNA-binding sequences, which were similar to other NF-
κB proteins and a putative NLS (Williams and Gilmore, 2020). These three proteins 
contained extended sequences N-terminal to the RHD, but they contained few C-terminal 
residues beyond the RHD (and no GRRs or ANK repeats). As a first step in 
characterizing these proteins, we created pcDNA FLAG vectors for As-NF-κB1, As-NF-
κB2, and As-NF-κB3 (Figure 5.9A) and transfected them into HEK 293T cells. As 
assessed by anti-FLAG Western blotting, each vector directed the expression of 
appropriately sized FLAG-tagged proteins (Figure 5.9B).  
To determine the subcellular localization properties of the three As-NF-κBs, we 
performed indirect immunofluorescence on DF-1 chicken fibroblasts and Capsaspora 
cells transfected with each FLAG-tagged vector. All three As-NF-κB proteins co-
localized with Hoechst-stained nuclei in both DF-1 cells (Figure 5.9C) and Capsaspora 
cells (Figure 5.9D). As with FLAG-tagged Co-NF-κB proteins, the FLAG-tagged As-NF-
κB proteins appeared as puncta within the nucleus of transfected Capsaspora cells. 





overexpressing each As-NF-κB, using Co-RHD as a positive control. As-NF-κB2 and 3 
bound the κB-site probe to nearly the same extent as Co-RHD, but As-NF-κB1 only 
weakly bound the probe (Figure 5.9E). We also assessed the transactivating ability of 
each As-NF-κB protein in a κB-site reporter assay in HEK 293T cells, using the strongly 
activating Co-RHD protein as a positive control. Both As-NF-κB2 and 3 were able to 
activate transcription of the luciferase reporter above vector control levels (~1.6- and 2.7-
fold, respectively) but As-NF-κB1 did not (Figure 5.9F). We also assessed the intrinsic 
transactivating ability of each As-NF-κB protein using a GAL4-fusion reporter assay in 
yeast cells. In this assay, all three As-NF-κBs activated transcription over vector control 
levels, although As-NF-κB1 and 3 activated to a much lesser degree than As-NF-κB2 
(Figure 5.9G). From these data, we hypothesized that the homodimeric version of As-NF-
κB1 was not capable of binding DNA and could not activate transcription using κB sites, 
but likely contained some intrinsic ability to activate transcription (as a GAL4-fusion 
protein), whereas homodimeric As-NF-κB2 and 3 could activate transcription both in 
human cell-based and yeast GAL4-fusion reporter assays.  
 Since As-NF-κB1 did not substantially bind DNA or activate transcription when 
transfected alone, we hypothesized that As-NF-κB1 ordinarily acts as a heterodimer with 
the other As-NF-κBs. Therefore, we performed a series of co-immunoprecipitation 
experiments to determine whether As-NF-κB1 could interact with As-NF-κB2 or As-NF-
κB3. To do this, we subcloned As-NF-κB2 and 3 into MYC-tagged vectors, co-
transfected each with FLAG-As-NF-κB1 in HEK 293T cells, and first 





and anti-MYC Western blotting on the immunoprecipitates to assess whether these NF-
κBs could interact. MYC-As-NF-κB2 and MYC-As-NF-κB3 were both co-
immunoprecipitated with FLAG-As-NF-κB1, as well as with each other (Figure 5.9H, 
IP). The MYC-As-NF-κB proteins were not seen when they were co-transfected with the 
empty vector control (Figure 5.9H, IP).  
      From these data, it appears that all three As-NF-κBs can enter the nucleus when 
expressed in vertebrate and protist cells, but they bind DNA and activate transcription to 
varying degrees. Furthermore, all three As-NF-κBs can form heterodimers with the other 
As-NF-κBs. As we discuss below, we think that the reduced ability of As-NF-κB1 to 
bind DNA and activate a reporter gene is due to a limited ability to form homodimers.  
 
5.8 Chapter 5 summary 
In this chapter, we have functionally characterized and compared, for the first time, NF-
κB proteins from two protists. Taken together, these results demonstrate that although 
functional DNA-binding and transcriptional-activating NF-κB proteins exist in these 
protists (Figure 5.10), the overall structures and regulation of these proteins varies 






Table 5.1 Quantification of NF-κB positive nuclei in DF-1 cells 
 
Localization of the FLAG-tagged protein in DF-1 cells (NF-
κB positive/total cells counted) 
Transfected 
Plasmid Nucleus Cytoplasm Cytoplasm/Nucleus 
FLAG-Nv-NF-κB  79/79 (100%) 0 0 
FLAG-Co-NF-κB  1/702 (0.1%) 701/702 (99.9%) 0 
FLAG-Co-RHD 1874/2114 (88.7%) 19/2114 (0.9%) 221/2114 (10.5%) 







Table 5.2  Genes that co-expression with NF-κB in the three life stages of 
Capsaspora, and genes that are annotated within that group  
Genes expressing 
with NF-κB   Protein product Length Protein Name 
CAOG_02491 XP_004349241.1 459 1-acyl-sn-glycerol-3-phosphate acyltransferase 
CAOG_04763 XP_004347514.1 350 2-acylglycerol O-acyltransferase 2-A 
CAOG_04187 XP_004348012.1 577 24-dehydrocholesterol reductase 
CAOG_05231 XP_004346916.2 372 2OG-Fe(II) oxygenase 
CAOG_02841 XP_004348654.2 470 3-oxoacyl-[acyl-carrier-protein] synthase 2, variant 2 
CAOG_00541 XP_004365412.1 82 40S ribosomal protein S21 
CAOG_00263 XP_004365134.1 56 40S ribosomal protein S29 




CAOG_02304 XP_004349054.1 1066 5\\'-AMP-activated protein kinase catalytic subunit alpha-1 
CAOG_05898 XP_004345488.1 513 5\\'-AMP-activated protein kinase catalytic subunit alpha-2 
CAOG_08769 XP_011270399.1 779 6-phosphofructokinase 
CAOG_02333 XP_004349083.2 945 AAA family ATPase 
CAOG_05007 XP_004346692.1 1529 ABC transporter 
CAOG_05822 XP_004345412.1 758 ABC transporter 
CAOG_07365 XP_004343224.1 209 Abca3 protein 
CAOG_04125 XP_004347950.1 322 ADP-ribosyl cyclase 
CAOG_03774 XP_004363502.1 184 ADP-ribosylation factor-like protein 8B 
CAOG_00796 XP_004365667.1 455 alkane-1 monooxygenase 








CAOG_07181 XP_004343905.2 845 ankyrin repeat domain-containing protein 13 
CAOG_07387 XP_004343246.1 392 aquaporin 10 
CAOG_05051 XP_004346736.2 829 archipelago beta form 
CAOG_05267 XP_004346952.1 436 ataxin-3 
CAOG_01086 XP_004365957.1 985 AtMMH-1 
CAOG_00397 XP_004365268.1 221 ATP synthase subunit delta 
CAOG_04594 XP_004347341.1 658 ATP-binding cassette 
CAOG_00533 XP_004365404.2 1769 ATP-binding cassette sub-family A member 1 
CAOG_00237 XP_004365108.2 616 ATP-binding cassette sub-family B member 10 
CAOG_03871 XP_004363599.2 734 ATP-binding cassette sub-family B member 7 
CAOG_04819 XP_004347570.2 621 ATP-binding cassette sub-family E member 1 
CAOG_06637 XP_004344258.2 767 ATP-binding cassette transporter sub-family G member 2c 
CAOG_06442 XP_004345191.1 257 ATP-dependent Clp protease proteolytic subunit 
CAOG_03162 XP_004364001.2 838 ATP-dependent DNA helicase 
CAOG_02749 XP_004349499.2 1149 ATP-dependent protease La 
CAOG_07773 XP_004342846.1 986 ATP-dependent protease La 
CAOG_00916 XP_004365787.1 352 ATPase 
CAOG_05593 XP_004346266.1 861 ATPase 
CAOG_04235 XP_004348060.1 1249 ATPase type 13A 
CAOG_09828   Atypical/RIO/RIO1 protein kinase, variant 4 
CAOG_06184 XP_004345774.2 433 B3GNTL1 protein 
CAOG_07333 XP_004343192.2 544 Beclin 
CAOG_00500 XP_004365371.1 533 betaine aldehyde dehydrogenase 
CAOG_00760 XP_004365631.1 338 branched-chain amino acid aminotransferase 
CAOG_00481 XP_004365352.2 455 Bystin 
CAOG_07134 XP_004343858.1 293 C-4 methylsterol oxidase 
CAOG_09996   Ca2+ transporting ATPase, plasma membrane 
CAOG_04295 XP_004348120.1 256 calcium-dependent cysteine protease 





CAOG_10057   CAMK/CAMKL/BRSK protein kinase 
CAOG_09592   CAMK/CAMKL/PASK protein kinase 
CAOG_02108 XP_004348858.2 1562 cAMP-dependent protein kinase catalytic subunit 
CAOG_07847 XP_004342925.1 249 carbonate dehydratase 
CAOG_01084 XP_004365955.2 325 carnitine/acylcarnitine carrier protein 
CAOG_00701 XP_004365572.1 355 carrier protein 
CAOG_03609 XP_004363337.2 352 carrier protein 
CAOG_04242 XP_004348067.1 473 carrier protein 
CAOG_02768 XP_004349521.1 308 casein kinase 
CAOG_05925 XP_004345515.2 493 cathepsin C 
CAOG_04515 XP_004347262.1 324 cathepsin L2 
CAOG_07286 XP_004343145.1 313 ccr4-associated factor 
CAOG_02644 XP_004349394.1 300 cell motility mediator 
CAOG_03528 XP_004348433.1 1194 ceramide kinase 
CAOG_02756 XP_004349506.2 548 cereblon 
CAOG_08208 XP_004342463.2 583 cholesterol acyltransferase 
CAOG_00569 XP_004365440.2 574 cholinesterase 
CAOG_02652 XP_004349402.1 365 chorismate mutase/prephenate dehydratase 
CAOG_01398 XP_004349918.1 205 chromatin modifying protein 1b 
CAOG_07361 XP_004343220.1 213 chromatin modifying protein 1b 
CAOG_04220 XP_004348045.2 223 chromatin modifying protein 2a 
CAOG_03362 XP_004364201.2 394 CHY zinc finger family protein 
CAOG_07281 XP_004343140.2 477 COBW domain-containing protein 
CAOG_00712 XP_004365583.1 591 collagen type IV alpha-3-binding protein 
CAOG_04276 XP_004348101.2 318 copine-9 
CAOG_04972 XP_004346657.1 1180 copper-transporting ATPase 
CAOG_01314 XP_004349834.2 480 coproporphyrinogen oxidase 
CAOG_06354 XP_004345103.1 471 cre 
CAOG_00172 XP_004365043.2 497 crk-like protein 
CAOG_01275 XP_004349795.2 837 Cullin 4 
CAOG_01396 XP_004349916.2 416 cyclin-box carrying protein isoform 
CAOG_04469 XP_004348297.1 450 cystathionine beta-lyase 





CAOG_06008 XP_004345598.2 488 cysteine desulfurylase 
CAOG_06337 XP_004345086.1 805 cytochrome b5 reductase 4 
CAOG_05595 XP_004346268.1 547 cytochrome P450 
CAOG_05678 XP_004346351.1 484 cytochrome P450 
CAOG_04035 XP_004347860.1 314 cytosolic Fe-S cluster assembling factor nbp35 
CAOG_05420 XP_004346093.2 588 Dcun1d3 protein 
CAOG_04252 XP_004348077.1 793 DDHD domain containing 2 
CAOG_06774 XP_004344395.2 598 DEAD box ATP-dependent RNA helicase 
CAOG_02709 XP_004349459.2 1324 DEAH helicase isoform 6 
CAOG_00393 XP_004365264.1 207 decarboxylase 
CAOG_08183 XP_004342784.1 336 delta-aminolevulinic acid dehydratase 
CAOG_03778 XP_004363506.1 340 deoxyhypusine synthase 
CAOG_04524 XP_004347271.1 634 deoxyribodipyrimidine photo-lyase 
CAOG_00128 XP_004364999.2 294 derlin-2 like protein 
CAOG_06433 XP_004345182.1 334 DHHC zinc finger domain-containing protein 
CAOG_05176 XP_004346861.1 396 diacylglycerol acyltransferase type 2A 
CAOG_07051 XP_004343775.2 1542 diacylglycerol kinase 1 
CAOG_01121 XP_004365992.2 363 diaphorase 
CAOG_08167 XP_004342768.2 411 dihydroderamide delta-4 desaturase 
CAOG_05518 XP_004346191.2 395 diphosphomevalonate decarboxylase 
CAOG_02451 XP_004349201.1 515 diphthamide biosynthesis protein 
CAOG_07910 XP_004342995.2 116 DNA-directed RNA polymerase II polypeptide 
CAOG_03769 XP_004363497.1 838 dolichyl-phosphate-mannose-protein mannosyltransferase 
CAOG_05442 XP_004346115.2 398 DREV methyltransferase 
CAOG_00863 XP_004365734.1 633 dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 1B 
CAOG_04903 XP_004347654.1 2072 E1A binding protein p300 
CAOG_09787   E3 ubiquitin-protein ligase NEDD4 
CAOG_03032 XP_004363871.1 797 efflux ABC transporter 
CAOG_08089 XP_004342690.1 1739 ephrin type-A receptor 4a 





CAOG_03741 XP_004363469.2 2217 eukaryotic translation initiation factor 2-alpha kinase 
CAOG_03792 XP_004363520.2 1048 eukaryotic translation initiation factor 2-alpha kinase 1 
CAOG_07494 XP_004343368.1 601 F-box/WD repeat-containing protein pof1 
CAOG_04544 XP_004347291.1 360 FAM72A protein 
CAOG_05028 XP_004346713.1 418 farnesyl-diphosphate farnesyltransferase 1 
CAOG_03987 XP_004347812.1 372 fatty acid elongase 
CAOG_01458 XP_004364326.2 268 ferredoxin 1-like protein 
CAOG_05797 XP_004345387.1 251 ferredoxin 1-like protein 
CAOG_05336 XP_004347021.1 587 ferrous ion membrane transporter DMT1 
CAOG_03584 XP_004363312.2 4679 G protein-coupled receptor 
CAOG_00499 XP_004365370.1 476 gamma-butyrobetaine dioxygenase 
CAOG_05023 XP_004346708.1 259 gamma-butyrobetaine dioxygenase 
CAOG_05409 XP_004346082.1 188 general stress protein 
CAOG_02947 XP_004363786.1 314 geranylgeranyl pyrophosphate synthetase 
CAOG_07422 XP_004343281.1 186 glucosamine-6-phosphate N-acetyltransferase 
CAOG_05976 XP_004345566.1 316 glutamate receptor Gr2 
CAOG_03218 XP_004364057.2 231 glutaredoxin-3 
CAOG_07508 XP_004343382.2 398 glutathione S-transferase 
CAOG_02422 XP_004349172.2 589 glycerol-3-phosphate acyltransferase 
CAOG_02549 XP_004349299.2 472 glycine hydroxymethyltransferase 
CAOG_00165 XP_004365036.2 823 glycosyltransferase-like protein LARGE1 
CAOG_01947 XP_004364815.2 685 gphn protein 
CAOG_05140 XP_004346825.2 933 growth hormone-regulated TBC protein 1 
CAOG_07977 XP_004342578.2 588 growth-inhibiting protein 1 
CAOG_03775 XP_004363503.1 640 GTP binding protein 4 
CAOG_02329 XP_004349079.1 205 GTP-binding protein yptV3 
CAOG_05271 XP_004346956.1 191 GTPase 
CAOG_04766 XP_004347517.2 2032 guanine nucleotide-exchange protein 
CAOG_00281 XP_004365152.1 568 heat shock factor 2 





CAOG_04678 XP_004347425.1 578 HLA-B associated transcript 5 
CAOG_04537 XP_004347284.1 573 hsp70-like protein 
CAOG_01499 XP_004364367.1 523 hydroxymethylglutaryl-CoA synthase 1 
CAOG_05029 XP_004346714.1 1125 hydroxymethylglutaryl-coenzyme A reductase 
CAOG_04522 XP_004347269.1 382 hydroxysteroid dehydrogenase 7 
CAOG_06367 pseudo gene  hypothetical protein 
CAOG_09260   hypothetical protein 
CAOG_09288   hypothetical protein 
CAOG_09291   hypothetical protein 
CAOG_09295   hypothetical protein 
CAOG_09302   hypothetical protein 
CAOG_09303   hypothetical protein 
CAOG_09304   hypothetical protein 
CAOG_09305   hypothetical protein 
CAOG_09317   hypothetical protein 
CAOG_09318   hypothetical protein 
CAOG_09321   hypothetical protein 
CAOG_09322   hypothetical protein 
CAOG_09324   hypothetical protein 
CAOG_09335   hypothetical protein 
CAOG_09336   hypothetical protein 
CAOG_09342   hypothetical protein 
CAOG_09343   hypothetical protein 
CAOG_09359   hypothetical protein 
CAOG_09360   hypothetical protein 
CAOG_09361   hypothetical protein 
CAOG_09364   hypothetical protein 
CAOG_09366   hypothetical protein 
CAOG_09367   hypothetical protein 
CAOG_09372   hypothetical protein 
CAOG_09379   hypothetical protein 
CAOG_09390   hypothetical protein 





CAOG_09398   hypothetical protein 
CAOG_09399   hypothetical protein 
CAOG_09400   hypothetical protein 
CAOG_09410   hypothetical protein 
CAOG_09412   hypothetical protein 
CAOG_09421   hypothetical protein 
CAOG_09426   hypothetical protein 
CAOG_09428   hypothetical protein 
CAOG_09459   hypothetical protein 
CAOG_09460   hypothetical protein 
CAOG_09463   hypothetical protein 
CAOG_09478   hypothetical protein 
CAOG_09490   hypothetical protein 
CAOG_09521   hypothetical protein 
CAOG_09531   hypothetical protein 
CAOG_09532   hypothetical protein 
CAOG_09534   hypothetical protein 
CAOG_09548   hypothetical protein 
CAOG_09561   hypothetical protein 
CAOG_09563   hypothetical protein 
CAOG_09574   hypothetical protein 
CAOG_09580   hypothetical protein 
CAOG_09581   hypothetical protein 
CAOG_09583   hypothetical protein 
CAOG_09584   hypothetical protein 
CAOG_09594   hypothetical protein 
CAOG_09595   hypothetical protein 
CAOG_09602   hypothetical protein 
CAOG_09603   hypothetical protein 
CAOG_09623   hypothetical protein 
CAOG_09624   hypothetical protein 
CAOG_09629   hypothetical protein 
CAOG_09634   hypothetical protein 





CAOG_09674   hypothetical protein 
CAOG_09689   hypothetical protein 
CAOG_09690   hypothetical protein 
CAOG_09692   hypothetical protein 
CAOG_09697   hypothetical protein 
CAOG_09698   hypothetical protein 
CAOG_09699   hypothetical protein 
CAOG_09702   hypothetical protein 
CAOG_09703   hypothetical protein 
CAOG_09709   hypothetical protein 
CAOG_09711   hypothetical protein 
CAOG_09712   hypothetical protein 
CAOG_09720   hypothetical protein 
CAOG_09725   hypothetical protein 
CAOG_09738   hypothetical protein 
CAOG_09739   hypothetical protein 
CAOG_09740   hypothetical protein 
CAOG_09749   hypothetical protein 
CAOG_09750   hypothetical protein 
CAOG_09759   hypothetical protein 
CAOG_09775   hypothetical protein 
CAOG_09777   hypothetical protein 
CAOG_09778   hypothetical protein 
CAOG_09786   hypothetical protein 
CAOG_09790   hypothetical protein 
CAOG_09801   hypothetical protein 
CAOG_09802   hypothetical protein 
CAOG_09808   hypothetical protein 
CAOG_09814   hypothetical protein 
CAOG_09818   hypothetical protein 
CAOG_09841   hypothetical protein 
CAOG_09845   hypothetical protein 
CAOG_09846   hypothetical protein 





CAOG_09864   hypothetical protein 
CAOG_09865   hypothetical protein 
CAOG_09868   hypothetical protein 
CAOG_09869   hypothetical protein 
CAOG_09872   hypothetical protein 
CAOG_09878   hypothetical protein 
CAOG_09887   hypothetical protein 
CAOG_09888   hypothetical protein 
CAOG_09895   hypothetical protein 
CAOG_09899   hypothetical protein 
CAOG_09902   hypothetical protein 
CAOG_09911   hypothetical protein 
CAOG_09915   hypothetical protein 
CAOG_09916   hypothetical protein 
CAOG_09926   hypothetical protein 
CAOG_09927   hypothetical protein 
CAOG_09935   hypothetical protein 
CAOG_09939   hypothetical protein 
CAOG_09942   hypothetical protein 
CAOG_09943   hypothetical protein 
CAOG_09963   hypothetical protein 
CAOG_09964   hypothetical protein 
CAOG_09967   hypothetical protein 
CAOG_09969   hypothetical protein 
CAOG_09976   hypothetical protein 
CAOG_09977   hypothetical protein 
CAOG_09990   hypothetical protein 
CAOG_10000   hypothetical protein 
CAOG_10013   hypothetical protein 
CAOG_10014   hypothetical protein 
CAOG_10016   hypothetical protein 
CAOG_10017   hypothetical protein 
CAOG_10024   hypothetical protein 





CAOG_10049   hypothetical protein 
CAOG_10051   hypothetical protein 
CAOG_10054   hypothetical protein 
CAOG_10056   hypothetical protein 
CAOG_10062   hypothetical protein 
CAOG_10074   hypothetical protein 
CAOG_10075   hypothetical protein 
CAOG_10078   hypothetical protein 
CAOG_10084   hypothetical protein 
CAOG_10085   hypothetical protein 
CAOG_10094   hypothetical protein 
CAOG_10106   hypothetical protein 
CAOG_10108   hypothetical protein 
CAOG_10109   hypothetical protein 
CAOG_10116   hypothetical protein 
CAOG_10122   hypothetical protein 
CAOG_10133   hypothetical protein 
CAOG_10145   hypothetical protein 
CAOG_10159   hypothetical protein 
CAOG_10160   hypothetical protein 
CAOG_10168   hypothetical protein 
CAOG_10174   hypothetical protein 
CAOG_10240   hypothetical protein 
CAOG_00002 XP_004364873.1 1261 hypothetical protein CAOG_00002 
CAOG_00003 XP_004364874.1 182 hypothetical protein CAOG_00003 
CAOG_00024 XP_004364895.2 2264 hypothetical protein CAOG_00024 
CAOG_00041 XP_004364912.2 485 hypothetical protein CAOG_00041 
CAOG_00061 XP_004364932.2 369 hypothetical protein CAOG_00061 
CAOG_00065 XP_004364936.2 1582 hypothetical protein CAOG_00065 
CAOG_00066 XP_004364937.2 662 hypothetical protein CAOG_00066 
CAOG_00072 XP_004364943.1 623 hypothetical protein CAOG_00072 
CAOG_00074 XP_004364945.2 1419 hypothetical protein CAOG_00074 
CAOG_00100 XP_004364971.1 208 hypothetical protein CAOG_00100 
CAOG_00103 XP_004364974.1 884 hypothetical protein CAOG_00103 





CAOG_00111 XP_004364982.2 1032 hypothetical protein CAOG_00111 
CAOG_00116 XP_004364987.1 566 hypothetical protein CAOG_00116 
CAOG_00118 XP_004364989.1 353 hypothetical protein CAOG_00118 
CAOG_00126 XP_004364997.2 399 hypothetical protein CAOG_00126 
CAOG_00127 XP_004364998.1 72 hypothetical protein CAOG_00127 
CAOG_00136 XP_004365007.2 96 hypothetical protein CAOG_00136 
CAOG_00138 XP_004365009.1 460 hypothetical protein CAOG_00138 
CAOG_00183 XP_004365054.1 602 hypothetical protein CAOG_00183 
CAOG_00195 XP_004365066.1 942 hypothetical protein CAOG_00195 
CAOG_00207 XP_004365078.1 359 hypothetical protein CAOG_00207 
CAOG_00209 XP_004365080.1 683 hypothetical protein CAOG_00209 
CAOG_00213 XP_004365084.1 1022 hypothetical protein CAOG_00213 
CAOG_00224 XP_004365095.1 147 hypothetical protein CAOG_00224 
CAOG_00228 XP_004365099.1 1263 hypothetical protein CAOG_00228 
CAOG_00230 XP_004365101.1 655 hypothetical protein CAOG_00230 
CAOG_00236 XP_004365107.1 528 hypothetical protein CAOG_00236 
CAOG_00242 XP_004365113.1 66 hypothetical protein CAOG_00242 
CAOG_00275 XP_004365146.2 759 hypothetical protein CAOG_00275 
CAOG_00280 XP_004365151.1 305 hypothetical protein CAOG_00280 
CAOG_00295 XP_004365166.2 478 hypothetical protein CAOG_00295 
CAOG_00298 XP_004365169.2 970 hypothetical protein CAOG_00298 
CAOG_00303 XP_004365174.2 854 hypothetical protein CAOG_00303 
CAOG_00333 XP_004365204.2 1075 hypothetical protein CAOG_00333 
CAOG_00340 XP_004365211.1 435 hypothetical protein CAOG_00340 
CAOG_00345 XP_004365216.1 842 hypothetical protein CAOG_00345 
CAOG_00362 XP_004365233.1 155 hypothetical protein CAOG_00362 
CAOG_00387 XP_004365258.1 573 hypothetical protein CAOG_00387 
CAOG_00395 XP_004365266.2 714 hypothetical protein CAOG_00395 
CAOG_00412 XP_004365283.2 715 hypothetical protein CAOG_00412 
CAOG_00466 XP_004365337.1 331 hypothetical protein CAOG_00466 
CAOG_00502 XP_004365373.1 366 hypothetical protein CAOG_00502 
CAOG_00504 XP_004365375.1 55 hypothetical protein CAOG_00504 
CAOG_00510 XP_004365381.1 138 hypothetical protein CAOG_00510 
CAOG_00526 XP_004365397.1 176 hypothetical protein CAOG_00526 
CAOG_00528 XP_004365399.2 1347 hypothetical protein CAOG_00528 
CAOG_00537 XP_004365408.1 341 hypothetical protein CAOG_00537 





CAOG_00540 XP_004365411.1 347 hypothetical protein CAOG_00540 
CAOG_00542 XP_004365413.1 330 hypothetical protein CAOG_00542 
CAOG_00548 XP_004365419.2 730 hypothetical protein CAOG_00548 
CAOG_00562 XP_004365433.1 534 hypothetical protein CAOG_00562 
CAOG_00574 XP_004365445.1 644 hypothetical protein CAOG_00574 
CAOG_00581 XP_004365452.1 195 hypothetical protein CAOG_00581 
CAOG_00585 XP_004365456.1 555 hypothetical protein CAOG_00585 
CAOG_00623 XP_004365494.2 126 hypothetical protein CAOG_00623 
CAOG_00651 XP_004365522.1 104 hypothetical protein CAOG_00651 
CAOG_00652 XP_004365523.2 908 hypothetical protein CAOG_00652 
CAOG_00710 XP_004365581.2 552 hypothetical protein CAOG_00710 
CAOG_00715 XP_004365586.2 619 hypothetical protein CAOG_00715 
CAOG_00737 XP_004365608.2 870 hypothetical protein CAOG_00737 
CAOG_00752 XP_004365623.1 442 hypothetical protein CAOG_00752 
CAOG_00758 XP_004365629.1 2958 hypothetical protein CAOG_00758 
CAOG_00780 XP_004365651.2 2048 hypothetical protein CAOG_00780 
CAOG_00781 XP_004365652.1 442 hypothetical protein CAOG_00781 
CAOG_00794 XP_004365665.2 453 hypothetical protein CAOG_00794 
CAOG_00799 XP_004365670.2 408 hypothetical protein CAOG_00799 
CAOG_00805 XP_004365676.1 878 hypothetical protein CAOG_00805 
CAOG_00833 XP_004365704.1 206 hypothetical protein CAOG_00833 
CAOG_00839 XP_004365710.1 311 hypothetical protein CAOG_00839 
CAOG_00842 XP_004365713.1 132 hypothetical protein CAOG_00842 
CAOG_00851 XP_004365722.1 263 hypothetical protein CAOG_00851 
CAOG_00866 XP_004365737.1 566 hypothetical protein CAOG_00866 
CAOG_00879 XP_004365750.1 136 hypothetical protein CAOG_00879 
CAOG_00883 XP_004365754.1 443 hypothetical protein CAOG_00883 
CAOG_00896 XP_004365767.2 593 hypothetical protein CAOG_00896 
CAOG_00912 XP_004365783.2 1721 hypothetical protein CAOG_00912 
CAOG_00924 XP_004365795.1 603 hypothetical protein CAOG_00924 
CAOG_00933 XP_004365804.2 386 hypothetical protein CAOG_00933 
CAOG_00946 XP_004365817.2 653 hypothetical protein CAOG_00946 
CAOG_00951 XP_004365822.1 458 hypothetical protein CAOG_00951 
CAOG_00967 XP_004365838.2 1184 hypothetical protein CAOG_00967 
CAOG_00973 XP_004365844.1 378 hypothetical protein CAOG_00973 
CAOG_00979 XP_004365850.2 169 hypothetical protein CAOG_00979 





CAOG_01001 XP_004365872.1 519 hypothetical protein CAOG_01001 
CAOG_01017 XP_004365888.2 859 hypothetical protein CAOG_01017 
CAOG_01030 XP_004365901.2 473 hypothetical protein CAOG_01030 
CAOG_01033 XP_004365904.1 222 hypothetical protein CAOG_01033 
CAOG_01038 XP_004365909.1 1045 hypothetical protein CAOG_01038 
CAOG_01070 XP_004365941.1 1606 hypothetical protein CAOG_01070 
CAOG_01083 XP_004365954.1 697 hypothetical protein CAOG_01083 
CAOG_01127 XP_004365998.2 245 hypothetical protein CAOG_01127 
CAOG_01129 XP_004366000.2 1413 hypothetical protein CAOG_01129 
CAOG_01136 XP_004366007.1 720 hypothetical protein CAOG_01136 
CAOG_01150 XP_004366021.2 590 hypothetical protein CAOG_01150 
CAOG_01167 XP_004366038.1 565 hypothetical protein CAOG_01167 
CAOG_01175 XP_004366046.1 217 hypothetical protein CAOG_01175 
CAOG_01191 XP_004349688.2 144 hypothetical protein CAOG_01191 
CAOG_01250 XP_004349770.2 221 hypothetical protein CAOG_01250 
CAOG_01256 XP_004349776.2 429 hypothetical protein CAOG_01256 
CAOG_01257 XP_004349777.2 706 hypothetical protein CAOG_01257 
CAOG_01276 XP_004349796.2 650 hypothetical protein CAOG_01276 
CAOG_01283 XP_004349803.2 1064 hypothetical protein CAOG_01283 
CAOG_01284 XP_004349804.2 1677 hypothetical protein CAOG_01284 
CAOG_01286 XP_004349806.1 397 hypothetical protein CAOG_01286 
CAOG_01310 XP_004349830.1 82 hypothetical protein CAOG_01310 
CAOG_01315 XP_004349835.2 435 hypothetical protein CAOG_01315 
CAOG_01328 XP_004349848.2 339 hypothetical protein CAOG_01328 
CAOG_01351 XP_004349871.2 531 hypothetical protein CAOG_01351 
CAOG_01353 XP_004349873.2 751 hypothetical protein CAOG_01353 
CAOG_01365 XP_004349885.1 531 hypothetical protein CAOG_01365 
CAOG_01379 XP_004349899.2 231 hypothetical protein CAOG_01379 
CAOG_01425 XP_004349945.1 968 hypothetical protein CAOG_01425 
CAOG_01434 XP_004349954.1 138 hypothetical protein CAOG_01434 
CAOG_01450 XP_004364318.2 465 hypothetical protein CAOG_01450 
CAOG_01456 XP_004364324.1 100 hypothetical protein CAOG_01456 
CAOG_01476 XP_004364344.1 229 hypothetical protein CAOG_01476 
CAOG_01483 XP_004364351.1 219 hypothetical protein CAOG_01483 
CAOG_01487 XP_004364355.2 1613 hypothetical protein CAOG_01487 
CAOG_01497 XP_004364365.1 261 hypothetical protein CAOG_01497 





CAOG_01515 XP_004364383.1 531 hypothetical protein CAOG_01515 
CAOG_01542 XP_004364410.2 906 hypothetical protein CAOG_01542 
CAOG_01543 XP_004364411.1 410 hypothetical protein CAOG_01543 
CAOG_01615 XP_004364483.2 313 hypothetical protein CAOG_01615 
CAOG_01616 XP_004364484.1 119 hypothetical protein CAOG_01616 
CAOG_01617 XP_004364485.1 236 hypothetical protein CAOG_01617 
CAOG_01624 XP_004364492.1 702 hypothetical protein CAOG_01624 
CAOG_01629 XP_004364497.1 519 hypothetical protein CAOG_01629 
CAOG_01631 XP_004364499.2 603 hypothetical protein CAOG_01631 
CAOG_01637 XP_004364505.1 585 hypothetical protein CAOG_01637 
CAOG_01653 XP_004364521.2 1263 hypothetical protein CAOG_01653 
CAOG_01656 XP_004364524.1 347 hypothetical protein CAOG_01656 
CAOG_01657 XP_004364525.1 561 hypothetical protein CAOG_01657 
CAOG_01710 XP_004364578.1 556 hypothetical protein CAOG_01710 
CAOG_01713 XP_004364581.2 915 hypothetical protein CAOG_01713 
CAOG_01718 XP_004364586.2 783 hypothetical protein CAOG_01718 
CAOG_01728 XP_004364596.1 406 hypothetical protein CAOG_01728 
CAOG_01736 XP_004364604.2 404 hypothetical protein CAOG_01736 
CAOG_01741 XP_004364609.1 173 hypothetical protein CAOG_01741 
CAOG_01767 XP_004364635.1 394 hypothetical protein CAOG_01767 
CAOG_01771 XP_004364639.1 862 hypothetical protein CAOG_01771 
CAOG_01795 XP_004364663.1 214 hypothetical protein CAOG_01795 
CAOG_01801 XP_004364669.1 403 hypothetical protein CAOG_01801 
CAOG_01821 XP_004364689.1 445 hypothetical protein CAOG_01821 
CAOG_01823 XP_004364691.1 166 hypothetical protein CAOG_01823 
CAOG_01852 XP_004364720.1 219 hypothetical protein CAOG_01852 
CAOG_01853 XP_004364721.1 1092 hypothetical protein CAOG_01853 
CAOG_01871 XP_004364739.1 229 hypothetical protein CAOG_01871 
CAOG_01882 XP_004364750.1 231 hypothetical protein CAOG_01882 
CAOG_01886 XP_004364754.1 304 hypothetical protein CAOG_01886 
CAOG_01893 XP_004364761.2 258 hypothetical protein CAOG_01893 
CAOG_01900 XP_004364768.1 117 hypothetical protein CAOG_01900 
CAOG_01902 XP_004364770.2 200 hypothetical protein CAOG_01902 
CAOG_01906 XP_004364774.2 464 hypothetical protein CAOG_01906 
CAOG_01922 XP_004364790.2 607 hypothetical protein CAOG_01922 
CAOG_01923 XP_004364791.1 141 hypothetical protein CAOG_01923 





CAOG_01941 XP_004364809.1 3082 hypothetical protein CAOG_01941 
CAOG_01958 XP_004364826.2 143 hypothetical protein CAOG_01958 
CAOG_01971 XP_004364839.1 387 hypothetical protein CAOG_01971 
CAOG_01977 XP_004364845.2 855 hypothetical protein CAOG_01977 
CAOG_01986 XP_004364854.2 1068 hypothetical protein CAOG_01986 
CAOG_02015 XP_004348765.1 829 hypothetical protein CAOG_02015 
CAOG_02019 XP_004348769.1 484 hypothetical protein CAOG_02019 
CAOG_02032 XP_004348782.1 346 hypothetical protein CAOG_02032 
CAOG_02054 XP_004348804.1 664 hypothetical protein CAOG_02054 
CAOG_02074 XP_004348824.1 592 hypothetical protein CAOG_02074 
CAOG_02077 XP_004348827.1 197 hypothetical protein CAOG_02077 
CAOG_02087 XP_004348837.1 154 hypothetical protein CAOG_02087 
CAOG_02088 XP_004348838.1 127 hypothetical protein CAOG_02088 
CAOG_02122 XP_004348872.1 737 hypothetical protein CAOG_02122 
CAOG_02148 XP_004348898.2 593 hypothetical protein CAOG_02148 
CAOG_02156 XP_004348906.2 681 hypothetical protein CAOG_02156 
CAOG_02158 XP_004348908.1 930 hypothetical protein CAOG_02158 
CAOG_02167 XP_004348917.1 1138 hypothetical protein CAOG_02167 
CAOG_02187 XP_004348937.2 300 hypothetical protein CAOG_02187 
CAOG_02190 XP_004348940.2 3356 hypothetical protein CAOG_02190 
CAOG_02192 XP_004348942.1 215 hypothetical protein CAOG_02192 
CAOG_02193 XP_004348943.1 2772 hypothetical protein CAOG_02193 
CAOG_02202 XP_004348952.1 385 hypothetical protein CAOG_02202 
CAOG_02206 XP_004348956.1 649 hypothetical protein CAOG_02206 
CAOG_02209 XP_004348959.1 248 hypothetical protein CAOG_02209 
CAOG_02210 XP_004348960.1 71 hypothetical protein CAOG_02210 
CAOG_02216 XP_004348966.1 447 hypothetical protein CAOG_02216 
CAOG_02227 XP_004348977.2 3131 hypothetical protein CAOG_02227 
CAOG_02233 XP_004348983.2 838 hypothetical protein CAOG_02233 
CAOG_02237 XP_004348987.1 1632 hypothetical protein CAOG_02237 
CAOG_02247 XP_004348997.1 880 hypothetical protein CAOG_02247 
CAOG_02257 XP_004349007.1 1314 hypothetical protein CAOG_02257 
CAOG_02265 XP_004349015.2 69 hypothetical protein CAOG_02265 
CAOG_02275 XP_004349025.1 2013 hypothetical protein CAOG_02275 
CAOG_02276 XP_004349026.1 116 hypothetical protein CAOG_02276 
CAOG_02281 XP_004349031.2 741 hypothetical protein CAOG_02281 





CAOG_02286 XP_004349036.1 69 hypothetical protein CAOG_02286 
CAOG_02288 XP_004349038.2 679 hypothetical protein CAOG_02288 
CAOG_02290 XP_004349040.1 192 hypothetical protein CAOG_02290 
CAOG_02303 XP_004349053.2 807 hypothetical protein CAOG_02303 
CAOG_02345 XP_004349095.1 428 hypothetical protein CAOG_02345 
CAOG_02355 XP_004349105.2 377 hypothetical protein CAOG_02355 
CAOG_02363 XP_004349113.2 561 hypothetical protein CAOG_02363 
CAOG_02369 XP_004349119.1 720 hypothetical protein CAOG_02369 
CAOG_02372 XP_004349122.1 1153 hypothetical protein CAOG_02372 
CAOG_02382 XP_004349132.2 626 hypothetical protein CAOG_02382 
CAOG_02423 XP_004349173.2 366 hypothetical protein CAOG_02423 
CAOG_02441 XP_004349191.1 221 hypothetical protein CAOG_02441 
CAOG_02442 XP_004349192.1 106 hypothetical protein CAOG_02442 
CAOG_02449 XP_004349199.1 445 hypothetical protein CAOG_02449 
CAOG_02503 XP_004349253.1 443 hypothetical protein CAOG_02503 
CAOG_02527 XP_004349277.2 1328 hypothetical protein CAOG_02527 
CAOG_02546 XP_004349296.1 557 hypothetical protein CAOG_02546 
CAOG_02568 XP_004349318.2 299 hypothetical protein CAOG_02568 
CAOG_02613 XP_004349363.1 688 hypothetical protein CAOG_02613 
CAOG_02645 XP_004349395.1 101 hypothetical protein CAOG_02645 
CAOG_02665 XP_004349415.1 288 hypothetical protein CAOG_02665 
CAOG_02668 XP_004349418.1 696 hypothetical protein CAOG_02668 
CAOG_02670 XP_004349420.2 213 hypothetical protein CAOG_02670 
CAOG_02683 XP_004349433.2 151 hypothetical protein CAOG_02683 
CAOG_02691 XP_004349441.2 1812 hypothetical protein CAOG_02691 
CAOG_02715 XP_004349465.1 126 hypothetical protein CAOG_02715 
CAOG_02729 XP_004349479.1 106 hypothetical protein CAOG_02729 
CAOG_02735 XP_004349485.1 826 hypothetical protein CAOG_02735 
CAOG_02741 XP_004349491.1 2316 hypothetical protein CAOG_02741 
CAOG_02744 XP_004349494.2 332 hypothetical protein CAOG_02744 
CAOG_02761 XP_004349512.1 376 hypothetical protein CAOG_02761 
CAOG_02778 XP_004349531.2 618 hypothetical protein CAOG_02778 
CAOG_02788 XP_004349541.1 488 hypothetical protein CAOG_02788 
CAOG_02794 XP_004349547.2 219 hypothetical protein CAOG_02794 
CAOG_02800 XP_004348613.1 727 hypothetical protein CAOG_02800 
CAOG_02818 XP_004348631.1 175 hypothetical protein CAOG_02818 





CAOG_02857 XP_004363696.1 968 hypothetical protein CAOG_02857 
CAOG_02864 XP_004363703.2 900 hypothetical protein CAOG_02864 
CAOG_02891 XP_004363730.1 231 hypothetical protein CAOG_02891 
CAOG_02900 XP_004363739.2 1050 hypothetical protein CAOG_02900 
CAOG_02908 XP_004363747.2 476 hypothetical protein CAOG_02908 
CAOG_02919 XP_004363758.1 1901 hypothetical protein CAOG_02919 
CAOG_02926 XP_004363765.1 290 hypothetical protein CAOG_02926 
CAOG_02927 XP_004363766.1 304 hypothetical protein CAOG_02927 
CAOG_02934 XP_004363773.1 162 hypothetical protein CAOG_02934 
CAOG_02935 XP_004363774.1 1392 hypothetical protein CAOG_02935 
CAOG_02943 XP_004363782.2 361 hypothetical protein CAOG_02943 
CAOG_02951 XP_004363790.2 1004 hypothetical protein CAOG_02951 
CAOG_02960 XP_004363799.2 609 hypothetical protein CAOG_02960 
CAOG_02969 XP_004363808.2 696 hypothetical protein CAOG_02969 
CAOG_02970 XP_004363809.2 234 hypothetical protein CAOG_02970 
CAOG_02973 XP_004363812.1 696 hypothetical protein CAOG_02973 
CAOG_02980 XP_004363819.1 98 hypothetical protein CAOG_02980 
CAOG_03031 XP_004363870.2 1526 hypothetical protein CAOG_03031 
CAOG_03050 XP_004363889.1 412 hypothetical protein CAOG_03050 
CAOG_03051 XP_004363890.2 646 hypothetical protein CAOG_03051 
CAOG_03053 XP_004363892.1 522 hypothetical protein CAOG_03053 
CAOG_03057 XP_004363896.1 386 hypothetical protein CAOG_03057 
CAOG_03072 XP_004363911.1 3668 hypothetical protein CAOG_03072 
CAOG_03081 XP_004363920.1 1398 hypothetical protein CAOG_03081 
CAOG_03096 XP_004363935.1 500 hypothetical protein CAOG_03096 
CAOG_03101 XP_004363940.1 300 hypothetical protein CAOG_03101 
CAOG_03124 XP_004363963.2 209 hypothetical protein CAOG_03124 
CAOG_03125 XP_004363964.2 314 hypothetical protein CAOG_03125 
CAOG_03129 XP_004363968.1 175 hypothetical protein CAOG_03129 
CAOG_03135 XP_004363974.1 834 hypothetical protein CAOG_03135 
CAOG_03144 XP_004363983.1 176 hypothetical protein CAOG_03144 
CAOG_03166 XP_004364005.1 602 hypothetical protein CAOG_03166 
CAOG_03168 XP_004364007.1 431 hypothetical protein CAOG_03168 
CAOG_03186 XP_004364025.2 815 hypothetical protein CAOG_03186 
CAOG_03190 XP_004364029.1 1180 hypothetical protein CAOG_03190 
CAOG_03206 XP_004364045.2 928 hypothetical protein CAOG_03206 





CAOG_03257 XP_004364096.2 486 hypothetical protein CAOG_03257 
CAOG_03266 XP_004364105.1 330 hypothetical protein CAOG_03266 
CAOG_03304 XP_004364143.2 1655 hypothetical protein CAOG_03304 
CAOG_03306 XP_004364145.2 412 hypothetical protein CAOG_03306 
CAOG_03307 XP_004364146.2 232 hypothetical protein CAOG_03307 
CAOG_03311 XP_004364150.2 361 hypothetical protein CAOG_03311 
CAOG_03315 XP_004364154.2 872 hypothetical protein CAOG_03315 
CAOG_03335 XP_004364174.2 659 hypothetical protein CAOG_03335 
CAOG_03345 XP_004364184.1 69 hypothetical protein CAOG_03345 
CAOG_03349 XP_004364188.1 85 hypothetical protein CAOG_03349 
CAOG_03392 XP_004364231.1 364 hypothetical protein CAOG_03392 
CAOG_03420 XP_004364259.2 495 hypothetical protein CAOG_03420 
CAOG_03422 XP_004364261.2 810 hypothetical protein CAOG_03422 
CAOG_03434 XP_004364273.2 961 hypothetical protein CAOG_03434 
CAOG_03448 XP_004364287.2 231 hypothetical protein CAOG_03448 
CAOG_03463 XP_004364302.2 832 hypothetical protein CAOG_03463 
CAOG_03467 XP_004348372.2 805 hypothetical protein CAOG_03467 
CAOG_03475 XP_004348380.1 334 hypothetical protein CAOG_03475 
CAOG_03503 XP_004348408.1 395 hypothetical protein CAOG_03503 
CAOG_03525 XP_004348430.2 1529 hypothetical protein CAOG_03525 
CAOG_03535 XP_004348440.1 112 hypothetical protein CAOG_03535 
CAOG_03548 XP_004348459.1 650 hypothetical protein CAOG_03548 
CAOG_03558 XP_004363286.1 929 hypothetical protein CAOG_03558 
CAOG_03581 XP_004363309.1 170 hypothetical protein CAOG_03581 
CAOG_03592 XP_004363320.1 440 hypothetical protein CAOG_03592 
CAOG_03611 XP_004363339.1 1750 hypothetical protein CAOG_03611 
CAOG_03618 XP_004363346.2 236 hypothetical protein CAOG_03618 
CAOG_03652 XP_004363380.1 961 hypothetical protein CAOG_03652 
CAOG_03659 XP_004363387.1 377 hypothetical protein CAOG_03659 
CAOG_03677 XP_004363405.1 384 hypothetical protein CAOG_03677 
CAOG_03686 XP_004363414.2 191 hypothetical protein CAOG_03686 
CAOG_03695 XP_004363423.1 6039 hypothetical protein CAOG_03695 
CAOG_03696 XP_004363424.1 264 hypothetical protein CAOG_03696 
CAOG_03707 XP_004363435.2 359 hypothetical protein CAOG_03707 
CAOG_03726 XP_004363454.1 433 hypothetical protein CAOG_03726 
CAOG_03761 XP_004363489.1 585 hypothetical protein CAOG_03761 





CAOG_03781 XP_004363509.2 522 hypothetical protein CAOG_03781 
CAOG_03783 XP_004363511.1 1055 hypothetical protein CAOG_03783 
CAOG_03809 XP_004363537.1 539 hypothetical protein CAOG_03809 
CAOG_03823 XP_004363551.1 271 hypothetical protein CAOG_03823 
CAOG_03833 XP_004363561.2 1057 hypothetical protein CAOG_03833 
CAOG_03837 XP_004363565.1 795 hypothetical protein CAOG_03837 
CAOG_03869 XP_004363597.2 249 hypothetical protein CAOG_03869 
CAOG_03870 XP_004363598.1 322 hypothetical protein CAOG_03870 
CAOG_03883 XP_004363611.1 499 hypothetical protein CAOG_03883 
CAOG_03900 XP_004363628.1 115 hypothetical protein CAOG_03900 
CAOG_03901 XP_004363629.1 186 hypothetical protein CAOG_03901 
CAOG_03912 XP_004363640.1 317 hypothetical protein CAOG_03912 
CAOG_03928 XP_004363656.2 494 hypothetical protein CAOG_03928 
CAOG_03931 XP_004363659.2 1027 hypothetical protein CAOG_03931 
CAOG_03941 XP_004363669.2 866 hypothetical protein CAOG_03941 
CAOG_03952 XP_004363680.1 289 hypothetical protein CAOG_03952 
CAOG_03986 XP_004347811.2 616 hypothetical protein CAOG_03986 
CAOG_04002 XP_004347827.1 638 hypothetical protein CAOG_04002 
CAOG_04003 XP_004347828.1 329 hypothetical protein CAOG_04003 
CAOG_04007 XP_004347832.1 258 hypothetical protein CAOG_04007 
CAOG_04023 XP_004347848.1 837 hypothetical protein CAOG_04023 
CAOG_04029 XP_004347854.2 665 hypothetical protein CAOG_04029 
CAOG_04034 XP_004347859.1 167 hypothetical protein CAOG_04034 
CAOG_04036 XP_004347861.1 419 hypothetical protein CAOG_04036 
CAOG_04039 XP_004347864.1 371 hypothetical protein CAOG_04039 
CAOG_04056 XP_004347881.2 342 hypothetical protein CAOG_04056 
CAOG_04135 XP_004347960.2 634 hypothetical protein CAOG_04135 
CAOG_04150 XP_004347975.1 1082 hypothetical protein CAOG_04150 
CAOG_04155 XP_004347980.1 481 hypothetical protein CAOG_04155, partial 
CAOG_04202 XP_004348027.1 241 hypothetical protein CAOG_04202 
CAOG_04207 XP_004348032.2 699 hypothetical protein CAOG_04207 
CAOG_04209 XP_004348034.1 1079 hypothetical protein CAOG_04209 
CAOG_04232 XP_004348057.1 454 hypothetical protein CAOG_04232 
CAOG_04240 XP_004348065.1 188 hypothetical protein CAOG_04240 
CAOG_04248 XP_004348073.2 359 hypothetical protein CAOG_04248 





CAOG_04272 XP_004348097.2 959 hypothetical protein CAOG_04272 
CAOG_04279 XP_004348104.2 427 hypothetical protein CAOG_04279 
CAOG_04309 XP_004348137.1 535 hypothetical protein CAOG_04309 
CAOG_04318 XP_004348146.1 413 hypothetical protein CAOG_04318 
CAOG_04324 XP_004348152.1 730 hypothetical protein CAOG_04324 
CAOG_04329 XP_004348157.1 212 hypothetical protein CAOG_04329 
CAOG_04364 XP_004348192.1 986 hypothetical protein CAOG_04364 
CAOG_04373 XP_004348201.1 421 hypothetical protein CAOG_04373 
CAOG_04382 XP_004348210.1 363 hypothetical protein CAOG_04382 
CAOG_04388 XP_004348216.1 225 hypothetical protein CAOG_04388 
CAOG_04391 XP_004348219.2 225 hypothetical protein CAOG_04391 
CAOG_04405 XP_004348233.1 225 hypothetical protein CAOG_04405 
CAOG_04412 XP_004348240.1 827 hypothetical protein CAOG_04412 
CAOG_04413 XP_004348241.2 123 hypothetical protein CAOG_04413 
CAOG_04419 XP_004348247.1 182 hypothetical protein CAOG_04419 
CAOG_04430 XP_004348258.2 968 hypothetical protein CAOG_04430 
CAOG_04437 XP_004348265.1 323 hypothetical protein CAOG_04437 
CAOG_04444 XP_004348272.2 2157 hypothetical protein CAOG_04444 
CAOG_04445 XP_004348273.1 190 hypothetical protein CAOG_04445 
CAOG_04448 XP_004348276.2 1486 hypothetical protein CAOG_04448 
CAOG_04451 XP_004348279.2 222 hypothetical protein CAOG_04451 
CAOG_04466 XP_004348294.1 323 hypothetical protein CAOG_04466 
CAOG_04470 XP_004348298.1 146 hypothetical protein CAOG_04470 
CAOG_04503 XP_004348331.1 228 hypothetical protein CAOG_04503 
CAOG_04516 XP_004347263.1 260 hypothetical protein CAOG_04516 
CAOG_04525 XP_004347272.1 962 hypothetical protein CAOG_04525 
CAOG_04534 XP_004347281.1 236 hypothetical protein CAOG_04534 
CAOG_04547 XP_004347294.1 1257 hypothetical protein CAOG_04547 
CAOG_04563 XP_004347310.2 357 hypothetical protein CAOG_04563 
CAOG_04569 XP_004347316.1 975 hypothetical protein CAOG_04569 
CAOG_04576 XP_004347323.1 185 hypothetical protein CAOG_04576 
CAOG_04579 XP_004347326.1 471 hypothetical protein CAOG_04579 
CAOG_04582 XP_004347329.1 1148 hypothetical protein CAOG_04582 
CAOG_04584 XP_004347331.2 111 hypothetical protein CAOG_04584 
CAOG_04588 XP_004347335.1 383 hypothetical protein CAOG_04588 
CAOG_04642 XP_004347389.1 669 hypothetical protein CAOG_04642 





CAOG_04666 XP_004347413.2 153 hypothetical protein CAOG_04666 
CAOG_04717 XP_004347464.1 1055 hypothetical protein CAOG_04717 
CAOG_04726 XP_004347473.1 519 hypothetical protein CAOG_04726 
CAOG_04781 XP_004347532.1 518 hypothetical protein CAOG_04781 
CAOG_04786 XP_004347537.2 704 hypothetical protein CAOG_04786 
CAOG_04796 XP_004347547.1 486 hypothetical protein CAOG_04796 
CAOG_04800 XP_004347551.1 103 hypothetical protein CAOG_04800 
CAOG_04812 XP_004347563.1 236 hypothetical protein CAOG_04812 
CAOG_04830 XP_004347581.2 217 hypothetical protein CAOG_04830 
CAOG_04835 XP_004347586.1 667 hypothetical protein CAOG_04835 
CAOG_04845 XP_004347596.1 383 hypothetical protein CAOG_04845 
CAOG_04847 XP_004347598.2 165 hypothetical protein CAOG_04847 
CAOG_04849 XP_004347600.2 716 hypothetical protein CAOG_04849 
CAOG_04859 XP_004347610.1 459 hypothetical protein CAOG_04859 
CAOG_04863 XP_004347614.1 177 hypothetical protein CAOG_04863 
CAOG_04872 XP_004347623.2 699 hypothetical protein CAOG_04872 
CAOG_04879 XP_004347630.2 801 hypothetical protein CAOG_04879 
CAOG_04884 XP_004347635.1 265 hypothetical protein CAOG_04884 
CAOG_04889 XP_004347640.1 802 hypothetical protein CAOG_04889 
CAOG_04892 XP_004347643.2 189 hypothetical protein CAOG_04892 
CAOG_04895 XP_004347646.1 84 hypothetical protein CAOG_04895 
CAOG_04908 XP_004347659.1 109 hypothetical protein CAOG_04908 
CAOG_04918 XP_004347669.1 407 hypothetical protein CAOG_04918 
CAOG_04926 XP_004347677.1 554 hypothetical protein CAOG_04926 
CAOG_04941 XP_004347692.1 1747 hypothetical protein CAOG_04941 
CAOG_04999 XP_004346684.1 360 hypothetical protein CAOG_04999 
CAOG_05003 XP_004346688.1 1349 hypothetical protein CAOG_05003 
CAOG_05022 XP_004346707.1 280 hypothetical protein CAOG_05022 
CAOG_05027 XP_004346712.2 284 hypothetical protein CAOG_05027 
CAOG_05042 XP_004346727.1 392 hypothetical protein CAOG_05042 
CAOG_05056 XP_004346741.2 503 hypothetical protein CAOG_05056 
CAOG_05075 XP_004346760.2 625 hypothetical protein CAOG_05075 
CAOG_05076 XP_004346761.2 209 hypothetical protein CAOG_05076 
CAOG_05083 XP_004346768.1 1890 hypothetical protein CAOG_05083 
CAOG_05085 XP_004346770.2 420 hypothetical protein CAOG_05085 
CAOG_05108 XP_004346793.2 143 hypothetical protein CAOG_05108 





CAOG_05142 XP_004346827.2 714 hypothetical protein CAOG_05142 
CAOG_05163 XP_004346848.1 363 hypothetical protein CAOG_05163 
CAOG_05168 XP_004346853.2 583 hypothetical protein CAOG_05168 
CAOG_05169 XP_004346854.1 364 hypothetical protein CAOG_05169 
CAOG_05183 XP_004346868.1 687 hypothetical protein CAOG_05183 
CAOG_05184 XP_004346869.1 117 hypothetical protein CAOG_05184 
CAOG_05189 XP_004346874.1 2742 hypothetical protein CAOG_05189 
CAOG_05190 XP_004346875.1 156 hypothetical protein CAOG_05190 
CAOG_05226 XP_004346911.2 1618 hypothetical protein CAOG_05226 
CAOG_05233 XP_004346918.2 266 hypothetical protein CAOG_05233 
CAOG_05238 XP_004346923.2 632 hypothetical protein CAOG_05238 
CAOG_05246 XP_004346931.1 94 hypothetical protein CAOG_05246 
CAOG_05248 XP_004346933.2 612 hypothetical protein CAOG_05248 
CAOG_05251 XP_004346936.1 732 hypothetical protein CAOG_05251 
CAOG_05254 XP_004346939.1 620 hypothetical protein CAOG_05254 
CAOG_05259 XP_004346944.1 416 hypothetical protein CAOG_05259 
CAOG_05288 XP_004346973.1 1106 hypothetical protein CAOG_05288 
CAOG_05289 XP_004346974.1 459 hypothetical protein CAOG_05289 
CAOG_05296 XP_004346981.1 353 hypothetical protein CAOG_05296 
CAOG_05308 XP_004346993.1 877 hypothetical protein CAOG_05308 
CAOG_05309 XP_004346994.1 1101 hypothetical protein CAOG_05309 
CAOG_05312 XP_004346997.1 555 hypothetical protein CAOG_05312 
CAOG_05323 XP_004347008.2 211 hypothetical protein CAOG_05323 
CAOG_05339 XP_004347024.2 461 hypothetical protein CAOG_05339 
CAOG_05381 XP_004347066.1 142 hypothetical protein CAOG_05381 
CAOG_05435 XP_004346108.1 766 hypothetical protein CAOG_05435 
CAOG_05459 XP_004346132.1 648 hypothetical protein CAOG_05459 
CAOG_05460 XP_004346133.2 397 hypothetical protein CAOG_05460 
CAOG_05461 XP_004346134.2 647 hypothetical protein CAOG_05461 
CAOG_05472 XP_004346145.2 275 hypothetical protein CAOG_05472 
CAOG_05485 XP_004346158.1 110 hypothetical protein CAOG_05485 
CAOG_05497 XP_004346170.1 494 hypothetical protein CAOG_05497 
CAOG_05502 XP_004346175.1 1026 hypothetical protein CAOG_05502 
CAOG_05508 XP_004346181.2 690 hypothetical protein CAOG_05508 
CAOG_05520 XP_004346193.1 1390 hypothetical protein CAOG_05520 
CAOG_05539 XP_004346212.1 338 hypothetical protein CAOG_05539 





CAOG_05559 XP_004346232.1 1329 hypothetical protein CAOG_05559 
CAOG_05567 XP_004346240.1 560 hypothetical protein CAOG_05567 
CAOG_05576 XP_004346249.1 163 hypothetical protein CAOG_05576 
CAOG_05589 XP_004346262.2 1269 hypothetical protein CAOG_05589 
CAOG_05603 XP_004346276.1 459 hypothetical protein CAOG_05603 
CAOG_05638 XP_004346311.2 740 hypothetical protein CAOG_05638 
CAOG_05647 XP_004346320.2 179 hypothetical protein CAOG_05647 
CAOG_05652 XP_004346325.1 712 hypothetical protein CAOG_05652 
CAOG_05661 XP_004346334.1 711 hypothetical protein CAOG_05661 
CAOG_05682 XP_004346355.1 499 hypothetical protein CAOG_05682 
CAOG_05708 XP_004346381.1 159 hypothetical protein CAOG_05708 
CAOG_05709 XP_004346382.1 1199 hypothetical protein CAOG_05709 
CAOG_05719 XP_004346392.2 787 hypothetical protein CAOG_05719 
CAOG_05726 XP_004346399.2 203 hypothetical protein CAOG_05726 
CAOG_05736 XP_004346409.2 114 hypothetical protein CAOG_05736 
CAOG_05777 XP_004346450.1 789 hypothetical protein CAOG_05777 
CAOG_05779 XP_004346452.1 749 hypothetical protein CAOG_05779 
CAOG_05781 XP_004346454.1 210 hypothetical protein CAOG_05781 
CAOG_05791 XP_004346464.2 744 hypothetical protein CAOG_05791 
CAOG_05794 XP_004346467.1 124 hypothetical protein CAOG_05794 
CAOG_05795 XP_004345385.1 100 hypothetical protein CAOG_05795 
CAOG_05809 XP_004345399.2 522 hypothetical protein CAOG_05809 
CAOG_05819 XP_004345409.1 164 hypothetical protein CAOG_05819 
CAOG_05844 XP_004345434.1 602 hypothetical protein CAOG_05844 
CAOG_05852 XP_004345442.2 522 hypothetical protein CAOG_05852 
CAOG_05856 XP_004345446.1 99 hypothetical protein CAOG_05856 
CAOG_05864 XP_004345454.2 119 hypothetical protein CAOG_05864 
CAOG_05871 XP_004345461.1 837 hypothetical protein CAOG_05871 
CAOG_05876 XP_004345466.1 437 hypothetical protein CAOG_05876 
CAOG_05901 XP_004345491.2 1430 hypothetical protein CAOG_05901 
CAOG_05984 XP_004345574.1 188 hypothetical protein CAOG_05984 
CAOG_05998 XP_004345588.1 102 hypothetical protein CAOG_05998 
CAOG_06011 XP_004345601.1 199 hypothetical protein CAOG_06011 
CAOG_06066 XP_004345656.1 172 hypothetical protein CAOG_06066 
CAOG_06077 XP_004345667.1 2246 hypothetical protein CAOG_06077 
CAOG_06086 XP_004345676.1 624 hypothetical protein CAOG_06086 





CAOG_06100 XP_004345690.1 1733 hypothetical protein CAOG_06100 
CAOG_06115 XP_004345705.2 279 hypothetical protein CAOG_06115 
CAOG_06119 XP_004345709.2 336 hypothetical protein CAOG_06119 
CAOG_06121 XP_004345711.1 744 hypothetical protein CAOG_06121 
CAOG_06129 XP_004345719.1 466 hypothetical protein CAOG_06129 
CAOG_06137 XP_004345727.1 2286 hypothetical protein CAOG_06137 
CAOG_06145 XP_004345735.1 1623 hypothetical protein CAOG_06145 
CAOG_06150 XP_004345740.1 108 hypothetical protein CAOG_06150 
CAOG_06161 XP_004345751.2 993 hypothetical protein CAOG_06161 
CAOG_06186 XP_004345776.1 530 hypothetical protein CAOG_06186 
CAOG_06198 XP_004345788.1 423 hypothetical protein CAOG_06198 
CAOG_06202 XP_004345792.1 216 hypothetical protein CAOG_06202 
CAOG_06204 XP_004345794.1 295 hypothetical protein CAOG_06204 
CAOG_06209 XP_004345799.1 60 hypothetical protein CAOG_06209 
CAOG_06227 XP_004344976.1 711 hypothetical protein CAOG_06227 
CAOG_06232 XP_004344981.2 384 hypothetical protein CAOG_06232 
CAOG_06236 XP_004344985.1 1380 hypothetical protein CAOG_06236 
CAOG_06242 XP_004344991.1 1184 hypothetical protein CAOG_06242 
CAOG_06260 XP_004345009.2 2217 hypothetical protein CAOG_06260 
CAOG_06268 XP_004345017.2 442 hypothetical protein CAOG_06268 
CAOG_06269 XP_004345018.2 704 hypothetical protein CAOG_06269 
CAOG_06271 XP_004345020.1 246 hypothetical protein CAOG_06271 
CAOG_06285 XP_004345034.1 712 hypothetical protein CAOG_06285 
CAOG_06290 XP_004345040.1 409 hypothetical protein CAOG_06290 
CAOG_06293 XP_004345042.2 1592 hypothetical protein CAOG_06293 
CAOG_06294 XP_004345043.2 536 hypothetical protein CAOG_06294 
CAOG_06308 XP_004345057.2 341 hypothetical protein CAOG_06308 
CAOG_06339 XP_004345088.1 185 hypothetical protein CAOG_06339 
CAOG_06351 XP_004345100.1 771 hypothetical protein CAOG_06351 
CAOG_06355 XP_004345104.1 910 hypothetical protein CAOG_06355 
CAOG_06371 XP_004345120.1 136 hypothetical protein CAOG_06371, partial 
CAOG_06383 XP_004345132.1 1457 hypothetical protein CAOG_06383 
CAOG_06392 XP_004345141.1 699 hypothetical protein CAOG_06392 
CAOG_06396 XP_004345145.1 69 hypothetical protein CAOG_06396 
CAOG_06403 XP_004345152.1 544 hypothetical protein CAOG_06403 





CAOG_06434 XP_004345183.2 869 hypothetical protein CAOG_06434 
CAOG_06455 XP_004345204.1 175 hypothetical protein CAOG_06455 
CAOG_06461 XP_004345210.1 272 hypothetical protein CAOG_06461 
CAOG_06475 XP_004345224.2 435 hypothetical protein CAOG_06475 
CAOG_06480 XP_004345229.2 948 hypothetical protein CAOG_06480 
CAOG_06523 XP_004345272.2 407 hypothetical protein CAOG_06523 
CAOG_06525 XP_004345274.1 869 hypothetical protein CAOG_06525 
CAOG_06547 XP_004345296.1 338 hypothetical protein CAOG_06547 
CAOG_06549 XP_004345298.1 2104 hypothetical protein CAOG_06549 
CAOG_06552 XP_004345301.2 579 hypothetical protein CAOG_06552 
CAOG_06560 XP_004345309.1 946 hypothetical protein CAOG_06560 
CAOG_06609 XP_004344230.1 1342 hypothetical protein CAOG_06609 
CAOG_06636 XP_004344257.1 268 hypothetical protein CAOG_06636 
CAOG_06641 XP_004344262.1 1000 hypothetical protein CAOG_06641 
CAOG_06646 XP_004344267.1 680 hypothetical protein CAOG_06646 
CAOG_06647 XP_004344268.2 306 hypothetical protein CAOG_06647 
CAOG_06653 XP_004344274.1 186 hypothetical protein CAOG_06653 
CAOG_06657 XP_004344278.2 334 hypothetical protein CAOG_06657 
CAOG_06659 XP_004344280.2 657 hypothetical protein CAOG_06659 
CAOG_06661 XP_004344282.2 349 hypothetical protein CAOG_06661 
CAOG_06684 XP_004344305.2 447 hypothetical protein CAOG_06684 
CAOG_06709 XP_004344330.2 311 hypothetical protein CAOG_06709 
CAOG_06724 XP_004344345.1 1541 hypothetical protein CAOG_06724 
CAOG_06726 XP_004344347.1 552 hypothetical protein CAOG_06726 
CAOG_06759 XP_004344380.1 301 hypothetical protein CAOG_06759 
CAOG_06761 XP_004344382.1 276 hypothetical protein CAOG_06761 
CAOG_06767 XP_004344388.1 946 hypothetical protein CAOG_06767 
CAOG_06776 XP_004344397.1 423 hypothetical protein CAOG_06776 
CAOG_06780 XP_004344401.1 109 hypothetical protein CAOG_06780 
CAOG_06781 XP_004344402.1 288 hypothetical protein CAOG_06781 
CAOG_06789 XP_004344410.1 112 hypothetical protein CAOG_06789 
CAOG_06805 XP_004344426.2 589 hypothetical protein CAOG_06805 
CAOG_06807 XP_004344428.2 415 hypothetical protein CAOG_06807 
CAOG_06808 XP_004344429.1 170 hypothetical protein CAOG_06808 
CAOG_06810 XP_004344431.1 63 hypothetical protein CAOG_06810 
CAOG_06820 XP_004344441.1 550 hypothetical protein CAOG_06820 





CAOG_06852 XP_004344473.1 250 hypothetical protein CAOG_06852 
CAOG_06854 XP_004344475.1 581 hypothetical protein CAOG_06854 
CAOG_06862 XP_004344483.1 985 hypothetical protein CAOG_06862 
CAOG_06865 XP_004344486.1 429 hypothetical protein CAOG_06865 
CAOG_06866 XP_004344487.2 786 hypothetical protein CAOG_06866 
CAOG_06869 XP_004344490.1 131 hypothetical protein CAOG_06869 
CAOG_06896 XP_004344517.2 692 hypothetical protein CAOG_06896 
CAOG_06911 XP_004344532.1 273 hypothetical protein CAOG_06911 
CAOG_06912 XP_004344533.1 243 hypothetical protein CAOG_06912 
CAOG_06928 XP_004344549.2 695 hypothetical protein CAOG_06928 
CAOG_06938 XP_004343662.1 117 hypothetical protein CAOG_06938 
CAOG_06952 XP_004343676.1 156 hypothetical protein CAOG_06952 
CAOG_06957 XP_004343681.2 496 hypothetical protein CAOG_06957 
CAOG_06970 XP_004343694.2 848 hypothetical protein CAOG_06970 
CAOG_06975 XP_004343699.1 499 hypothetical protein CAOG_06975 
CAOG_06976 XP_004343700.2 334 hypothetical protein CAOG_06976 
CAOG_06980 XP_004343704.1 563 hypothetical protein CAOG_06980 
CAOG_06999 XP_004343723.1 888 hypothetical protein CAOG_06999 
CAOG_07015 XP_004343739.1 491 hypothetical protein CAOG_07015 
CAOG_07036 XP_004343760.1 354 hypothetical protein CAOG_07036 
CAOG_07045 XP_004343769.1 619 hypothetical protein CAOG_07045 
CAOG_07062 XP_004343786.1 540 hypothetical protein CAOG_07062 
CAOG_07084 XP_004343808.2 298 hypothetical protein CAOG_07084 
CAOG_07099 XP_004343823.2 162 hypothetical protein CAOG_07099 
CAOG_07117 XP_004343841.1 541 hypothetical protein CAOG_07117 
CAOG_07124 XP_004343848.2 584 hypothetical protein CAOG_07124 
CAOG_07125 XP_004343849.1 498 hypothetical protein CAOG_07125 
CAOG_07128 XP_004343852.1 545 hypothetical protein CAOG_07128 
CAOG_07130 XP_004343854.1 325 hypothetical protein CAOG_07130 
CAOG_07136 XP_004343860.2 267 hypothetical protein CAOG_07136 
CAOG_07155 XP_004343879.2 548 hypothetical protein CAOG_07155 
CAOG_07160 XP_004343884.1 268 hypothetical protein CAOG_07160 
CAOG_07180 XP_004343904.2 334 hypothetical protein CAOG_07180 
CAOG_07191 XP_004343915.1 805 hypothetical protein CAOG_07191 
CAOG_07192 XP_004343916.2 645 hypothetical protein CAOG_07192 
CAOG_07202 XP_004343926.1 176 hypothetical protein CAOG_07202 





CAOG_07207 XP_004343931.1 3184 hypothetical protein CAOG_07207 
CAOG_07214 XP_004343073.1 181 hypothetical protein CAOG_07214 
CAOG_07217 XP_004343076.2 1611 hypothetical protein CAOG_07217 
CAOG_07223 XP_004343082.2 396 hypothetical protein CAOG_07223 
CAOG_07229 XP_004343088.1 1511 hypothetical protein CAOG_07229 
CAOG_07235 XP_004343094.1 521 hypothetical protein CAOG_07235 
CAOG_07246 XP_004343105.1 409 hypothetical protein CAOG_07246 
CAOG_07266 XP_004343125.1 1561 hypothetical protein CAOG_07266 
CAOG_07269 XP_004343128.1 989 hypothetical protein CAOG_07269 
CAOG_07271 XP_004343130.2 2985 hypothetical protein CAOG_07271 
CAOG_07284 XP_004343143.2 1141 hypothetical protein CAOG_07284 
CAOG_07334 XP_004343193.1 452 hypothetical protein CAOG_07334 
CAOG_07343 XP_004343202.1 814 hypothetical protein CAOG_07343 
CAOG_07348 XP_004343207.1 79 hypothetical protein CAOG_07348 
CAOG_07354 XP_004343213.2 223 hypothetical protein CAOG_07354 
CAOG_07370 XP_004343229.2 661 hypothetical protein CAOG_07370 
CAOG_07388 XP_004343247.2 185 hypothetical protein CAOG_07388 
CAOG_07418 XP_004343277.1 333 hypothetical protein CAOG_07418 
CAOG_07429 XP_004343288.1 1880 hypothetical protein CAOG_07429 
CAOG_07434 XP_004343293.2 860 hypothetical protein CAOG_07434 
CAOG_07446 XP_004343305.1 839 hypothetical protein CAOG_07446 
CAOG_07451 XP_004343310.1 612 hypothetical protein CAOG_07451 
CAOG_07453 XP_004343312.1 360 hypothetical protein CAOG_07453 
CAOG_07458 XP_004343317.1 271 hypothetical protein CAOG_07458 
CAOG_07459 XP_004343318.1 385 hypothetical protein CAOG_07459 
CAOG_07463 XP_004343337.1 641 hypothetical protein CAOG_07463 
CAOG_07468 XP_004343342.2 326 hypothetical protein CAOG_07468 
CAOG_07481 XP_004343355.1 108 hypothetical protein CAOG_07481 
CAOG_07503 XP_004343377.1 166 hypothetical protein CAOG_07503 
CAOG_07507 XP_004343381.1 64 hypothetical protein CAOG_07507 
CAOG_07516 XP_004343390.1 101 hypothetical protein CAOG_07516 
CAOG_07517 XP_004343391.1 431 hypothetical protein CAOG_07517 
CAOG_07563 XP_004343437.1 100 hypothetical protein CAOG_07563 
CAOG_07590 XP_004343464.2 428 hypothetical protein CAOG_07590 
CAOG_07620 XP_004343494.1 155 hypothetical protein CAOG_07620 
CAOG_07622 XP_004343496.2 283 hypothetical protein CAOG_07622 





CAOG_07652 XP_004343526.1 472 hypothetical protein CAOG_07652 
CAOG_07674 XP_004343548.1 177 hypothetical protein CAOG_07674 
CAOG_07675 XP_004343549.1 1044 hypothetical protein CAOG_07675 
CAOG_07697 XP_004343571.1 306 hypothetical protein CAOG_07697 
CAOG_07755 XP_004342828.2 452 hypothetical protein CAOG_07755, partial 
CAOG_07760 XP_004342833.1 842 hypothetical protein CAOG_07760 
CAOG_07766 XP_004342839.2 6160 hypothetical protein CAOG_07766 
CAOG_07771 XP_004342844.1 382 hypothetical protein CAOG_07771 
CAOG_07777 XP_004342850.1 308 hypothetical protein CAOG_07777 
CAOG_07805 XP_004342878.1 221 hypothetical protein CAOG_07805 
CAOG_07806 XP_004342879.1 2199 hypothetical protein CAOG_07806 
CAOG_07815 XP_004342888.1 1484 hypothetical protein CAOG_07815 
CAOG_07821 XP_004342894.1 86 hypothetical protein CAOG_07821 
CAOG_07834 XP_004342907.1 111 hypothetical protein CAOG_07834 
CAOG_07839 XP_004342912.1 1656 hypothetical protein CAOG_07839 
CAOG_07844 XP_004342918.1 1615 hypothetical protein CAOG_07844 
CAOG_07856 XP_004342941.2 813 hypothetical protein CAOG_07856 
CAOG_07858 XP_004342943.1 2627 hypothetical protein CAOG_07858 
CAOG_07861 XP_004342946.1 506 hypothetical protein CAOG_07861 
CAOG_07894 XP_004342979.1 467 hypothetical protein CAOG_07894 
CAOG_07899 XP_004342984.1 478 hypothetical protein CAOG_07899 
CAOG_07901 XP_004342986.1 703 hypothetical protein CAOG_07901 
CAOG_07903 XP_004342988.1 199 hypothetical protein CAOG_07903 
CAOG_07909 XP_004342994.1 508 hypothetical protein CAOG_07909 
CAOG_07914 XP_004342999.2 628 hypothetical protein CAOG_07914 
CAOG_07930 XP_004343015.1 224 hypothetical protein CAOG_07930 
CAOG_07942 XP_004343030.1 295 hypothetical protein CAOG_07942 
CAOG_08008 XP_004342609.1 436 hypothetical protein CAOG_08008 
CAOG_08011 XP_004342612.1 4326 hypothetical protein CAOG_08011 
CAOG_08013 XP_004342614.1 518 hypothetical protein CAOG_08013 
CAOG_08014 XP_004342615.1 351 hypothetical protein CAOG_08014 
CAOG_08055 XP_004342656.1 147 hypothetical protein CAOG_08055 
CAOG_08074 XP_004342675.1 237 hypothetical protein CAOG_08074 
CAOG_08099 XP_004342700.1 116 hypothetical protein CAOG_08099 
CAOG_08109 XP_004342710.2 733 hypothetical protein CAOG_08109 





CAOG_08126 XP_004342727.1 1593 hypothetical protein CAOG_08126 
CAOG_08139 XP_004342740.2 255 hypothetical protein CAOG_08139 
CAOG_08144 XP_004342745.2 513 hypothetical protein CAOG_08144 
CAOG_08163 XP_004342764.1 180 hypothetical protein CAOG_08163 
CAOG_08166 XP_004342767.2 763 hypothetical protein CAOG_08166 
CAOG_08169 XP_004342770.1 233 hypothetical protein CAOG_08169 
CAOG_08173 XP_004342774.1 449 hypothetical protein CAOG_08173 
CAOG_08185 XP_004342786.1 796 hypothetical protein CAOG_08185 
CAOG_08209 XP_004342464.2 694 hypothetical protein CAOG_08209 
CAOG_08212 XP_004342467.1 86 hypothetical protein CAOG_08212 
CAOG_08225 XP_004342480.1 62 hypothetical protein CAOG_08225 
CAOG_08251 XP_004342420.1 430 hypothetical protein CAOG_08251 
CAOG_08259 XP_004342428.1 1777 hypothetical protein CAOG_08259 
CAOG_08261 XP_004342430.1 438 hypothetical protein CAOG_08261 
CAOG_08270 XP_004342439.1 210 hypothetical protein CAOG_08270 
CAOG_08283 XP_004342006.1 423 hypothetical protein CAOG_08283 
CAOG_08337 XP_004340960.2 279 hypothetical protein CAOG_08337 
CAOG_08338 XP_004340787.1 237 hypothetical protein CAOG_08338 
CAOG_08346 XP_004340843.1 566 hypothetical protein CAOG_08346, partial 
CAOG_08352 XP_004340771.1 184 hypothetical protein CAOG_08352 
CAOG_08353 XP_004340833.1 155 hypothetical protein CAOG_08353 
CAOG_08357 XP_004340773.2 972 hypothetical protein CAOG_08357 
CAOG_08360 XP_004340463.1 135 hypothetical protein CAOG_08360 
CAOG_08367 XP_004340491.2 448 hypothetical protein CAOG_08367 
CAOG_08383 XP_011269953.1 1330 hypothetical protein CAOG_08383 
CAOG_08384 XP_011269954.1 395 hypothetical protein CAOG_08384 
CAOG_08391 XP_011269961.1 453 hypothetical protein CAOG_08391 
CAOG_08418 XP_011269989.1 484 hypothetical protein CAOG_08418 
CAOG_08425 XP_011269996.1 158 hypothetical protein CAOG_08425 
CAOG_08426 XP_011269997.1 635 hypothetical protein CAOG_08426 
CAOG_08429 XP_011270000.1 708 hypothetical protein CAOG_08429 
CAOG_08434 XP_011270005.1 322 hypothetical protein CAOG_08434 
CAOG_08443 XP_011270014.1 202 hypothetical protein CAOG_08443 
CAOG_08455 XP_011270027.1 955 hypothetical protein CAOG_08455 
CAOG_08462 XP_011270034.1 605 hypothetical protein CAOG_08462 





CAOG_08470 XP_011270042.1 917 hypothetical protein CAOG_08470 
CAOG_08475 XP_011270047.1 169 hypothetical protein CAOG_08475, partial 
CAOG_08476 XP_011270048.1 695 hypothetical protein CAOG_08476 
CAOG_08499 XP_011270081.1 759 hypothetical protein CAOG_08499 
CAOG_08511 XP_011270093.1 114 hypothetical protein CAOG_08511 
CAOG_08513 XP_011270095.1 102 hypothetical protein CAOG_08513 
CAOG_08529 XP_011270110.1 191 hypothetical protein CAOG_08529 
CAOG_08536 XP_011270117.1 157 hypothetical protein CAOG_08536 
CAOG_08544 XP_011270126.1 88 hypothetical protein CAOG_08544 
CAOG_08546 XP_011270128.1 505 hypothetical protein CAOG_08546 
CAOG_08550 XP_011270132.1 211 hypothetical protein CAOG_08550, partial 
CAOG_08560 XP_011270142.1 212 hypothetical protein CAOG_08560, partial 
CAOG_08566 XP_011270148.1 535 hypothetical protein CAOG_08566 
CAOG_08588 XP_011270188.1 80 hypothetical protein CAOG_08588 
CAOG_08590 XP_011270190.1 128 hypothetical protein CAOG_08590, partial 
CAOG_08598 XP_011270198.1 310 hypothetical protein CAOG_08598 
CAOG_08605 XP_011270205.1 908 hypothetical protein CAOG_08605 
CAOG_08623 XP_011270223.1 286 hypothetical protein CAOG_08623 
CAOG_08630 XP_011270230.1 2056 hypothetical protein CAOG_08630 
CAOG_08644 XP_011270255.1 592 hypothetical protein CAOG_08644 
CAOG_08652 XP_011270263.1 86 hypothetical protein CAOG_08652 
CAOG_08662 XP_011270273.1 328 hypothetical protein CAOG_08662 
CAOG_08666 XP_011270277.1 283 hypothetical protein CAOG_08666 
CAOG_08681 XP_011270292.1 321 hypothetical protein CAOG_08681 
CAOG_08686 XP_011270297.1 97 hypothetical protein CAOG_08686 
CAOG_08705 XP_011270325.1 1328 hypothetical protein CAOG_08705 
CAOG_08710 XP_011270330.1 768 hypothetical protein CAOG_08710 
CAOG_08712 XP_011270332.1 945 hypothetical protein CAOG_08712 
CAOG_08716 XP_011270336.1 113 hypothetical protein CAOG_08716 
CAOG_08720 XP_011270340.1 374 hypothetical protein CAOG_08720 
CAOG_08727 XP_011270347.1 992 hypothetical protein CAOG_08727 
CAOG_08775 XP_011270405.1 1030 hypothetical protein CAOG_08775 
CAOG_08783 XP_011270413.1 2093 hypothetical protein CAOG_08783 





CAOG_08789 XP_011270429.1 142 hypothetical protein CAOG_08789, partial 
CAOG_08801 XP_011270441.1 103 hypothetical protein CAOG_08801 
CAOG_08806 XP_011270446.1 389 hypothetical protein CAOG_08806 
CAOG_08808 XP_011270448.1 829 hypothetical protein CAOG_08808 
CAOG_08816 XP_011270456.1 157 hypothetical protein CAOG_08816 
CAOG_08820 XP_011270460.1 313 hypothetical protein CAOG_08820 
CAOG_08825 XP_011270465.1 412 hypothetical protein CAOG_08825 
CAOG_08826 XP_011270466.1 508 hypothetical protein CAOG_08826 
CAOG_08836 XP_011270477.1 418 hypothetical protein CAOG_08836 
CAOG_08845 XP_011270499.1 432 hypothetical protein CAOG_08845 
CAOG_08846 XP_011270500.1 887 hypothetical protein CAOG_08846 
CAOG_08859 XP_011270513.1 669 hypothetical protein CAOG_08859 
CAOG_08863 XP_011270518.1 803 hypothetical protein CAOG_08863 
CAOG_08864 XP_011270519.1 2586 hypothetical protein CAOG_08864 
CAOG_08865 XP_011270520.1 452 hypothetical protein CAOG_08865 
CAOG_08878 XP_011270533.1 939 hypothetical protein CAOG_08878, partial 
CAOG_08886 XP_011270548.1 62 hypothetical protein CAOG_08886 
CAOG_08887 XP_011270549.1 573 hypothetical protein CAOG_08887 
CAOG_08898 XP_011270560.1 249 hypothetical protein CAOG_08898 
CAOG_08906 XP_011270568.1 461 hypothetical protein CAOG_08906 
CAOG_08909 XP_011270571.1 386 hypothetical protein CAOG_08909 
CAOG_08934 XP_011270605.1 337 hypothetical protein CAOG_08934 
CAOG_08935 XP_011270606.1 1985 hypothetical protein CAOG_08935 
CAOG_08939 XP_011270610.1 214 hypothetical protein CAOG_08939 
CAOG_08940 XP_011270611.1 723 hypothetical protein CAOG_08940 
CAOG_08946 XP_011270617.1 622 hypothetical protein CAOG_08946 
CAOG_08962 XP_011270640.1 133 hypothetical protein CAOG_08962 
CAOG_08974 XP_011270652.1 700 hypothetical protein CAOG_08974 
CAOG_08985 XP_011270663.1 980 hypothetical protein CAOG_08985 
CAOG_08994 XP_011270672.1 375 hypothetical protein CAOG_08994 
CAOG_08996 XP_011270683.1 1611 hypothetical protein CAOG_08996 
CAOG_09003 XP_011270690.1 2463 hypothetical protein CAOG_09003 
CAOG_09004 XP_011270691.1 380 hypothetical protein CAOG_09004 





CAOG_09010 XP_011270697.1 506 hypothetical protein CAOG_09010, partial 
CAOG_09019 XP_011270706.1 921 hypothetical protein CAOG_09019 
CAOG_09036 XP_011270724.1 377 hypothetical protein CAOG_09036 
CAOG_09045 XP_011270733.1 1026 hypothetical protein CAOG_09045 
CAOG_09048 XP_011270736.1 498 hypothetical protein CAOG_09048 
CAOG_09056 XP_011270789.1 331 hypothetical protein CAOG_09056 
CAOG_09077 XP_011270810.1 3369 hypothetical protein CAOG_09077 
CAOG_09083 XP_011270816.1 839 hypothetical protein CAOG_09083 
CAOG_09095 XP_011270752.1 394 hypothetical protein CAOG_09095 
CAOG_09100 XP_011270757.1 211 hypothetical protein CAOG_09100 
CAOG_09101 XP_011270758.1 333 hypothetical protein CAOG_09101, partial 
CAOG_09116 XP_011270773.1 501 hypothetical protein CAOG_09116 
CAOG_09120 XP_011270777.1 294 hypothetical protein CAOG_09120, partial 
CAOG_09125 XP_011270835.1 1573 hypothetical protein CAOG_09125 
CAOG_09133 XP_011270843.1 12732 hypothetical protein CAOG_09133 
CAOG_09134 XP_011270844.1 350 hypothetical protein CAOG_09134 
CAOG_09140 XP_011270850.1 797 hypothetical protein CAOG_09140 
CAOG_09146 XP_011270859.1 725 hypothetical protein CAOG_09146 
CAOG_09164 XP_011270877.1 244 hypothetical protein CAOG_09164, partial 
CAOG_09172 XP_011270885.1 822 hypothetical protein CAOG_09172 
CAOG_09187 XP_011270904.1 279 hypothetical protein CAOG_09187, partial 
CAOG_09188 XP_011270905.1 592 hypothetical protein CAOG_09188, partial 
CAOG_09192 XP_011270909.1 1420 hypothetical protein CAOG_09192 
CAOG_09203 XP_011270920.1 127 hypothetical protein CAOG_09203 
CAOG_09207 XP_011270924.1 287 hypothetical protein CAOG_09207 
CAOG_09208 XP_011270944.1 241 hypothetical protein CAOG_09208, partial 
CAOG_09223 XP_011270935.1 813 hypothetical protein CAOG_09223 
CAOG_05909 XP_004345499.1 190 import inner membrane translocase subunit Tim22 
CAOG_06578 XP_004345327.1 524 inosine monophosphate dehydrogenase 2 





CAOG_02408 XP_004349158.1 260 integral membrane protein 
CAOG_07424 XP_004343283.1 309 iron-sulfur protein I 
CAOG_08016 XP_004342617.1 467 iron/zinc purple acid phosphatase-like protein 
CAOG_02772 XP_004349525.1 308 ketohexokinase 
CAOG_07968 XP_004343056.1 832 krox-20 
CAOG_03608 XP_004363336.1 978 krueppel-like factor 16 
CAOG_05737 XP_004346410.1 476 L-gulono-gamma-lactone oxidase 
CAOG_03827 XP_004363555.1 321 L-isoaspartyl protein carboxyl methyltransferase 
CAOG_00854 XP_004365725.1 511 leucine-rich repeat containing protein 
CAOG_03990 XP_004347815.2 1110 leucine-rich repeat-containing protein 28 
CAOG_02239 XP_004348989.1 2004 leucine-rich repeat-containing protein 69 
CAOG_06135 XP_004345725.1 521 lipase, family member N 
CAOG_03075 XP_004363914.1 645 long-chain-fatty-acid-CoA ligase ACSBG2 
CAOG_01478 XP_004364346.1 738 lss protein 
CAOG_04352 XP_004348180.2 506 lung seven transmembrane receptor 
CAOG_07225 XP_004343084.2 216 LYR domain-containing protein-containing protein 5 
CAOG_04258 XP_004348083.2 711 lysophosphatidylcholine acyltransferase 2-B 
CAOG_04992 XP_004346677.1 431 lysophosphatidylcholine acyltransferase 3 
CAOG_00329 XP_004365200.1 786 lysosomal alpha-N-acetyl glucosaminidase 
CAOG_07000 XP_004343724.1 217 lysozyme 
CAOG_05009 XP_004346694.1 411 macrophage erythroblast attacher protein 
CAOG_06815 XP_004344436.1 245 Maf1-pending-prov protein 
CAOG_06529 XP_004345278.1 597 max-like protein X 
CAOG_08090 XP_004342691.1 358 metal-binding domain in RNase L inhibitor 
CAOG_08049 XP_004342650.1 426 metallo-beta-lactamase 
CAOG_00476 XP_004365347.1 282 methyltransferase 
CAOG_07700 XP_004343574.1 117 microtubule associated protein 





CAOG_04640 XP_004347387.1 2280 mitogen-activated protein kinase kinase kinase 1 
CAOG_03065 XP_004363904.2 1156 mitogen-activated protein kinase kinase kinase 3 
CAOG_08035 XP_004342636.2 531 mitogen-activated protein kinase kinase kinase kinase 
CAOG_02162 XP_004348912.2 657 molybdenum cofactor synthesis 1 isoform 1 
CAOG_04319 XP_004348147.1 305 molybdenum cofactor synthesis protein 2 large subunit 
CAOG_06543 XP_004345292.2 462 molybdopterin synthase sulfurylase 
CAOG_00650 XP_004365521.2 240 Mrto4 protein 
CAOG_07710 XP_004343584.1 546 mthfr-prov protein 
CAOG_02706 XP_004349456.2 1491 multi-sensor hybrid histidine kinase 
CAOG_02063 XP_004348813.2 2168 myosin IXA 
CAOG_00121 XP_004364992.2 1291 N-acetylglucosamine-1-phosphate transferase 
CAOG_04189 pseudo gene  n-acetylglucosamine-6-phosphate deacetylase 
CAOG_10025   NAD-dependent deacetylase sirtuin 7 
CAOG_03222 XP_004364061.1 334 NAD-dependent epimerase/dehydratase 
CAOG_03621 XP_004363349.1 127 NADH dehydrogenase 1 beta subcomplex subunit 9 
CAOG_07923 XP_004343008.1 709 NADPH-cytochrome P450 reductase 
CAOG_03423 XP_004364262.1 215 Nat9 protein 
CAOG_00591 XP_004365462.1 257 natural killer cell-specific antigen KLIP1 
CAOG_01134 XP_004366005.1 1447 neuropathy target esterase 
CAOG_01936 XP_004364804.1 1063 neutral sphingomyelinase activation associated factor 
CAOG_05761 XP_004346434.2 997 non-receptor protein kinase 
CAOG_08366 XP_004340478.1 1380 non-receptor protein kinase, partial 
CAOG_02457 XP_004349207.1 2031 NPR2 protein 
CAOG_06310 XP_004345059.1 635 NTRK3 protein 
CAOG_01270 XP_004349790.1 957 nuclear elongation and deformation protein 1 
CAOG_07127 XP_004343851.2 343 nuclease Le3 





CAOG_04115 XP_004347940.1 274 nucleotide-binding protein 2 
CAOG_06336 XP_004345085.1 700 oxidation resistance protein 1 
CAOG_07035 XP_004343759.2 1349 patatin-like phospholipase domain-containing protein 7 
CAOG_04074 XP_004347899.2 448 peptidase M19 
CAOG_03679 XP_004363407.1 660 peptidase S8 and S53 
CAOG_06448 XP_004345197.1 172 peptide methionine sulfoxide reductase 
CAOG_01957 XP_004364825.1 583 periodic tryptophan protein 
CAOG_00607 XP_004365478.1 462 phenylalanyl-tRNA synthetase 
CAOG_07357 XP_004343216.1 547 phosphate transporter 
CAOG_02967 XP_004363806.2 777 phosphatidylethanolamine N-methyltransferase 
CAOG_01921 XP_004364789.1 251 phosphatidylinositol glycan anchor biosynthesis 
CAOG_00043 XP_004364914.2 340 phospho-2-dehydro-3-deoxyheptonate aldolase 
CAOG_04210 XP_004348035.2 1564 phosphodiesterase 1B 
CAOG_04883 XP_004347634.1 719 phosphodiesterase 2A 
CAOG_02238 XP_004348988.2 945 phosphoinositide-3-kinase 
CAOG_06640 XP_004344261.1 164 phospholipid transfer protein 
CAOG_00556 XP_004365427.1 249 phosphomannomutase 
CAOG_00222 XP_004365093.1 303 phosphopantothenoylcysteine decarboxylase 
CAOG_05987 XP_004345577.1 299 phosphopantothenoylcysteine synthetase 
CAOG_04597 XP_004347344.1 299 phosphoribosylaminoimidazole-succinocarboxamide synthase 
CAOG_07423 XP_004343282.2 1970 Pik4cb protein 
CAOG_06417 XP_004345166.1 353 pirin domain-containing protein domain-containing protein 
CAOG_03564 XP_004363292.2 884 polyadenylate-binding protein 
CAOG_00164 XP_004365035.2 610 potassium channel tetramerisation domain-containing protein 
CAOG_00596 XP_004365467.2 176 prefoldin 
CAOG_05548 XP_004346221.2 242 programmed cell death protein 
CAOG_04153 XP_004347978.1 950 protease m1 zinc metalloprotease 
CAOG_05835 XP_004345425.2 643 protein arginine methyltransferase 3 
CAOG_00972 XP_004365843.1 487 protein disulfide-isomerase ERp60 





CAOG_05528 XP_004346201.2 1200 protein kinase 
CAOG_08111 XP_004342712.1 231 protein-S-isoprenylcysteine O-methyltransferase 
CAOG_06163 XP_004345753.2 1446 protein-tyrosine-phosphatase 
CAOG_02035 XP_004348785.2 308 pyridoxamine 5\\'-phosphate oxidase 
CAOG_04392 XP_004348220.2 474 queuine tRNA-ribosyltransferase 
CAOG_05584 XP_004346257.1 480 radical S-adenosyl methionine domain-containing protein 1 
CAOG_01797 XP_004364665.2 1007 radixin isoform a 
CAOG_00452 XP_004365323.2 1090 rap guanine nucleotide exchange factor GEF2 
CAOG_00294 XP_004365165.1 187 ras family protein 
CAOG_06717 XP_004344338.1 956 ras guanine nucleotide exchange factor, partial 
CAOG_10093   Ras like enriched 
CAOG_08182 XP_004342783.1 202 Ras-like protein Rab-21 
CAOG_00778 XP_004365649.1 1052 ras-specific guanine nucleotide-releasing factor RalGPS1 
CAOG_01664 XP_004364532.2 413 Rbm22 protein 
CAOG_02716 XP_004349466.1 176 receptor accessory protein 5 
CAOG_02461 XP_004349211.2 1533 response regulator receiver 
CAOG_05966 XP_004345556.1 827 response regulator receiver domain-containing protein 
CAOG_05260 XP_004346945.2 494 rho GTPase activating protein 
CAOG_05230 XP_004346915.1 1876 rho GTPase-activating protein 
CAOG_07539 XP_004343413.1 455 rho GTPase-activating protein 8 
CAOG_02310 XP_004349060.2 361 ribonuclease P/MRP 30 subunit 
CAOG_01734 XP_004364602.1 60 ribosomal protein L29e 
CAOG_03983 XP_004347808.2 326 ribosomal RNA large subunit methyltransferase J 
CAOG_07203 XP_004343927.1 173 ring finger protein, partial 
CAOG_07739 XP_004343613.2 648 RIO kinase 3 
CAOG_03214 XP_004364053.1 1179 RNA binding domain-containing protein 
CAOG_07410 XP_004343269.2 302 RNA-binding protein PNO1 
CAOG_00935 XP_004365806.2 428 saccharopine dehydrogenase 
CAOG_00040 XP_004364911.1 215 SapB domain-containing protein 





CAOG_03476 XP_004348381.1 557 selenocysteine-specific elongation factor 
CAOG_05807 XP_004345397.2 1951 sensor protein GacS 
CAOG_03468 XP_004348373.1 609 sentrin/SUMO-specific protease 15 
CAOG_02174 XP_004348924.1 252 sepiapterin reductase 
CAOG_07938 XP_004343026.1 428 Ser/Thr kinase 
CAOG_05563 XP_004346236.1 825 serine/threonine protein kinase 
CAOG_08028 XP_004342629.1 340 serine/threonine protein kinase 
CAOG_00905 XP_004365776.1 2948 serine/threonine protein kinase 15 
CAOG_01911 XP_004364779.2 509 serine/threonine-protein kinase gad8 
CAOG_03006 XP_004363845.2 1600 serine/threonine-protein kinase ppk15 
CAOG_02400 XP_004349150.2 876 serine/threonine-protein kinase SAPK2 
CAOG_05649 XP_004346322.2 1172 serine/threonine-specific protein kinase NAK 
CAOG_04062 XP_004347887.2 1154 serologically defined colon cancer antigen 1 
CAOG_00420 XP_004365291.2 559 serum/glucocorticoid regulated kinase 2 
CAOG_04446 XP_004348274.1 723 sestrin 1 
CAOG_03488 XP_004348393.1 607 SFRS protein kinase 1 
CAOG_04695 XP_004347442.1 365 Sh3yl1-prov protein 
CAOG_03052 XP_004363891.1 221 small GTP-binding protein Rab4 
CAOG_04656 XP_004347403.1 177 small HspC2 heat shock protein 
CAOG_07464 XP_004343338.2 447 SMYD5 protein 
CAOG_04776 XP_004347527.1 199 SNARE Ykt6 
CAOG_06772 XP_004344393.2 1785 snrk protein 
CAOG_01682 XP_004364550.2 97 snRNP core protein SMX5 
CAOG_04882 XP_004347633.1 466 snurportin-1 
CAOG_00414 XP_004365285.1 988 sodium/calcium exchanger protein 
CAOG_01804 XP_004364672.1 296 soluble NSF attachment protein 
CAOG_07131 XP_004343855.2 574 solute carrier family 24 
CAOG_02881 XP_004363720.1 330 solute carrier family 25 
CAOG_04976 XP_004346661.1 310 solute carrier family 25 
CAOG_07519 XP_004343393.1 381 solute carrier family 25 
CAOG_00501 XP_004365372.1 405 solute carrier family 35 
CAOG_06826 XP_004344447.1 435 solute carrier family 35 member C2 





CAOG_04923 XP_004347674.2 499 solute carrier family 39 
CAOG_07012 XP_004343736.1 754 solute carrier family 47 
CAOG_04621 XP_004347368.2 815 sphingosine kinase SphK 
CAOG_06412 XP_004345161.2 527 spinster like protein 
CAOG_02700 XP_004349450.2 500 SPRY domain-containing protein 
CAOG_07297 XP_004343156.1 527 squalene monooxygenase 
CAOG_00304 XP_004365175.2 608 ST7 protein 
CAOG_04243 XP_004348068.2 527 STAM binding protein 
CAOG_09263   STE/STE7 protein kinase 
CAOG_04722 XP_004347469.1 285 sterol desaturase 
CAOG_05258 XP_004346943.1 363 sterol-4-alpha-carboxylate 3-dehydrogenase 
CAOG_05285 XP_004346970.2 418 Sua5/YciO/YrdC/YwlC family protein 
CAOG_06766 XP_004344387.1 542 sugar transporter 
CAOG_05077 XP_004346762.1 740 syk-prov protein 
CAOG_08354 XP_004340834.2 782 syk-prov protein 
CAOG_07641 XP_004343515.1 334 syntaxin 5A 
CAOG_05240 XP_004346925.1 289 syntaxin-6 
CAOG_05526 XP_004346199.2 1260 T-box transcription factor TBX4 
CAOG_01193 XP_004349690.1 878 TBC1 domain family protein 
CAOG_05197 XP_004346882.1 235 testis enhanced transcript 
CAOG_05847 XP_004345437.2 1008 testis-specific protein kinase 1 
CAOG_02776 XP_004349529.2 260 TGF beta-inducible nuclear protein 1 
CAOG_02459 XP_004349209.2 518 Tgs1 protein 
CAOG_04267 XP_004348092.2 362 thiamin pyrophosphokinase 1 
CAOG_00550 XP_004365421.1 538 ThiF family protein 
CAOG_01239 XP_004349759.1 2246 thyroid hormone receptor interactor 12 
CAOG_09258  670 TKL protein kinase 
CAOG_09665   TKL protein kinase 
CAOG_09920   TKL protein kinase 
CAOG_05478 XP_004346151.2 830 tnf receptor-associated factor 7 
CAOG_04891 XP_004347642.2 309 TPA regulated locus 
CAOG_00603 XP_004365474.2 835 transcription factor 25 
CAOG_04493 XP_004348321.2 236 transcription factor FET5 





CAOG_01960 XP_004364828.1 200 translation initiation factor SUI1 
CAOG_03576 XP_004363304.1 111 translation initiation factor SUI1 
CAOG_02863 XP_004363702.2 594 transmembrane 9 superfamily member 1 
CAOG_00427 XP_004365298.2 425 transmembrane protein 
CAOG_01822 XP_004364690.2 511 transmembrane protein 
CAOG_00931 XP_004365802.2 278 transmembrane protein 41B 
CAOG_03235 XP_004364074.2 325 Trip1-PA 
CAOG_00199 XP_004365070.1 283 tRNA methyltransferase 
CAOG_09256   tRNA-ALA 
CAOG_02975 XP_004363814.1 741 tRNA-dihydrouridine synthase 3 
CAOG_02807 XP_004348620.2 541 type I phosphodiesterase/nucleotide pyrophosphatase 
CAOG_06007 XP_004345597.1 1378 tyrosine-protein kinase CSK 
CAOG_08227 XP_004342482.1 1866 tyrosine-protein kinase CSK 
CAOG_00226 XP_004365097.2 583 tyrosine-protein kinase Src42A 
CAOG_01470 XP_004364338.2 797 tyrosine-protein kinase Srms 
CAOG_05691 XP_004346364.2 830 tyrosine-protein kinase Srms 
CAOG_04919 XP_004347670.2 740 tyrosine-protein kinase transforming protein Abl 
CAOG_04506 XP_004348334.2 810 tyrosine-protein kinase transforming protein Fes 
CAOG_07889 XP_004342974.1 730 tyrosine-protein phosphatase non-receptor type 11 
CAOG_05870 XP_004345460.2 655 ubiquitin carboxyl-terminal hydrolase 
CAOG_03638 XP_004363366.1 247 ubiquitin conjugating enzyme protein 26 
CAOG_05967 XP_004345557.2 781 ubiquitin ligase E3A isoform 1 
CAOG_07320 XP_004343179.1 451 ubiquitin specific peptidase 12 
CAOG_05894 XP_004345484.1 1177 ubiquitin specific protease 41 
CAOG_07247 XP_004343106.1 332 ubiquitin thioesterase OTU1 
CAOG_08184 XP_004342785.1 412 ubiquitin-activating enzyme 5 
CAOG_07990 XP_004342591.2 419 ubiquitin-conjugating enzyme E2 
CAOG_06956 XP_004343680.2 289 ubiquitin-conjugating enzyme E2 R1 
CAOG_04633 XP_004347380.1 156 ubiquitin-conjugating enzyme E2I 
CAOG_02291 XP_004349041.2 152 ubiquitin-conjugating enzyme E2N 
CAOG_07576 XP_004343450.1 151 ubiquitin-conjugating enzyme HR6A 





CAOG_04078 XP_004347903.1 184 ubiquitin-protein ligase 
CAOG_03163 XP_004364002.1 444 UDP-N-acetylglucosamine 2-epimerase 
CAOG_02196 XP_004348946.2 1261 Usp8 protein 
CAOG_03371 XP_004364210.1 163 V-type ATPase 
CAOG_02575 XP_004349325.2 620 V-type proton ATPase catalytic subunit A 
CAOG_04328 XP_004348156.1 116 vacuolar ATP synthase subunit G 
CAOG_03924 XP_004363652.1 428 vacuolar protein sorting-associated protein 
CAOG_02427 XP_004349177.1 236 vacuolar protein sorting-associated protein 28 
CAOG_01737 XP_004364605.1 1014 vacuolar proton ATPase 
CAOG_01054 XP_004365925.1 110 VMA21 domain-containing protein 
CAOG_05253 XP_004346938.1 516 voltage-dependent potassium channel protein 
CAOG_04223 XP_004348048.1 315 WD repeat domain-containing protein 
CAOG_08061 XP_004342662.1 1018 WD repeat domain-containing protein 
CAOG_04821 XP_004347572.1 671 WD-repeat protein 
CAOG_05929 XP_004345519.1 586 WD-repeat protein 50 
CAOG_02049 XP_004348799.1 273 WD40 repeat-containing protein 
CAOG_01873 XP_004364741.2 936 xenotropic and polytropic murine leukemia virus receptor xpr1 
CAOG_00279 XP_004365150.1 432 XPA binding protein 1 
CAOG_03653 XP_004363381.2 640 ZC3H3 protein 
CAOG_06521 XP_004345270.1 1579 zinc finger CCCH domain-containing protein 37 
CAOG_05935 XP_004345525.2 633 zinc finger family protein 
CAOG_01096 XP_004365967.2 450 zinc finger protein 
CAOG_07032 XP_004343756.2 479 zinc finger protein 
CAOG_03804 XP_004363532.1 505 zinc finger RAD18 domain-containing protein C1, partial 
CAOG_02096 XP_004348846.1 214 zinc-binding dehydrogenase 







The 389 annotated genes from the 1348 genes and their corresponding UniProt IDs: 
Gene Name UniProt ID 
1-acyl-sn-glycerol-3-phosphate acyltransferase GPAT3 
2-acylglycerol O-acyltransferase 2-A MOGAT1 
24-dehydrocholesterol reductase DHCR24 
2OG-Fe(II) oxygenase 11412086 
3-oxoacyl-[acyl-carrier-protein] synthase 2, variant 2 KASII 
40S ribosomal protein S21 RPS21 
40S ribosomal protein S29 RPS29 
5-methyltetrahydrofolate-homocysteine methyltransferase 
reductase MTR 
5\\'-AMP-activated protein kinase catalytic subunit alpha-1 PRKAA1 
5\\'-AMP-activated protein kinase catalytic subunit alpha-2 PRKAA2 
6-phosphofructokinase PFKL 
AAA family ATPase ATAD2 
ABC transporter ABCA2 
ABC transporter ABCA2 
Abca3 protein ABCA3 
ADP-ribosyl cyclase CD38 
ADP-ribosylation factor-like protein 8B ARL8B 
alkane-1 monooxygenase alkB 
amidophosphoribosyltransferase PPAT 
ankyrin repeat domain-containing protein 13 ANKRD13B 
aquaporin 10 AQP10 
archipelago beta form LW93_5577 
ataxin-3 ATXN3 
AtMMH-1 FPG1 
ATP synthase subunit delta ATP5F1D 
ATP-binding cassette ABCG2 
ATP-binding cassette sub-family A member 1 ABCA2 
ATP-binding cassette sub-family B member 10 ABCB9 
ATP-binding cassette sub-family B member 7 ABCB7 
ATP-binding cassette sub-family E member 1 ABCE1 
ATP-binding cassette transporter sub-family G member 2c ABCB9 
ATP-dependent Clp protease proteolytic subunit CLPP 
ATP-dependent DNA helicase DNA2 





ATP-dependent protease La LONP1 
ATPase  
ATPase  
ATPase type 13A ATP13A1 
Atypical/RIO/RIO1 protein kinase, variant 4 PHSY_000610 
B3GNTL1 protein B3GNTL1 
beclin BECN1 
betaine aldehyde dehydrogenase ALDH7A1 
branched-chain amino acid aminotransferase BCAT2 
bystin BYSL 
C-4 methylsterol oxidase MSMO1 
Ca2+ transporting ATPase, plasma membrane ACA8 
calcium-dependent cysteine protease CAPNS1 
calcium-translocating P-type ATPase TELCIR_04040 
CAMK/CAMKL/BRSK protein kinase SPPG_02241 
CAMK/CAMKL/PASK protein kinase PGTG_14851 
cAMP-dependent protein kinase catalytic subunit PRKX 
carbonate dehydratase CA1 
carnitine/acylcarnitine carrier protein SLC25A20 
carrier protein  
carrier protein  
carrier protein  
casein kinase CSNK1D 
cathepsin C CTSC 
cathepsin L2 CTSV 
ccr4-associated factor CNOT7 
cell motility mediator MEMO1 
ceramide kinase CERK 
cereblon CRBN 
cholesterol acyltransferase LCAT 
cholinesterase BCHE 
chorismate mutase/prephenate dehydratase pheA 
chromatin modifying protein 1b CHMP1B 
chromatin modifying protein 1b CHMP1B 
chromatin modifying protein 2a CHMP2A 
CHY zinc finger family protein RZPF34 





collagen type IV alpha-3-binding protein CERT1 
copine-9 CPNE9 
copper-transporting ATPase ATP7B 
coproporphyrinogen oxidase hemN 
cre AHK4 
crk-like protein CRKL 
Cullin 4 CUL4A 
cyclin-box carrying protein isoform CAOG_001396 
cystathionine beta-lyase metC 
cystathionine gamma-synthase CGS1 
cysteine desulfurylase 102586162 
cytochrome b5 reductase 4 CYB5R4 
cytochrome P450 CYP2C8 
cytochrome P450 CYP2C8 
cytosolic Fe-S cluster assembling factor nbp35 K457DRAFT_140382 
Dcun1d3 protein DCUN1D3 
DDHD domain containing 2 DDHD2 
DEAD box ATP-dependent RNA helicase DDX54 
DEAH helicase isoform 6 DHX9 
decarboxylase GAD1 
delta-aminolevulinic acid dehydratase ALAD 
deoxyhypusine synthase DHPS 
deoxyribodipyrimidine photo-lyase PHR1 
derlin-2 like protein DERL2 
DHHC zinc finger domain-containing protein ZDHHC8 
diacylglycerol acyltransferase type 2A DGAT2 
diacylglycerol kinase 1 DGKA 
diaphorase NQO1 
dihydroderamide delta-4 desaturase CAOG_008167 
diphosphomevalonate decarboxylase MVD 
diphthamide biosynthesis protein DPH1 
DNA-directed RNA polymerase II polypeptide POLR2B 
dolichyl-phosphate-mannose-protein mannosyltransferase POMT1 
DREV methyltransferase METTL9 
dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 1B 
E1A binding protein p300 EP300 





efflux ABC transporter ABCA1 
ephrin type-A receptor 4a epha4a 
eukaryotic peptide chain release factor subunit 1 GSPT1 
eukaryotic translation initiation factor 2-alpha kinase EIF2AK1 
eukaryotic translation initiation factor 2-alpha kinase 1 EIF2AK1 
F-box/WD repeat-containing protein pof1 pof1 
FAM72A protein FAM72A 
farnesyl-diphosphate farnesyltransferase 1 FDFT1 
fatty acid elongase ELOVL1 
ferredoxin 1-like protein FDX2 
ferredoxin 1-like protein FDX2 
ferrous ion membrane transporter DMT1 SLC11A2 
G protein-coupled receptor GPER1 
gamma-butyrobetaine dioxygenase BBOX1 
gamma-butyrobetaine dioxygenase BBOX1 
general stress protein mgsR 
geranylgeranyl pyrophosphate synthetase GGPS1 
glucosamine-6-phosphate N-acetyltransferase GNPNAT1 
glutamate receptor Gr2 Gria2 
glutaredoxin-3 GLRX3 
glutathione S-transferase GSTO1 
glycerol-3-phosphate acyltransferase GPAT3 
glycine hydroxymethyltransferase SHMT2 
glycosyltransferase-like protein LARGE1 LARGE1 
gphn protein GPHN 
growth hormone-regulated TBC protein 1 GRTP1 
growth-inhibiting protein 1 ING1 
GTP binding protein 4 GTPBP1 
GTP-binding protein yptV3 YPTV3 
GTPase KRAS 
guanine nucleotide-exchange protein ARFGEF1 
heat shock factor 2 HSF2 
HIT domain-containing protein ZNHIT1 
HLA-B associated transcript 5 BAG6 
hsp70-like protein HSPBP1 
hydroxymethylglutaryl-CoA synthase 1 HMGCS1 





hydroxysteroid dehydrogenase 7 HSD17B10 
import inner membrane translocase subunit Tim22 TIMM22 
inosine monophosphate dehydrogenase 2 IMPDH2 
insect-derived growth factor-B-like protein  
integral membrane protein GPR180 
iron-sulfur protein I NUBPL 
iron/zinc purple acid phosphatase-like protein papl 
ketohexokinase KHK 
krox-20 EGR2 
krueppel-like factor 16 KLF16 
L-gulono-gamma-lactone oxidase GULO 
L-isoaspartyl protein carboxyl methyltransferase PCMT1 
leucine-rich repeat containing protein LRRC1 
leucine-rich repeat-containing protein 28 LRRC28 
leucine-rich repeat-containing protein 69 LRRC69 
lipase, family member N LIPN 
long-chain-fatty-acid-CoA ligase ACSBG2 ACSBG2 
lss protein LSS 
lung seven transmembrane receptor GPR107 
LYR domain-containing protein-containing protein 5 ETFRF1 
lysophosphatidylcholine acyltransferase 2-B LPCAT2 
lysophosphatidylcholine acyltransferase 3 LPCAT3 
lysosomal alpha-N-acetyl glucosaminidase  
lysozyme SPACA3 
macrophage erythroblast attacher protein MAEA 
Maf1-pending-prov protein MAF1 
max-like protein X MLX 
metal-binding domain in RNase L inhibitor RNASEL 
metallo-beta-lactamase blaNDM-1 
methyltransferase DNMT1 
microtubule associated protein MAP1S 
mitogen-activated protein kinase kinase kinase 1 MAP3K1 
mitogen-activated protein kinase kinase kinase 1 MAP3K1 
mitogen-activated protein kinase kinase kinase 3 MAP3K3 
mitogen-activated protein kinase kinase kinase kinase SLK 
molybdenum cofactor synthesis 1 isoform 1 MOCS1 





molybdopterin synthase sulfurylase MOCS3 
Mrto4 protein MRTO4 
mthfr-prov protein MTHFR 
multi-sensor hybrid histidine kinase Psta_0819 
myosin IXA MYO9A 
N-acetylglucosamine-1-phosphate transferase DPAGT1 
n-acetylglucosamine-6-phosphate deacetylase AMDHD2 
NAD-dependent deacetylase sirtuin 7 SIRT7 
NAD-dependent epimerase/dehydratase azf 
NADH dehydrogenase 1 beta subcomplex subunit 9 NDUFB9 
NADPH-cytochrome P450 reductase POR 
Nat9 protein NAT9 
natural killer cell-specific antigen KLIP1 YIPF3 
neuropathy target esterase PNPLA6 
neutral sphingomyelinase activation associated factor NSMAF 
non-receptor protein kinase TNK1 
non-receptor protein kinase, partial TNK1 
NPR2 protein NPR2 
NTRK3 protein NTRK3 
nuclear elongation and deformation protein 1 NED1 
nuclease Le3 CAOG_007127 
nucleic acid binding protein PCBP1 
nucleotide-binding protein 2 RACK1 
oxidation resistance protein 1 OXR1 
patatin-like phospholipase domain-containing protein 7 PNPLA7 
peptidase M19 A1D17_16880 
peptidase S8 and S53 Peptidase_S8/S53_dom 
peptide methionine sulfoxide reductase MSRA 
periodic tryptophan protein PWP1 
phenylalanyl-tRNA synthetase FARS2 
phosphate transporter SLC20A2 
phosphatidylethanolamine N-methyltransferase PEMT 
phosphatidylinositol glycan anchor biosynthesis PIGU 
phospho-2-dehydro-3-deoxyheptonate aldolase DHS1 
phosphodiesterase 1B PDE1B 






phospholipid transfer protein PLTP 
phosphomannomutase PMM1 
phosphopantothenoylcysteine decarboxylase PPCDC 
phosphopantothenoylcysteine synthetase PPCS 
phosphoribosylaminoimidazole-succinocarboxamide synthase PAICS 
Pik4cb protein PI4KB 
pirin domain-containing protein domain-containing protein PYDC1 
polyadenylate-binding protein PABPN1 
potassium channel tetramerisation domain-containing protein KCTD1 
prefoldin PFDN1 
programmed cell death protein PDCD1 
protease m1 zinc metalloprotease APM1 
protein arginine methyltransferase 3 PRMT3 
protein disulfide-isomerase ERp60 PDIA3 
protein kinase CHK1  
protein kinase CHK1  
protein-S-isoprenylcysteine O-methyltransferase ICMT 
protein-tyrosine-phosphatase PTPRU 
pyridoxamine 5\\'-phosphate oxidase PNPO 
queuine tRNA-ribosyltransferase QTRT1 
radical S-adenosyl methionine domain-containing protein 1 RSAD2 
radixin isoform a SLC9A3R1 
rap guanine nucleotide exchange factor GEF2 RAPGEF6 
ras family protein MRAS 
ras guanine nucleotide exchange factor, partial RASGRF2 
Ras like enriched RHEB 
Ras-like protein Rab-21 RAB21 
ras-specific guanine nucleotide-releasing factor RalGPS1 RALGPS1 
Rbm22 protein RBM22 
receptor accessory protein 5 REEP5  
response regulator receiver Dace_1490 
response regulator receiver domain-containing protein BG023_111682 
rho GTPase activating protein ARHGAP1 
rho GTPase-activating protein ARHGAP1 
rho GTPase-activating protein 8 ARHGAP8 
ribonuclease P/MRP 30 subunit RPP30 





ribosomal RNA large subunit methyltransferase J rlmJ 
ring finger protein, partial RNF11 
RIO kinase 3 RIOK3 
RNA binding domain-containing protein PNO1 
RNA-binding protein PNO1 PNO1 
saccharopine dehydrogenase AASS 
SapB domain-containing protein spp-1 
SEC14-like protein SEC14L1 
selenocysteine-specific elongation factor EEFSEC 
sensor protein GacS gacS 
sentrin/SUMO-specific protease 15 SENP1 
sepiapterin reductase SPR 
Ser/Thr kinase CSNK1A1 
serine/threonine protein kinase STK32C 
serine/threonine protein kinase STK16 
serine/threonine protein kinase 15 AURKA 
serine/threonine-protein kinase gad8 gad8 
serine/threonine-protein kinase ppk15 ppk15 
serine/threonine-protein kinase SAPK2 MAPK11 
serine/threonine-specific protein kinase NAK AAK1 
serologically defined colon cancer antigen 1 ENTR1 
serum/glucocorticoid regulated kinase 2 SGK2 
sestrin 1 SESN1 
SFRS protein kinase 1 SRPK1 
Sh3yl1-prov protein SH3YL1 
small GTP-binding protein Rab4 RAB4A 
small HspC2 heat shock protein HSP90AB1 
SMYD5 protein SMYD5 
SNARE Ykt6 YKT6 
snrk protein SNRK 
snRNP core protein SMX5 LSM2 
snurportin-1 SNUPN 
sodium/calcium exchanger protein SLC8B1 
soluble NSF attachment protein NAPA 
solute carrier family 24 SLC25A24 
solute carrier family 25 SLC25A25 





solute carrier family 25 SLC25A25 
solute carrier family 35 SLC35B1 
solute carrier family 35 member C2 SLC35C2 
solute carrier family 39 SLC39A7 
solute carrier family 39 SLC39A7 
solute carrier family 47 SLC47A1 
sphingosine kinase SphK SPHK1 
spinster like protein SPNS1 
SPRY domain-containing protein FSD2 
squalene monooxygenase SQLE 
ST7 protein ST7 
STAM binding protein STAMBP 
STE/STE7 protein kinase  
sterol desaturase SC5D 
sterol-4-alpha-carboxylate 3-dehydrogenase NSDHL 
Sua5/YciO/YrdC/YwlC family protein US98_C0002G0004 
sugar transporter ESL1 
syk-prov protein SYK 
syk-prov protein SYK 
syntaxin 5A STX5 
syntaxin-6 STX6 
T-box transcription factor TBX4 TBX4 
TBC1 domain family protein TBC1D1 
testis enhanced transcript  
testis-specific protein kinase 1 TSSK1B 
TGF beta-inducible nuclear protein 1 TINP1 
Tgs1 protein TGS1 
thiamin pyrophosphokinase 1 TPK1 
ThiF family protein thiF 
thyroid hormone receptor interactor 12 TRIP12 
TKL protein kinase TNNI3K 
TKL protein kinase TNNI3K 
TKL protein kinase TNNI3K 
tnf receptor-associated factor 7 TRAF7 
TPA regulated locus PLAT 
transcription factor 25 TCF25 





translation factor pelota ETF1 
translation initiation factor SUI1 EIF1 
translation initiation factor SUI1 EIF1 
transmembrane 9 superfamily member 1 TM9SF1 
transmembrane protein  
transmembrane protein  
transmembrane protein 41B TMEM41B 
Trip1-PA EIF3I 
tRNA methyltransferase METTL1 
tRNA-ALA DUS3L 
tRNA-dihydrouridine synthase 3  
type I phosphodiesterase/nucleotide pyrophosphatase phoD 
tyrosine-protein kinase CSK CSK 
tyrosine-protein kinase CSK CSK 
tyrosine-protein kinase Src42A SRC 
tyrosine-protein kinase Srms SRMS 
tyrosine-protein kinase Srms SRMS 
tyrosine-protein kinase transforming protein Abl ABL1 
tyrosine-protein kinase transforming protein Fes ABL1 
tyrosine-protein phosphatase non-receptor type 11 PTPN11 
ubiquitin carboxyl-terminal hydrolase UCHL1 
ubiquitin conjugating enzyme protein 26 UBE2D2 
ubiquitin ligase E3A isoform 1 UBE3A 
ubiquitin specific peptidase 12 USP12 
ubiquitin specific protease 41 USP41 
ubiquitin thioesterase OTU1 YOD1 
ubiquitin-activating enzyme 5 UBA5 
ubiquitin-conjugating enzyme E2 CDC34 
ubiquitin-conjugating enzyme E2 R1 CDC34 
ubiquitin-conjugating enzyme E2I UBE2I 
ubiquitin-conjugating enzyme E2N UBE2N 
ubiquitin-conjugating enzyme HR6A HR6A 
ubiquitin-fold modifier-conjugating enzyme 1 UFC1 
ubiquitin-protein ligase RBX1 
UDP-N-acetylglucosamine 2-epimerase GNE 
Usp8 protein USP8 





V-type proton ATPase catalytic subunit A ATP6V0A1 
vacuolar ATP synthase subunit G ATP6V1G1 
vacuolar protein sorting-associated protein VPS13A 
vacuolar protein sorting-associated protein 28 VPS28 
vacuolar proton ATPase ATP6V0A1 
VMA21 domain-containing protein VMA21 
voltage-dependent potassium channel protein CACNA1D 
WD repeat domain-containing protein WDFY1 
WD repeat domain-containing protein WDFY1 
WD-repeat protein  
WD-repeat protein 50 WDR77 
WD40 repeat-containing protein SMU1 
xenotropic and polytropic murine leukemia virus receptor xpr1 XPR1 
XPA binding protein 1 GPN1 
ZC3H3 protein ZC3H3 
zinc finger CCCH domain-containing protein 37 HUA1 
zinc finger family protein  
zinc finger protein  
zinc finger protein  
zinc finger RAD18 domain-containing protein C1, partial RAD18 
zinc-binding dehydrogenase PTGR2 
zipper protein kinase MAP3K12 
All 1348 genes that are expressed in the same way as NF-κB across the three life stages 
of Capsaspora.  The 389 annotated genes from the 1348 genes and their corresponding 






Table 5.3 Capsaspora gene homologs related to development and immunity  
Developmental Process 
Genes in Capsaspora (47 
genes) 
Immune System Process 
Genes in Capsaspora (26 
genes) 
Total Number of 
Unique Genes in 
Developmental and 
Immune System Process 
in Capsaspora 









Coronin ATP-dependent RNA 
helicase 




E3 ubiquitin-protein ligase 
NEDD4 
heat shock protein 
ephrin type-B receptor 3 hydrolase 
flightless-1 integral membrane protein 
G protein-coupled receptor mitogen-activated protein 
kinase kinase kinase (SLK) 
GTP-binding protein peroxiredoxin-2 
GTPase phospholipase A2 
guanine nucleotide exchange 
factor 
programmed cell death 
protein 
integral membrane protein protein kinase C 
kinesin-1 protein tyrosine kinase 
leucine-rich repeat-containing 
protein 
ring finger protein 
microtubule-associated protein RNA helicase 
mitogen-activated protein 
kinase kinase kinase (SLK) 
RNA-binding protein 
myosin-VI SH3 domain-containing 
protein 
myosin-VIIa transcriptional regulator 
Myotubularin tyrosine-protein kinase 
CSK 

















phosphoglucomutase zinc finger protein 
protein phosphatase 2 

















tyrosine-protein kinase Srms 
tyrosine-protein kinase SYK 
tyrosine-protein kinase 







WD-repeat protein 50 







All Capsaspora gene homologs that are annotated within the genome present in the 
Developmental and Immune system process GO categories. The genes highlighted in red 





Table 5.4 JASPER NF-κB motif search results sites combined  
Sequence	Name	 Strand	 Start	 End	
CAOG_07458	 -	 373	 382	
CAOG_00002	 -	 233	 243	
CAOG_00199	 -	 334	 344	
CAOG_01030	 -	 96	 106	
CAOG_01542	 +	 45	 55	
CAOG_01771	 +	 473	 482	
CAOG_02202	 -	 430	 440	
CAOG_02706	 -	 111	 121	
CAOG_02716	 +	 402	 412	
CAOG_03349	 -	 81	 91	
CAOG_03422	 +	 16	 25	
CAOG_04633	 -	 29	 39	
CAOG_05576	 +	 293	 302	
CAOG_06780	 +	 317	 327	
CAOG_08652	 -	 75	 85	
CAOG_09305	 +	 270	 279	
CAOG_09674	 +	 376	 385	
CAOG_09720	 -	 283	 292	
CAOG_09786	 -	 195	 204	
CAOG_09996	 -	 98	 107	
CAOG_00003	 +	 410	 420	
CAOG_00061	 -	 204	 213	
CAOG_00172	 +	 81	 90	
CAOG_00207	 -	 202	 211	
CAOG_00226	 -	 220	 232	
CAOG_00281	 -	 147	 159	
CAOG_00387	 -	 171	 181	
CAOG_00420	 +	 266	 275	
CAOG_00476	 +	 357	 366	
CAOG_00499	 +	 98	 108	
CAOG_00500	 -	 43	 53	
CAOG_00526	 +	 68	 78	
CAOG_00542	 +	 409	 418	
CAOG_00574	 +	 92	 102	





CAOG_00758	 -	 156	 165	
CAOG_00760	 +	 135	 145	
CAOG_00982	 -	 111	 121	
CAOG_01083	 -	 327	 337	
CAOG_01134	 -	 191	 200	
CAOG_01284	 +	 194	 203	
CAOG_01365	 -	 214	 223	
CAOG_01398	 +	 112	 122	
CAOG_01458	 +	 342	 352	
CAOG_01736	 -	 371	 381	
CAOG_01767	 -	 233	 243	
CAOG_01886	 -	 23	 33	
CAOG_01906	 -	 460	 470	
CAOG_01960	 +	 42	 54	
CAOG_01971	 +	 385	 395	
CAOG_02015	 -	 21	 30	
CAOG_02032	 -	 100	 112	
CAOG_02148	 -	 427	 437	
CAOG_02167	 -	 40	 50	
CAOG_02196	 +	 141	 151	
CAOG_02233	 +	 483	 495	
CAOG_02239	 -	 226	 236	
CAOG_02290	 -	 195	 205	
CAOG_02369	 +	 17	 26	
CAOG_02372	 -	 83	 93	
CAOG_02408	 +	 285	 294	
CAOG_02441	 -	 226	 236	
CAOG_02442	 +	 347	 357	
CAOG_02575	 -	 77	 87	
CAOG_02668	 -	 108	 118	
CAOG_02709	 +	 210	 220	
CAOG_02749	 -	 461	 470	
CAOG_02772	 +	 242	 252	
CAOG_02776	 -	 123	 132	
CAOG_03051	 -	 181	 191	
CAOG_03135	 -	 168	 177	
CAOG_03168	 -	 281	 293	





CAOG_03315	 +	 487	 497	
CAOG_03476	 +	 268	 278	
CAOG_03528	 +	 130	 140	
CAOG_03609	 -	 79	 89	
CAOG_03621	 -	 79	 89	
CAOG_03679	 +	 414	 423	
CAOG_03774	 -	 195	 204	
CAOG_03781	 +	 9	 19	
CAOG_03987	 -	 30	 40	
CAOG_04035	 +	 67	 77	
CAOG_04056	 +	 317	 326	
CAOG_04062	 -	 252	 261	
CAOG_04153	 -	 324	 333	
CAOG_04223	 -	 408	 418	
CAOG_04295	 -	 164	 174	
CAOG_04329	 +	 61	 71	
CAOG_04391	 +	 16	 26	
CAOG_04516	 +	 84	 93	
CAOG_04563	 -	 69	 79	
CAOG_04594	 +	 65	 77	
CAOG_04642	 -	 282	 291	
CAOG_04819	 +	 323	 333	
CAOG_04849	 -	 65	 75	
CAOG_04882	 -	 155	 165	
CAOG_04892	 -	 274	 284	
CAOG_04908	 +	 425	 435	
CAOG_04992	 +	 436	 448	
CAOG_05007	 -	 466	 476	
CAOG_05042	 -	 175	 185	
CAOG_05075	 +	 89	 99	
CAOG_05168	 -	 160	 172	
CAOG_05184	 +	 103	 113	
CAOG_05190	 +	 109	 118	
CAOG_05197	 -	 161	 171	
CAOG_05238	 +	 16	 25	
CAOG_05251	 -	 314	 324	
CAOG_05258	 +	 202	 212	





CAOG_05336	 -	 458	 468	
CAOG_05381	 -	 95	 104	
CAOG_05508	 -	 417	 426	
CAOG_05528	 -	 337	 347	
CAOG_05649	 +	 67	 76	
CAOG_05652	 +	 127	 136	
CAOG_05719	 -	 80	 90	
CAOG_05726	 +	 323	 333	
CAOG_06135	 +	 91	 100	
CAOG_06137	 -	 143	 153	
CAOG_06290	 +	 21	 30	
CAOG_06339	 -	 229	 238	
CAOG_06392	 +	 180	 189	
CAOG_06415	 -	 89	 99	
CAOG_06578	 -	 456	 465	
CAOG_06657	 +	 59	 69	
CAOG_06709	 +	 146	 156	
CAOG_06774	 -	 384	 393	
CAOG_06776	 -	 146	 156	
CAOG_06810	 -	 357	 367	
CAOG_06815	 +	 488	 500	
CAOG_06865	 -	 232	 242	
CAOG_06896	 -	 378	 390	
CAOG_06938	 -	 67	 76	
CAOG_06970	 +	 38	 48	
CAOG_06975	 +	 85	 95	
CAOG_07084	 +	 362	 372	
CAOG_07134	 +	 222	 232	
CAOG_07207	 -	 46	 56	
CAOG_07214	 -	 411	 420	
CAOG_07348	 -	 362	 372	
CAOG_07365	 -	 289	 299	
CAOG_07463	 +	 320	 330	
CAOG_07597	 +	 440	 450	
CAOG_08008	 +	 413	 423	
CAOG_08035	 +	 39	 48	
CAOG_08055	 +	 181	 191	





CAOG_08167	 -	 30	 40	
CAOG_08182	 +	 159	 168	
CAOG_08185	 +	 450	 460	
CAOG_08270	 +	 154	 164	
CAOG_08353	 -	 279	 289	
CAOG_08354	 -	 269	 279	
CAOG_08360	 -	 55	 65	
CAOG_08384	 -	 434	 444	
CAOG_08463	 +	 459	 468	
CAOG_08550	 -	 451	 461	
CAOG_08705	 +	 31	 41	
CAOG_08859	 -	 447	 457	
CAOG_08864	 -	 427	 436	
CAOG_08909	 +	 102	 112	
CAOG_08935	 +	 126	 138	
CAOG_09048	 +	 322	 331	
CAOG_09134	 +	 9	 21	
CAOG_09172	 -	 448	 457	
CAOG_09187	 -	 60	 70	
CAOG_09324	 +	 49	 58	
CAOG_09343	 -	 225	 235	
CAOG_09359	 -	 316	 325	
CAOG_09379	 -	 278	 290	
CAOG_09595	 +	 455	 465	
CAOG_09692	 -	 415	 425	
CAOG_09703	 -	 257	 266	
CAOG_09709	 +	 288	 298	
CAOG_09738	 +	 104	 113	
CAOG_09828	 +	 110	 120	
CAOG_09865	 -	 207	 217	
CAOG_09878	 +	 406	 416	
CAOG_09887	 -	 345	 355	
CAOG_09902	 -	 128	 138	
CAOG_09920	 -	 352	 362	
CAOG_09939	 -	 486	 496	
CAOG_09943	 +	 296	 306	
CAOG_09964	 +	 366	 376	





CAOG_10017	 -	 156	 165	
CAOG_10024	 -	 211	 221	
CAOG_10056	 +	 475	 485	
CAOG_10074	 -	 45	 55	
CAOG_10108	 -	 479	 489	
CAOG_00002	 +	 323	 333	
CAOG_00061	 -	 203	 213	
CAOG_00061	 -	 203	 213	
CAOG_00199	 -	 333	 343	
CAOG_00199	 -	 62	 72	
CAOG_00226	 +	 220	 232	
CAOG_00281	 +	 147	 159	
CAOG_00420	 -	 266	 275	
CAOG_00420	 -	 266	 276	
CAOG_00420	 +	 266	 276	
CAOG_00420	 -	 265	 275	
CAOG_00476	 +	 357	 367	
CAOG_00476	 +	 356	 366	
CAOG_00476	 +	 357	 367	
CAOG_00526	 +	 67	 77	
CAOG_00542	 +	 409	 419	
CAOG_00542	 +	 408	 418	
CAOG_00574	 -	 92	 102	
CAOG_00574	 -	 91	 103	
CAOG_00574	 -	 90	 102	
CAOG_00574	 +	 91	 103	
CAOG_00574	 +	 90	 102	
CAOG_00574	 +	 90	 102	
CAOG_00574	 -	 90	 102	
CAOG_00710	 -	 82	 92	
CAOG_00710	 +	 83	 93	
CAOG_00710	 -	 82	 94	
CAOG_01030	 +	 123	 133	
CAOG_01030	 +	 96	 106	
CAOG_01030	 -	 123	 133	
CAOG_01030	 -	 122	 134	
CAOG_01030	 +	 95	 107	





CAOG_01030	 -	 95	 107	
CAOG_01030	 -	 122	 134	
CAOG_01030	 +	 122	 134	
CAOG_01030	 -	 95	 107	
CAOG_01030	 +	 95	 107	
CAOG_01134	 -	 190	 200	
CAOG_01134	 +	 190	 200	
CAOG_01134	 +	 189	 201	
CAOG_01542	 +	 344	 356	
CAOG_01542	 +	 44	 56	
CAOG_01542	 -	 44	 56	
CAOG_01542	 -	 344	 356	
CAOG_01542	 +	 44	 56	
CAOG_01771	 -	 147	 157	
CAOG_01771	 +	 473	 483	
CAOG_02148	 +	 428	 438	
CAOG_02196	 -	 141	 151	
CAOG_02196	 +	 140	 152	
CAOG_02202	 -	 259	 269	
CAOG_02233	 -	 483	 495	
CAOG_02369	 +	 17	 27	
CAOG_02369	 +	 16	 26	
CAOG_02408	 +	 285	 295	
CAOG_02706	 -	 357	 367	
CAOG_02709	 -	 210	 220	
CAOG_02716	 -	 251	 261	
CAOG_03135	 -	 167	 177	
CAOG_03135	 -	 167	 177	
CAOG_03168	 +	 281	 293	
CAOG_03281	 -	 153	 163	
CAOG_03281	 -	 153	 163	
CAOG_03281	 +	 152	 164	
CAOG_03281	 -	 152	 164	
CAOG_03281	 +	 152	 164	
CAOG_03349	 +	 385	 395	
CAOG_03422	 -	 462	 471	
CAOG_03422	 +	 16	 26	





CAOG_03774	 -	 194	 204	
CAOG_03774	 -	 194	 204	
CAOG_04062	 +	 251	 261	
CAOG_04062	 +	 252	 262	
CAOG_04062	 +	 251	 261	
CAOG_04062	 -	 250	 262	
CAOG_04153	 +	 324	 334	
CAOG_04153	 -	 325	 335	
CAOG_04223	 +	 408	 418	
CAOG_04223	 -	 407	 419	
CAOG_04223	 +	 407	 419	
CAOG_04223	 +	 407	 419	
CAOG_04329	 -	 60	 70	
CAOG_04329	 +	 59	 71	
CAOG_04329	 -	 59	 71	
CAOG_04329	 +	 59	 71	
CAOG_04516	 +	 84	 94	
CAOG_04594	 -	 65	 77	
CAOG_04633	 -	 50	 60	
CAOG_04642	 -	 281	 291	
CAOG_04642	 -	 281	 291	
CAOG_04992	 -	 436	 448	
CAOG_04992	 -	 436	 448	
CAOG_04992	 +	 436	 448	
CAOG_05007	 -	 465	 477	
CAOG_05007	 +	 465	 477	
CAOG_05007	 -	 465	 477	
CAOG_05168	 +	 160	 172	
CAOG_05190	 +	 108	 120	
CAOG_05238	 +	 16	 26	
CAOG_05381	 -	 94	 104	
CAOG_05381	 -	 95	 105	
CAOG_05381	 -	 94	 104	
CAOG_05508	 -	 416	 426	
CAOG_05508	 +	 417	 427	
CAOG_05576	 -	 293	 302	
CAOG_05576	 +	 333	 342	





CAOG_05576	 -	 292	 302	
CAOG_05576	 +	 333	 343	
CAOG_05576	 +	 293	 303	
CAOG_05576	 -	 292	 302	
CAOG_05576	 +	 333	 343	
CAOG_05576	 -	 332	 342	
CAOG_05576	 +	 291	 303	
CAOG_05576	 -	 292	 304	
CAOG_05652	 -	 127	 137	
CAOG_05652	 -	 126	 136	
CAOG_05652	 +	 126	 138	
CAOG_05652	 -	 126	 138	
CAOG_06135	 +	 91	 101	
CAOG_06290	 -	 22	 31	
CAOG_06290	 +	 21	 31	
CAOG_06290	 -	 21	 31	
CAOG_06290	 +	 21	 31	
CAOG_06290	 +	 22	 32	
CAOG_06290	 -	 20	 32	
CAOG_06290	 +	 20	 32	
CAOG_06290	 +	 20	 32	
CAOG_06290	 -	 20	 32	
CAOG_06339	 +	 228	 237	
CAOG_06339	 +	 229	 238	
CAOG_06339	 -	 228	 237	
CAOG_06339	 -	 228	 238	
CAOG_06339	 +	 228	 238	
CAOG_06339	 +	 229	 239	
CAOG_06339	 -	 228	 238	
CAOG_06339	 +	 227	 239	
CAOG_06339	 -	 227	 239	
CAOG_06339	 -	 226	 238	
CAOG_06339	 -	 227	 239	
CAOG_06339	 +	 227	 239	
CAOG_06339	 +	 226	 238	
CAOG_06339	 -	 226	 238	
CAOG_06392	 -	 181	 190	





CAOG_06392	 +	 180	 190	
CAOG_06392	 -	 180	 190	
CAOG_06392	 +	 180	 190	
CAOG_06392	 -	 179	 191	
CAOG_06392	 +	 179	 191	
CAOG_06392	 +	 179	 191	
CAOG_06392	 -	 179	 191	
CAOG_06709	 -	 145	 157	
CAOG_06780	 +	 356	 366	
CAOG_06938	 -	 66	 76	
CAOG_06938	 -	 67	 77	
CAOG_07084	 -	 361	 373	
CAOG_07084	 +	 361	 373	
CAOG_07207	 -	 45	 57	
CAOG_07207	 +	 45	 57	
CAOG_07207	 +	 45	 57	
CAOG_07214	 -	 410	 420	
CAOG_07214	 -	 410	 420	
CAOG_07214	 +	 411	 421	
CAOG_07458	 -	 372	 382	
CAOG_07458	 -	 484	 494	
CAOG_07458	 +	 446	 456	
CAOG_08035	 +	 39	 49	
CAOG_08035	 -	 39	 49	
CAOG_08035	 +	 38	 50	
CAOG_08035	 -	 38	 50	
CAOG_08463	 +	 459	 469	
CAOG_08652	 +	 52	 62	
CAOG_08705	 -	 30	 42	
CAOG_08864	 -	 426	 436	
CAOG_08864	 -	 426	 436	
CAOG_08864	 +	 425	 437	
CAOG_08864	 -	 425	 437	
CAOG_08864	 -	 425	 437	
CAOG_08935	 -	 126	 138	
CAOG_08935	 +	 126	 138	
CAOG_08935	 -	 126	 138	





CAOG_09048	 +	 321	 331	
CAOG_09048	 +	 322	 332	
CAOG_09048	 -	 321	 333	
CAOG_09134	 -	 9	 21	
CAOG_09134	 -	 9	 21	
CAOG_09134	 +	 9	 21	
CAOG_09305	 +	 270	 280	
CAOG_09305	 -	 270	 280	
CAOG_09305	 +	 223	 233	
CAOG_09359	 +	 315	 325	
CAOG_09379	 +	 278	 290	
CAOG_09674	 +	 376	 386	
CAOG_09674	 +	 67	 77	
CAOG_09703	 +	 256	 265	
CAOG_09703	 +	 256	 266	
CAOG_09703	 -	 256	 266	
CAOG_09703	 -	 255	 265	
CAOG_09703	 +	 255	 265	
CAOG_09703	 +	 256	 266	
CAOG_09703	 +	 255	 267	
CAOG_09703	 -	 255	 267	
CAOG_09703	 +	 254	 266	
CAOG_09703	 -	 254	 266	
CAOG_09703	 -	 255	 267	
CAOG_09703	 +	 255	 267	
CAOG_09703	 +	 254	 266	
CAOG_09703	 -	 254	 266	
CAOG_09720	 +	 430	 439	
CAOG_09720	 +	 430	 440	
CAOG_09720	 -	 282	 292	
CAOG_09720	 +	 430	 440	
CAOG_09720	 -	 282	 292	
CAOG_09720	 +	 429	 441	
CAOG_09786	 -	 68	 78	
CAOG_09902	 -	 127	 137	
CAOG_09996	 -	 19	 29	






The results of the JASPER NF-κB motif search of genes that are co-regulated with NF-
κB. These genes contain one, two or three κB sites within their putative promoters. Each 









Figure 5.1 Protist NF-κB proteins differ in domain structure and choanoflagellates 
show evidence of gene duplication. 
(A) The general domain structures of both Capsaspora NF-κB and the choanoflagellate 
RHD-only proteins. Green, RHD (Rel Homology Domain); Purple, nuclear localization 
sequence; Blue, GRR (glycine-rich region); Black bars, Ankryin repeats; Pink, sequences 





estimation using maximum likelihood (bootstrapped 1000 times) of choanoflagellate 












Figure 5.2 DNA-binding and transcriptional activation activity of Co-NF-κB. 
(A) Protein binding microarray (PBM) DNA-binding profiles of Co-NF-κB as compared 
to Nematostella vectensis (Nv) NF-κB cysteine (cys) allele (top, left), human (Hu) RelA 
(top, right), human p52 (bottom, left), and human cRel (bottom, right). The axes are z-
scores. Red dots represent random background sequences, and blue dots represent NF-κB 
binding sites. (B) FLAG-tagged expression vectors used in these experiments. From top 
to bottom, the drawings depict the naturally shortened Nv-NF-κB, the full-length Co-NF-
κB protein, an N-terminal-only mutant containing the RHD and GRR (Co-RHD), and a 
C-terminal-only mutant containing the ANK repeats and other C-terminal sequences (Co-
Cterm). (C) Anti-FLAG Western blot of lysates of HEK 293T cells transfected with the 
indicated expression vectors. (D) Indirect immunofluorescence of DF-1 chicken 
fibroblast cells transfected with the indicated expression vectors. Cells were then stained 
with anti-FLAG antiserum (left panels) and HOESCHT (middle panels), and then 
MERGED on the right panels. (E) A κB-site electromobility shift assay (EMSA) using 
each of the indicated lysates from (C). The NF-κB complexes and free probe are 
indicated by arrows. (F) A κB-site luciferase reporter gene assay was performed with the 
indicated proteins in HEK 293 cells. Luciferase activity is relative (Rel.) to that seen with 
the empty vector control (1.0), and values are averages of three assays performed with 
triplicate samples with standard error. (G) A GAL4-site LacZ reporter gene assay was 
performed in yeast Y190 cells. Values are average units from seven assays performed 







Figure 5.3 IKK-mediated processing of NF-κB arose with multicellularity. 
(A) Co-transfection with various kinases does not induce processing of FLAG-Co-NF-κB 
in HEK 293T cells. Arrows indicate the various FLAG- or HA-tagged kinases used in 
these assays. Full-length Co-NF-κB and processed Co-NF-κB are also indicated. (B) Co-
NF-κB with C-terminal IKK target serines from Aiptasia NF-κB (Co-NF-κB-SER) or 
serine-to-alanine mutants (Co-NF-κB-ALA) were co-transfected with constitutively 
active human HA-IKKβ (SS/EE). Transfecting Co-NF-κB-SER and HA-IKKβ (SS/EE) 
resulted in the appearance of an increased amount of the lower band, but the alanine 






Figure 5.4 MG132 inhibits constitutive processing of Co-NF-κB.  
HEK 293T cells were transfected with FLAG-Ap-NF-κB or FLAG-Co-NF-κB and either 
a vector control or a FLAG-IKKβ expression vector. Where indicated, MG132 (40 uM) 









Figure 5.5 Transfected FLAG-Co-NF-κB and FLAG-Co-RHD proteins are located 
in the nucleus of Capsaspora cells. 
Capsaspora cells were transfected with FLAG-tagged vectors for full-length Co-NF-κB, 
mutant Co-RHD, and mutant Co-Cterm. The cells were stained using anti-FLAG 
antiserum (left panels) and HOECHST (middle panels), and then MERGED (right 





Figure 5.6 Full-length Co-NF-κB localizes to the nucleus of Capsaspora cells.  
Capsaspora cells were transfected with an expression plasmid for FLAG-Co-NF-κB and 









Figure 5.7 NF-κB mRNA levels and activity differ in different life stages 
of Capsaspora and proposed roles for NF-κB in Capsaspora development and 
immunity. 
(A) Top: The FPKM values from Sebé-Pedrós et al. (2013) of NF-κB at each life stage, 
done in triplicate. Agg, Aggregative (yellow), Filo, Filopodic (green), Cys, Cystic (blue). 
Error bars are standard deviation. Bottom: Images taken with a light microscope of each 





(B) Capsaspora whole-cell extracts were created from each life stage (see Methods). 70 
μg of each extract was then used in an electromobility shift assay (EMSA). Lane 1 
contains only free probe. Lanes 2-4 contain lysates from Agg, Filo, and Cys life stages 
incubated with a radioactive κB-site probe. Lanes 5 and 9 are empty. Lanes 6-8, and lanes 
10-12 contain lysates from Agg, Filo, and Cys life stages as indicated, and were 
incubated with an excess (10X and 25X, respectively) of unlabeled κB-site probe. Lane 
13 contains the Cys lysate incubated with 25X unlabeled IRF-site probe. NF-κB 
complexes and Free Probe are indicated with arrows. The dashed lines indicate where the 
gel was cut to remove excess lanes. (C) NF-κB expression may influence the expression 
of genes that are involved in developmental and immune system processes. The 
expression profiles of these genes correlate with NF-κB mRNA expression in each life 
stage (Agg, low; Filo, medium; Cys, high), and were identified via Biological Processes 
GO analysis. Two of the genes in this list (SYK and SRC) also contain κB sites in the 







Figure 5.8 GO analysis of annotated Capsaspora genes co-expressing with Co-NF-
κB.  
GO enrichment analysis was performed on the 305 annotated Capsaspora gene homologs 
that show the same expression pattern as Co-NF-κB mRNA across the three Capsaspora 







Figure 5.9 Characterization of cellular and molecular properties of three 
choanoflagellate NF-κBs. 
(A) FLAG-tagged NF-κB proteins used in these experiments. From top to bottom the 





(5). RHDs are in green (Rel Homology Domain). (B) Anti-FLAG Western blot of lysates 
from HEK 293T cells transfected with the indicated expression vectors. (C and D) 
Indirect immunofluorescence of DF-1 chicken cells (C) or Capsaspora cells (D) 
transfected with the indicated expression vectors. Cells were then stained with anti-FLAG 
antiserum (left panels) and HOESCHT (middle panels), and then MERGED in the right 
panels. Yellow scale bar in Capsaspora panels is 2 μM. (E) A κB-site electromobility 
shift assay (EMSA) using each of the indicated lysates from (B). The NF-κB complexes 
and free probe are indicated by arrows. (F) A κB-site luciferase reporter gene assay was 
performed with the indicated proteins in HEK 293 cells. Luciferase activity is relative 
(Rel.) to that seen with the empty vector control (1.0), and values are averages of three 
assays performed with triplicate samples with standard error. Values are shown on a log 
scale. (G) A GAL4-site LacZ reporter gene assay was performed with GAL4-fusion 
proteins in yeast Y190 cells. Values are average units of two assays performed with four 
samples with standard error. (H) Coimmunoprecipitation (IP) assays of MYC-tagged As-
NF-κB2 and As-NF-κB3. In each IP assay, MYC-As-NF-κBs were co-transfected with 
pcDNA FLAG, FLAG-As-NF-κB1, 2 or 3 as indicated. An IP using anti-FLAG beads 
was performed. Anti-FLAG (top) and anti-MYC (middle) Western blotting was then 








Figure 5.10 Schematic of the proteins found in the simplified TLR pathway of 
various organisms.  
For each protein, the presence of a homolog is indicated according to the color legend on 









Prior to this thesis, the only information that was known about NF-κB signaling in 
cnidarians were studies conducted in organisms such as Aiptasia, Nematostella, and 
Hydra (Franzenburg et al., 2012; Wolenski et al, 2013; Mansfield et al., 2017; Brennan et 
al., 2017). No information was known about NF-κB signaling in more ecologically 
relevant cnidarians such as endangered corals or in organisms basal to cnidarians other 
than that homologs existed in the transcriptomes or genomes. As such, the molecular and 
functional characterization of NF-κB signaling in corals, sponges, and protists required 
the development of novel tools and assays, and a deeper understanding of NF-κB 
functions across basal phyla. The work presented in this thesis provides a foundation for 
future studies that seek to understand the role of NF-κB signaling in basal organisms in 
vivo, including more biological information concerning this important, conserved 
signaling pathway.  
 In the coral Orbicella faveolata, and the sponge Amphimedon queenslandica, it 
appears that NF-κB might play a role in pathogen response. That is, tissue that is 
stimulated with a potent activator of NF-κB in higher organisms, LPS, results in pathway 
activation and increased expression of NF-κB molecules in these organisms. While the 
way this activation appears to be induced in cell culture appears most consistent with the 
IKK-mediated activation seen in the p100 NF-κB protein of vertebrates, the actual 





NF-κB is unknown. However, in Capsaspora, NF-κB likely plays different and unique 
roles in different life stages, given its differential expression in each life stage. How Co-
NF-κB behaves in the natural symbiotic setting of the snail could be different from what 
we have described in our in vitro experiments. In the choanoflagellates, up to three NF-
κB-like proteins exist in each organism. For the first time outside the Animal kingdom, it 
is demonstrated that NF-κB can create heterodimers, demonstrating that subclasses of 
NF-κB have evolved at least twice in evolution. These results suggest that in 
choanoflagellates such as A. spectibilis, there is unique and distinct DNA binding of these 
heterodimers that could allow for transcriptional flexibility and pathway activation.  
 
6.2 Chapter Three Discussion  
6.2.1 Summary 
The data presented in Chapter three suggest that there are highly conserved 
elements of a TLR-to-NF-κB innate immune pathway in the endangered coral O. 
faveolata. That is, we show that the intracellular TIR domain of the single Of-TLR 
protein is most similar by sequence analysis to human TLR4, and that the TIR domain of 
Of-TLR can directly interact with human MYD88 (Figure 3.3), which is an essential 
adapter protein for human TLR4-based signaling to NF-κB. Moreover, the single Of-NF-
κB protein has sequence similarity, an overall structural organization, and transactivation 
properties that are more like human NF-κB proteins than human Rel proteins (Figure 
3.5). Furthermore, the Of-NF-κB protein can be processed in response to overexpression 





pathway processing of NF-κB p100 in human cells (Figure 3.6 and 3.7). Finally, we show 
that a mammalian ligand of TLR4-to-NF-κB activation, namely gram-negative bacterial 
LPS, activates a gene expression profile in isolated O. faveolata tissue that is consistent 
with overall activation of NF-κB pathway genes (Table 3.2).  
6.2.2 TLR-to-NF-κB pathway components in cnidarians 
To date, a handful of studies have identified TLR-to-NF-κB pathway components 
in environmentally stressed cnidarians. Anderson et al. (2016) and Pinzón et al. (2015) 
identified transcripts encoding NF-κB signaling components in their transcriptomes from 
bleached O. faveolata. In the coral Acropora palmata, transcripts for a putative tumor 
necrosis factor receptor-associated factor 3 (TRAF3) homolog and NF-κB were shown to 
be upregulated when coral were exposed to increased water temperature (DeSalvo et al., 
2010). The upregulation of NF-κB pathway components at the transcriptional level has 
also recently been described in the sea anemone A. pallida following treatment with heat 
or chemicals that induce bleaching (Mansfield et al., 2017). However, the precise 
mechanisms by which these conserved signal transduction pathways elicit their 
responses, the gene targets regulated by NF-κB in these organisms, and their biological 
roles in these cnidarians remain largely unknown.  
6.2.3 LPS treatment of O. faveolata indicate an activation of the NF-κB pathway 
Treatment of O. faveolata tissue with LPS results in significant differential 
expression of genes in a manner indicating activation of the NF-κB pathway. These 
results are consistent with other studies that have reported upregulation of NF-κB 





Franzenburg et al. (2012) demonstrated that microbial infection of Hydra elicits a TLR-
like pathway response and bacterial flagellin can activate a TLR-to-NF-κB signaling 
when the Hydra TLRs are expressed in mammalian cells (Bosch et al., 2009). Similarly, 
Brennan et al. (2017) have shown that a coral bacterial pathogen can activate the N. 
vectensis TLR. However, our results are the first to show that NF-κB pathway 
components in an endangered coral are upregulated in response to treatment with a 
known mammalian inducer of NF-κB, i.e., LPS. Whether this activation of NF-κB 
components by LPS occurs through the Of-TLR that we characterize here is not known at 
this time. Interestingly, a recent paper demonstrated that about 40 gram-negative marine 
microbes, as well as their purified LPS molecules, evaded detection by mammalian 
immune systems, which might be due to the lack of co-evolution between mammals and 
marine microbes, as well as longer side-chains on the lipid portion of the LPS (Gauthier 
et al., 2021). It is tempting to speculate that this range of microbes gives rise to a receptor 
that has a promiscuous ability to recognize a variety of microbes, such as the TLR 
described here, or perhaps, a range of receptors capable of recognizing this diversity that 
is yet discovered in marine organisms. To support the former hypothesis, as noted in this 
thesis, there are significantly less immune-related receptors present in basal organisms.  
6.2.4 Activation of the NF-κB pathway is likely different mammalian and basal 
organisms 
Although our results suggest a link between LPS treatment and activation of NF-
κB in O. faveolata, it is important to note the differences between our findings and the 





That is, our results show that the levels of mRNAs encoding several NF-κB pathway 
components are upregulated approximately 4 h after treatment of O. faveolata tissue with 
LPS. In contrast, LPS-induced activation of NF-κB in mammalian systems is usually 
studied as the rapid nuclear localization of a latent cytoplasmic NF-κB complex 
approximately 10-30 min following treatment with LPS. Thus, we have not directly 
shown that LPS treatment activates the NF-κB protein in a conventional sense.  
6.2.5 O. faveolata has non-canonical and canonical components of NF-κB signaling  
Our results suggest that the TLR-to-NF-κB pathway in O. faveolata has 
characteristics of both non-canonical and canonical NF-κB signaling in mammals. On the 
one hand, the Of-NF-κB pathway is like the mammalian non-canonical pathway in that 1) 
the overall organization of Of-NF-κB is similar to the mammalian NF-κB protein p100, 
2) C-terminal truncation leads to nuclear localization, enhanced DNA binding, and 
enhanced transactivation in vertebrate cells, 3) IKKs can induce partial processing of 
overexpressed Of-NF-κB in human cells, 4) sites of IKK-dependent serine 
phosphorylation in p100 are conserved in Of-NF-κB, and 5) these serine residues are 
required for processing of Of-NF-κB in human cells. On the other hand, human IKKβ, 
which is normally associated with canonical NF-κB signaling in mammalian cells, is as 
active as, if not even more active than, Of-IKK towards Of-NF-κB in our in vitro 
phosphorylation and human cell induction experiments. Moreover, TLR4 generally 
activates the canonical NF-κB pathway in mammalian cells. Furthermore, although the 
TIR domain of the Of-TLR has properties of human TLR4, the extracellular LRR domain 





TLR) than to TLR4 (a single cysteine cluster TLR protein, similar to what is seen with 
Nv-TLR (Brennan et al., 2017). Finally, the clustering of the TIR domain of Of-TLR with 
human TLR4 is not seen with other methods of phylogenetic analysis (e.g., maximum-
likelihood and maximum parsimony [data not shown]). Thus, the evolutionary processes 
by which cnidarian TLR and TLR-like proteins, as well as a single cnidarian IKK, 
diversified into the multiple member higher metazoan TLR and IKK families vis-à-vis 
canonical vs. non-canonical signaling to NF-κB are not obvious.  
 
6.3 Chapter Four Discussion  
6.3.1 Summary 
In Chapter four, we demonstrate that at least two sponges have active NF-κB 
proteins. First, we show that the A. queenslandica NF-κB protein is phylogenetically and 
structurally similar to other metazoan NF-κB proteins (Figure 4.1), and that its DNA-
binding profile, transactivation properties, and subcellular regulation by C-terminal 
sequences are similar to NF-κB proteins found in other species (Figure 4.2-4.4). We also 
demonstrate that a black encrusting demosponge contains a protein that can bind a 
conserved κB site in an EMSA and two proteins that can be detected by an anti-NF-κB 
antibody in Western blots and tissue immunofluorescence (Figure 4.5-4.6). Furthermore, 
treatment of this sponge tissue with LPS leads to further activation of its putative NF-κB 
protein, as shown by both increased processing and increased DNA binding (Fig 4.7). 
Finally, we also show that A. queenslandica contains homologs to many components of a 





have a highly conserved NF-κB pathway, which is expressed in a subset of cells that 
likely are involved in an innate immune response. 
6.3.2 A. queenslandica expresses an NF-κB protein that is most homologous to a 
human p100 NF-κB protein 
Consistent with previous results (Gauthier and Degnan, 2008), our results indicate 
that Aq-NF-κB is structurally similar to the human NF-κB p100 protein and to our 
previously characterized sea anemone Aiptasia and coral O. faveolata NF-κB proteins 
(Sun, 2011; Mansfield et al., 2017; Williams et al., 2018). In our cell-based assays, 
removal of the ANK repeat domain allowed for localization of Aq-NF-κB to the nucleus 
and liberation of its transcription activation activity.  
The occurrence of bipartite NF-κB proteins that contain both the RHD and the C-
terminal ANK repeats in sponges (A. queenslandica) and the protist C. owczarzaki is 
different than what is seen in some cnidarians, such as N. vectensis, which contains 
separate RHD and IκB-like ANK-repeat proteins. More specifically, we and others have 
demonstrated that the sponge and protist NF-κB proteins are more closely related 
structurally to the human p100 and p105 NF-κB proteins  (Gauthier and Degnan, 2008; 
Mansfield et al., 2017; Williams et al., 2018), suggesting that genes such as the naturally 
shortened N. vectensis NF-κB protein (Wolenski et al., 2011) are the result of organism-
specific gene splitting events. Such gene-splitting events are not uncommon in  






6.3.3 The structure of A. queenslandica NF-κB might be responsible for its unique 
DNA-binding properties 
Surprisingly, full-length Aq-NF-κB bound to DNA to a similar extent as the Aq-
RHD protein (deleted of the C-terminal ANK repeats) (Figure 4.2F). Therefore, the C-
terminal ANK repeat domain of Aq-NF-κB appears to inhibit nuclear translocation 
(Figure 4.3A), but not DNA binding. In addition, two protein-DNA complexes were seen 
in EMSAs when using extracts from cells overexpressing full-length Aq-NF-κB. We 
suspect that these two complexes correspond to dimer and tetramer forms of Aq-NF-κB. 
Of note, NF-κB complexes larger than dimers have been reported for mammalian NF-κB 
p100 and p105 proteins (Savinova et al., 2009). In all other NF-κB proteins analyzed to 
date (as well as with Of-NF-κB and Co-NF-κB), the C-terminal ANK repeat domain 
inhibits the DNA-binding activity of RHD sequences in assays similar to those that we 
have performed in Chapter four. As we note, Aq-NF-κB contains an unusually long 
sequence between its RHD and the start of its ANK repeats. It is possible that this 
extended sequence interferes with the ability of the ANK repeat domain to inhibit DNA 
binding by the RHD. In any case, the ANK repeat domain can block nuclear translocation 
(Figure 4.3A) and transcriptional activation by Aq-NF-κB in reporter gene assays (Figure 
4.2D), and inhibition of nuclear translocation would functionally block Aq-NF-κB’s 
ability to activate gene transcription in cells. Why there are extra sequences between the 
RHD and the ANK repeat domain in Aq-NF-κB and whether these sequences are 
important for any NF-κB–related processes in sponges are not known. However, the 





processing of Aq-NF-κB by known IKKs (Figure 4.3C).  
6.3.4 Sponges have both canonical and non-canonical signaling components  
A. queenslandica is similar to other evolutionarily basal organisms in that its 
genome encodes one NF-κB protein and no Rel proteins. Additionally, Aq-NF-κB 
contains serine residues C-terminal to the ANK repeats that can be phosphorylated in 
vitro by the human IKKβ kinase (an activator of canonical NF-κB signaling in humans), 
and these conserved serines are required for IKK-induced processing of Aq-NF-κB in 
human cells in tissue culture. It is also of interest that activation of canonical signaling 
(by IKKβ) in 293T cells can promote processing of Aq-NF-κB (Figure 4.3C), as well as 
some cnidarian NF-κB proteins (Mansfield et al., 2017; Williams et al., 2018). Given that 
cnidarians and poriferans lack Rel-like proteins, their NF-κB proteins appear to be 
obligate homodimers, whereas human p100 is generally in a heterodimer with RelB. 
Thus, basal NF-κB signaling may have aspects of both the canonical and non-canonical 
signaling pathways found in mammals.  
6.3.5 Constitutively processed NF-κB in the sponge 
In any case, the majority of a putative NF-κB protein in tissue from a black 
encrusting sponge appears to be processed, binds to DNA, and is located in the nucleus of 
cells. Thus, in this sponge, most of its NF-κB protein appears to be constitutively in its 
active form. We have previously shown that most of the NF-κB protein of the sea 
anemone Aiptasia is also a constitutively nuclear and processed protein in animals 
(Mansfield et al., 2017). Moreover, the majority of mouse NF-κB p100 is in its processed 





(Senftleben et al., 2001). The factors that promote constitutive processing of NF-κB 
proteins in these diverse organisms and tissues in vivo are not known. However, it is 
interesting to speculate that continual exposure to pathogens or other activating ligands 
induces NF-κB processing in each of these situations. Further studies should be directed 
at determining the requirements for the production of the constitutively active sponge 
NF-κB protein, whether this constitutive activity is also found in other poriferans, the 
trade-offs to this constitutive activity, and the situations in which this processing does not 
occur.  
6.3.6 IKKs can process Aq-NF-κB, but are not encoded in the in the A. 
queenslandica genome 
Two IKK-like proteins are encoded in genomic sequences of A. queenslandica 
(NCBI Accession numbers XP_019854889.1 and XP_003387126.1), and both appear 
more similar to the TBK/IKKε subclass of IKKs than to the IKKα/β subclass (data not 
shown). In general, the mammalian TBK/IKKε kinases do not phosphorylate IκBs or C-
terminal serines in p100. Therefore, although our results in 293T cells suggest that A. 
queenslandica has a kinase that is capable of inducing processing of Aq-NF-κB, such a 
kinase has yet to be identified, either because there is a lack of genomic coverage to 
identify it or this kinase has no obvious sequence homology to other known metazoan 
IKKs.  
6.3.7 A receptor for LPS exists in the sponge 
We also found that treatment of fresh sponge tissue with LPS for 30 min resulted 





κB-site binding activity. In the demosponge Suberites domuncula it has been shown that 
LPS can be bound by an LPS-interacting protein (Wiens et al., 2007), which is capable of 
binding and dimerizing with an Sd-MyD88 homologous protein. Currently, there is no 
identified LPS-interacting protein homolog in A. queenslandica, but it does contain a 
homolog of the TIR-domain adapter protein MyD88 (Table 4.2). Nevertheless, our data 
suggest that the black encrusting sponge possesses an LPS-interacting protein and/or a 
receptor capable of recognizing LPS. 
6.3.8 Homologs to the NF-κB pathway exist in the sponge 
Although we have yet to identify a sponge kinase capable of processing Aq-NF-
κB, we have identified many other homologs of a likely NF-κB pathway in A. 
queenslandica (Figure 4.9). A. queenslandica lacks a complete Toll-like receptor (TLR), 
but does express what appears to be a homolog of the Interleukin 1 receptor (IL-1R), 
which contains an intracellular Toll-interleukin receptor (TIR) domain as well as 
extracellular immunoglobulin domains. While mammalian TLR and IL-1R proteins bind 
different ligands due to their different extracellular domains, both receptors contain 
intracellular TIR domains that can interact with many of the same downstream signaling 
proteins (e.g., MYD88).  
6.3.9 Cell-specific expression of NF-κB in the sponge 
Recently, it was shown that A. queenslandica NF-κB transcripts are expressed in 
at least two cell types: choanocytes, which are cells that reside in the chambers that allow 
the sponge to filter feed, and to a lesser extent in archaeocytes, which are pluripotent cells 





that we examined, primarily nuclear NF-κB protein was detected in a subset of cells that 
appeared to be within the tissue mesoglea. We did not detect any choanocyte chambers in 
our images. Therefore, we believe that the cells that are stained with our NF-κB 
antiserum are likely either archaeocytes or another cell type that has yet to be identified. 
Archaeocytes are known to be amoeboid-like and to transport particulate matter taken-up 
by choanocytes into the sponge tissue. Therefore, it is possible that archaeocytes require 
NF-κB-related immune functions due to their continuous exposure to water-borne 
microbes. Furthermore, archaeocytes are also known to be totipotent and capable of 
differentiation into many cell types (Buscema et al., 1980), and it is well established that 
NF-κB plays a role in the differentiation of several cell types in vertebrates (Guttridge et 
al., 1999; Bottero et al., 2006; Zhang et al., 2012). 
6.3.10 Other roles of NF-κB in the sponge 
The ability of E. coli-derived LPS to further activate NF-κB in sponge tissue 
suggests that NF-κB has role in poriferan anti-bacterial immunity. However, there is 
likely to also be an early developmental role for NF-κB in poriferans. That is, Gauthier  
and Degnan (2008) showed that NF-κB transcripts are present during early development 
of A. queenslandica, especially in granular cells and flask cells (Gauthier and Degnan, 
2008). Dual roles in embryonic development and adult immunity have been shown for 
the NF-κB protein Dorsal in Drosophila and have been postulated for the NF-κB protein 






6.4 Chapter Five Discussion 
6.4.1 Summary 
In Chapter five, we have functionally characterized and compared, for the first 
time, NF-κB proteins from two protists. Taken together, these results demonstrate that 
although functional DNA-binding and transcriptional-activating NF-κB proteins exist in 
these protists, the overall structures and regulation of these proteins vary considerably, 
both among protists and when compared to animal NF-κBs.  
6.4.2 Proteasome-mediated processing without an IKK in Capsaspora 
In the vertebrate NF-κB proteins p100 and p105, C-terminal ANK repeats inhibit 
the DNA-binding activity of the RHD, and proteasome-mediated processing of the ANK 
repeats is terminated by and within the GRR (Sun, 2011). In the Drosophila Relish 
protein, the C-terminal ANK repeats also inhibit DNA binding, but the C-terminal ANK 
repeats are removed by an internal site-specific cleavage event, which does not involve 
the proteasome, and Relish has no GRR (Stöven et al., 2003). Thus, the presence of ANK 
repeats and a GRR in Co-NF-κB suggests that proteasomal processing would lead to 
nuclear translocation and activation of its DNA-binding activity. Indeed, removal of the 
C-terminal residues of Co-NF-κB does allow it to enter the nucleus of vertebrate cells and 
unleashes its DNA-binding activity (Figs. 5.2D and E). Moreover, treatment of cells with 
the proteasome inhibitor MG132 blocks the basal processing of Co-NF-κB that is seen in 
transfected 293T cells (Figure 5.4). However, this basal processing of Co-NF-κB in 293T 
cells is not enhanced by co-expression of IKK (unless C-terminal IKK target sequences 





are there any IKK homologues in the Capsaspora genome. Furthermore, most of the Co-
NF-κB appears to be in the nucleus when it is overexpressed in Capsaspora cells (Figure 
5.5 and 5.6), suggesting that it is constitutively processed to its RHD. If Co-NF-κB does 
undergo a signal-induced proteasomal processing in Capsaspora cells, then it is unlikely 
to be dependent on an IKK-like kinase. Alternatively, but probably less likely, full-length 
Co-NF-κB enters the nucleus of Capsaspora cells but not DF-1 chicken cells. In the 
absence of a Co-NF-κB-specific antiserum, we cannot distinguish between these 
possibilities.  
6.4.3 Regulation of choanoflagellate NF-κBs is unclear 
In contrast to Capsaspora, the choanoflagellate NF-κB proteins lack C-terminal 
ANK repeats and GRRs, and all three As-NF-κB proteins are constitutively in the nucleus 
when overexpressed in vertebrate or Capsaspora cells (Figure 5.9). We have not been 
able to identify an IκB-like protein in the A. spectabilis genome. Thus, it is unclear 
whether choanoflagellate NF-κB is regulated by an ANK-dependent cytoplasmic 
retention mechanism, or whether, for example, choanoflagellate proteins are 
constitutively nuclear in their native settings. Nevertheless, it is clear that the regulation 
of both Capsaspora and choanoflagellate NF-κB proteins is distinct from what is seen 
with NF-κB proteins in higher metazoans. 
6.4.4 Constitutive processing of NF-κB in protists  
Of interest, constitutively nuclear localization of NF-κB proteins has also been 
seen in other settings. That is, we have previously shown that in both the sea anemone 





processed in their native settings (Mansfield et al., 2017; Williams et al., 2020). Thus, we 
have argued previously (Williams and Gilmore, 2020) that these basal NF-κB proteins 
may be constitutively in an active state, perhaps due to continual interaction with 
upstream activating ligands or pathogens. Of note, most NF-κB p100 is also in its 
processed form in mouse spleen tissue (Senftleben et al., 2001).  
6.4.5 NF-κB likely has a specialized, rather than general function in 
choanoflagellates 
Among the 21 choanoflagellates for which there is sufficient 
transcriptomic/genomic information, it appears that only 12 have any NF-κB genes. 
Surprisingly, in seven of these 12 choanoflagellates there are multiple NF-κB genes. 
Thus, it is clear that there have been gains and losses of NF-κB genes among the 
choanoflagellates. We note that NF-κB has also been lost in other organisms including C. 
elegans and ctenophores (Wolenski and Gilmore, 2012). The absence of NF-κB in some 
choanoflagellates and its expansion in others (e.g., A. spectabilis) suggests that NF-κB 
has a specialized, rather than a general, biological function in choanoflagellates.  
6.4.6 Choanoflagellate NF-κBs likely dimerize in vivo for specialized transcriptional 
control 
The presence of three NF-κB-like heterodimerizing proteins in A. spectabilis is 
the first example of an organism in a lineage that predates flies with multiple NF-κB 
family proteins that are capable of forming heterodimers. Thus, expansion of NF-κB 
genes has occurred multiple times in evolution, i.e., at least once in the metazoan lineage 





different ability to bind DNA and activate transcription, it appears that there are 
subclasses of NF-κB within A. spectabilis and likely also within other choanoflagellates 
that have multiple NF-κBs. It is interesting to note that As-NF-κB1, 2, and 3 are 
phylogenetically separate and cluster most closely with NF-κBs from certain other 
choanoflagellate species that contain multiple NF-κBs. For example, Savillea parva 
contains three NF-κBs, each of which clusters with a separate As-NF-κB (Figure 5.9B). 
Thus, we hypothesize that choanoflagellates, like vertebrates, have evolved a mechanism 
for differential transcriptional control of genes through the use of combinatorial dimer 
formation. 
6.4.7 Regulation of NF-κB in protists is different than vertebrates 
The differential mRNA expression and DNA-binding activity of NF-κB among 
different life stages of Capsaspora suggest that NF-κB has life stage-specific functions. It 
is notable that the DNA-binding activity of NF-κB in these different life stages correlates 
with differences in the levels of NF-κB mRNA, rather than as differences in induced 
activity. That is, in most metazoans, the activity of NF-κB is regulated at the post-
transcriptional level, whereas in Aiptasia and corals, we have found that NF-κB mRNA 
levels and DNA-binding activity appear to be coordinately regulated, suggesting 
transcriptional regulation. That is, in Aiptasia, thermal bleaching causes transcriptional 
upregulation of NF-κB, which also results in increased protein expression of nuclear, 
DNA binding-active NF-κB (Mansfield et al., 2017), which is similar to what we see with 
NF-κB across the Capsaspora life stages. Similarly, treatment of the coral O. faveolata 





increased post-translational activation of NF-κB (Williams et al., 2018). Thus, it appears 
that in several basal organisms NF-κB proteins are constitutively nuclear and that 
increases in their activity is the result of transcriptional upregulation of NF-κB mRNA, 
rather than induced proteolysis, which occurs in most mammalian and fly systems. 
6.4.8 NF-κB in many basal organisms are constitutively processed 
Activation of NF-κB by signal-induced degradation of IκB sequences is 
essentially dogma in vertebrates. Although several basal NF-κBs, including Co-NF-κB, 
can be formulated to undergo IKK-induced processing when expressed in human cells in 
culture (Mansfield et al., 2017; Williams et al., 2018; Williams et al., 2020), there is 
much evidence that such regulation may not occur in the native organisms. For example, 
although sponge and sea anemone Aiptasia NF-κBs have C-terminal ANK repeats and 
GRRs, they are largely processed and nuclear in the animals themselves (Mansfield et al., 
2017; Williams et al., 2018; Williams et al., 2020). Moreover, induction of NF-κB DNA- 
binding activity and protein levels by loss of symbiosis in Aiptasia appears to be 
primarily a result of increased transcription of NF-κB and not due to induced ANK repeat 
degradation. Similarly, the increased NF-κB DNA-binding activity seen in different life 
stages of Capsaspora is paralleled by increased expression of NF-κB mRNA in these life 
stages. Furthermore, when Co-NF-κB is overexpressed in Capsaspora cells it is primarily 
in the nucleus, likely due to constitutive processing to the RHD form. We note here that 
the nuclear staining of transfected FLAG-Co-NF-κB appears punctate, which may be due 
its localization at sites of active gene transcription, or “nuclear bodies” (Brasch and Ochs, 





conditions stop them from being processed. Of note, the three As-NF-κBs do not have C-
terminal ANK repeats and we have not been able to identify a putative IκB in A. 
spectabilis transcriptomic databases. Therefore, it is possible that the activity of these 
constitutively nuclear choanoflagellate NF-κBs is fully regulated by transcriptional 
control of their genes.  
6.4.9 Target genes of Capsaspora NF-κB  
Of the nearly 1350 genes whose expression correlated with NF-κB expression 
across different Capsaspora life stages, almost 20% contained NF-κB binding sites 
within 500 base pairs upstream their TSS (Figure 5.7). While this result might be an 
overestimate of NF-κB gene targets or genes indirectly influenced by expression of NF-
κB, there are likely additional NF-κB binding sites that could affect target gene 
expression. For example, ATAC-seq data have suggested that the regulatory sites in the 
Capsaspora genome are present in first introns, 5’ UTRs, as well as the proximal 
intergenic regions (Sebé-Pedrós et al., 2016). Among the ~1350 genes that we identified 
with expression patterns similar to NF-κB, there are 192 genes that contain NF-κB 
binding sites in their proximal promoters. Two of these genes are homologs of SYK and 
SRC (CAOG_08354 and CAOG_00206), which are known in higher organisms to be 
involved in immunity and development (Mócsai et al., 2010; Lowell, 2011). However, 
the list of ~1350 genes most certainly contains genes that are controlled by other 
transcription factors or are regulated by signaling or developmental events that are 
partially or not at all affected by NF-κB. Nevertheless, it is clear that NF-κB might play 





6.4.10 The biological function of Capsaspora NF-κB remains unclear 
Our studies suggest that the regulation and associated biology of NF-κB in single-
celled organisms are different from what is seen in multicellular vertebrates and flies. 
Perhaps, the concerted effort of aggregation in Capsaspora and the correlative decrease 
in NF-κB in these aggregated cells reflect a need to suppress collective immunity to form 
a symbiotic group. Alternatively, Capsaspora is normally a symbiont in the hemolymph 
of the snail B. glabrata, where NF-κB may play a role in maintaining symbiosis, which 
has been suggested as one function of NF-κB in other organisms (Mansfield and Gilmore, 
2019).  
6.4.11 NF-κB pathway signaling in protists 
It is not clear what type of pathway might lead to activation of NF-κB in protists. 
Across the animal kingdom, the binding of a ligand to receptors such as TLRs/IL-1Rs or 
TNFRs initiates signaling pathways that converge on an IKK complex which then 
activates NF-κB (Gilmore, 2006). However, in basal organisms, many of these 
components are missing, few in number, or lack critical domains (Williams and Gilmore, 
2020). For example, while some cnidarians contain homologs to TLRs, other cnidarians, 
some sponges, and choanoflagellates contain only TIR-domain proteins that lack the 
important extracellular components of the TLR (King et al., 2008;  Brennan and Gilmore, 
2018; Richter et al., 2018; Williams et al., 2018; Williams et al., 2020). Furthermore, 






6.5 Unanswered questions and future experimental goals 
Although this research has studied the phylogeny, structure, and function of several 
basal NF-κB proteins, these results beget many questions about the role of NF-κB in 
basal organisms. Some of these unanswered questions are discussed below.  
1. Does TLR activate an NF-κB pathway in corals? We have shown that exposure 
of O. faveolata tissue to LPS indues an expression profile that implies that members of 
the TLR-to-NF-κB pathway are activated. Nevertheless, these results do not explicitly 
answer whether TLR is the receptor responsible for activation of this pathway in corals. 
Our lab has previously shown that exogenous expression of the anemone Nv-TLR can 
activate canonical NF-κB signaling in human cells by reporter assays and by induction of 
IκBα phosphorylation, however, we have not been able to show activation of Nv-NF-κB 
in anemones or isolated anemone structures such as nematosomes (Brennan et al., 2017). 
For example, AP-1 is also a transcription factor downstream of NF-κB in vertebrates 
(Roy et al., 2016), and this could be the effector pathway for TLR-induced immunity in 
Nematostella. 
Human TLRs typically activate canonical NF-κB signaling, as we have 
demonstrated with Nv-TLR-dependent activation of NF-κB in 293 cells (Brennan et al., 
2017). However, cnidarian NF-κB pathways appear to consist of elements that resemble 
both canonical and non-canonical NF-κB pathways (Wolenski et al. 2011; Mansfield et 
al. 2017; Williams et al. 2018). Therefore, the molecular mechanism(s) by which Of-TLR 





2. Are basal organisms constitutively processing NF-κB, i.e., is NF-κB 
constitutively activated in basal organisms? In data from our lab and others, it has 
become apparent that the activation of NF-κB in basal organisms may be different than 
what is seen in higher organisms. For example, in Aiptasia (Mansfield et al. 2017), as 
well as in one coral (Mansfield et al. 2019) and one sponge described here (Fig. 4.5), 
whole-cell extracts and immunofluorescence staining of tissue from basal organisms 
reveal that most of the endogenous NF-κB protein in these animals is in its processed 
form and primarily in the nucleus (Mansfield et al., 2017; Figure 4.5). Exogenous FLAG-
Co-NF-κB is also primarily in the nucleus when overexpressed in Capsaspora (Figures 
5.5-5.6). Furthermore, when undergoing an apparent immunological response (i.e., 
bleaching or stimulating with LPS), the amount of NF-κB protein increases in a sea 
anemone and a sponge (Mansfield et al., 2017; Figure 4.7). Additionally, when O. 
faveolata is stimulated with E. coli-derived LPS, the overall expression of NF-κB 
pathway members increases (Table 3.2). Taken together, the basal expression and 
activation of NF-κB in basal organisms seems quite different from what is seen in higher 
animals. That is, in vertebrates, the activation of NF-κB is carried out by a multi-
component signal transduction process in response to a stimulus, which is followed by 
nuclear translocation of NF-κB to activate its target genes. In contrast, it appears that NF-
κB in some, if not many, basal organisms, is constitutively processed and in the nucleus. 
Whether this phenomenon is due to a continual exposure to pathogens, a naturally 





3. What mechanism may cause the constitutive processing of basal NF-κB 
proteins? If basal organisms constitutively process NF-κB, this leads to further questions: 
1) What is the mechanism by which this constitutive processing occurs, and 2) in what 
states are basal organisms not constitutively activating NF-κB?  It is possible that the 
activation and control of NF-κB is carried out on a transcriptional level, rather than a 
processing level. For example, the expression of NF-κB pathway members in O. 
favoelata, rather than the nuclear translocation of NF-κB, occurs after exposure to a 
stimulus. Another possibility is that alternative splicing to generate different forms of the 
NF-κB protein occurs during mRNA expression. Furthermore, most basal organisms 
encode a full-length bipartite (RHD-ANK) NF-κB protein. In what setting then, does the 
organism express a full-length non-processed NF-κB protein? Would constitutive 
processing occur in a completely sterile setting, or a setting that lacks certain external 
cues? At the present time, it is not known what promotes or inhibits the constitutive NF-
κB processing that occurs in most basal organisms that have been studied.  
4. What are the biological functions of NF-κB in protists such as Capsaspora and 
choanoflagellates? Although the data presented here suggest that NF-κB plays a role in 
immunity and/or development in Capsaspora, there is no evidence to date that this is the 
actually the biological role of NF-κB. In fact, very little empirical data exist for the role 
of NF-κB in organisms basal to flies. Therefore, future research should be directed at the 
study of the biological outcomes of basal NF-κB. For example, the actual function of 
Capsaspora NF-κB might be quite different from what is seen in multicellular animals. 





contains an immune system. How does NF-κB work in the context of a single-celled 
organism? Perhaps NF-κB plays a larger role in not only the immunological state of the 
single cell, but also to initiate signaling pathways to communicate between other single-
celled organisms or other organisms that they inhabit. The GO enrichment analysis 
performed on Capsaspora RNA-seq data suggest that NF-κB plays roles that have to do 
with signaling between organisms. For example, other top hits for the genes that co-
migrated with NF-κB were “Multi-organism process,” “Interspecies interaction between 
organisms,” and “Multicellular organismal process” (Figure 5.8). Indeed, Capsaspora 
naturally lives in the hemolymph of the snail Biomphalaria glabrata and thus, NF-κB 
may regulate a symbiont-host interaction. 
In choanoflagellates, the role of NF-κB is unclear. No data to date have suggested 
a biological role for NF-κB in choanoflagellates. However, these organisms are more 
closely related to animals than Capsaspora, contain multiple NF-κB-like proteins, 
sometimes live colonially, and contain homologs to upstream members of the NF-κB 
pathway (Richter et al., 2018). Therefore, the choanoflagellate NF-κB proteins might 
play more conserved roles to animals than Capsaspora, i.e., related to immunity or 
development. Then again, choanoflagellates have undergone incredible divergence 
alongside the evolution of animals, including undergoing their own gene duplications and 
loss of NF-κB. Further research should be directed at the functional understanding of the 
multiple NF-κB protein sequences present in the transcriptomes of these organisms, and 





5.  Does NF-κB signaling actually have a role in immunity in basal organisms? 
Perhaps one of the most important implications of this thesis is that aspects of vertebrate 
innate immunity, specifically TLR-to-NF-κB and NF-κB signaling pathways, are present 
and are, functional, in basal phyla. As discussed in Chapter 6 (section 6.2.4), TLR-
directed activation of NF-κB has not yet been directly demonstrated in any cnidarian 
system, or basal system, to date. While MyD88-deficient Hydra show increased 
sensitivity to bacterial infection (Franzenburg et al. 2012), and reconstituted Nv-TLR in 
activates HEK 293T cells NF-κB pathway (Brennan et al., 2017), studies have yet to 
directly implicate a NF-κB signaling pathway in basal immunity. Furthermore, as 
discussed in section 6.3.7, in organisms like the sponge, there are no clear homologs to 
TLR, yet NF-κB activation in response to a TLR-ligand (namely, E. coli LPS) appears to 
occur. 
To directly address whether TLR-to-NF-κB and NF-κB signaling has a role in 
basal immunity, ongoing efforts should be directed at genetically manipulating (e.g., by 
CRISPR/Cas9) NF-κB signaling in basal organisms. Currently, we are attempting to 
accomplish this in the model organism N. vectensis by generating Nv-NF-κB knockout 
animals and testing their susceptibility to known pathogens, among other biological 
processes. Future experiments should take advantage of the increased genomic and 
transcriptomic sequencing efforts of basal organisms, and attempt genetic manipulation 
of NF-κB in these organisms. One opportunity for genetically modifying NF-κB would 
be using Capsaspora, since it is an amenable organism in several ways: the genome has 





efficiency, and presumably transfected cells could be selected in culture and analyzed for 
genome modifications.  
7. What are the important downstream effector genes of NF-κB in basal 
organisms? To date, there is no direct evidence of target genes of NF-κB in basal 
organisms. However, some efforts have been made. For example, in cnidarians, one gene 
has been suggested as a target gene of Nv-NF-κB: Nv-TRAF3, in that it contains three κB 
binding sites in its promoter and has been tested using luciferase assays. It was found that 
the reporter assay showed activation with Nv-NF-κB, and reduced activation when the 
κB binding sites were removed (Brennan et al., 2017). Nevertheless, no empirical 
evidence has been done beyond this work, and in no other basal organisms have any 
target genes been identified. In this thesis, we identified two potential target genes of Co-
NF-κB, and ongoing work is attempting to clone the putative promoters of these genes to 
assay for NF-κB-responsiveness in reporter assays. SYK and SRC are known to be 
immune-related genes in higher organisms, but whether they are target genes in 
Capsaspora remain to be seen. Ideally, performing ChIP-seq using a sensitive antibody 
for NF-κB would identify target genes of NF-κB and help elucidate the biological roles of 
basal NF-κBs. These findings would validate the importance of comparative studies of 
immune signaling pathways in basal organisms, as has been performed in this thesis. 
 
6.6 Conclusions and perspectives 
Since its discovery, NF-κB has been studied as a prominent player in many 





κB was not known to be present in the genomes of organisms basal to insects. The 
discovery of NF-κBs in single-celled protists, and the data gathered from this dissertation 
has led to improved hypotheses for how and why this transcription factor evolved (Figure 
6.1). That is, we propose that prior to the rise of holozoan life, ANK repeats were present 
in bacteria and archaea genomes. Some ancestral organism developed a primordial RHD-
only protein that eventually fused to an ANK repeat protein, resulting in the modern-day 
bipartite NF-κB protein. RHDs then diversified in choanoflagellates, while the metazoan 
lineage retained the full-length NF-κB fusion protein and also developed separate NF-
κB/Rel and IκB proteins, likely from gene-splitting and duplication events (Figure 6.1).  
Overall, our results show that NF-κB is generally structurally and functionally 
conserved in all animals, but lacks certain attributes in earlier branching organisms. That 
is, the most basal phyla of animals, sponges and corals, contain single NF-κB proteins 
that have conserved, functional sequences, but earlier branching organisms like 
Capsaspora lack residues important for processing seen in higher organisms. 
Furthermore, the diversified group of choanoflagellates has exhibited gains and losses of 
NF-κB. Several studies, including the data from this dissertation, have now demonstrated 
that the NF-κB proteins of evolutionarily basal organisms have many of the same 
structural features, activities, modes of regulation, and biological effects that are found in 
the expanded set of NF-κB and Rel proteins of more complex organisms. For example, 
ANK repeat regulation of the NF-κB RHD is even found in protists, and NF-κB is likely 
to have dual roles in development and immunity in organisms ranging from sponges to 





is the finding that NF-κB proteins appear to be constitutively processed and active in 
some sponges, anemones, and perhaps Capsaspora, and that induced activation of the 
NF-κB pathway may be at the transcriptional level in some of the same basal organisms. 
It is interesting to speculate that continuous exposure to pathogens or other activating 
ligands induces NF-κB processing in these situations and results in a constant heightened 
immunological state. We note that this concept of heightened immunity has been 
suggested in more complex organisms as well; for example, some species of bats appear 
to have constitutively active immune systems due to their microbe-rich habitats (Banerjee 
et al., 2017; Brook et al., 2020). 
Overall, the research gathered in this dissertation contributes to our understanding 
of basal immunity. There are a number of proposed effector and immune regulatory 
molecules that have been identified in invertebrates (Table 6.1), but it is clear that 
research on the evolution of NF-κB has only scratched the surface of what is yet to be 
discovered. Future studies will likely seek to identify the most primitive biological 
processes controlled by NF-κB in protists. Moreover, the identification of NF-κB target 
genes and the development of genetic systems to study gene function will certainly reveal 
much about the function of NF-κB in cnidarians and sponges. In particular, the 
identification of the immune response gene targets of NF-κB in basal organisms may 
provide insights into novel antimicrobials, as well as reveal information about the 
molecular processes underlying global ecological crises of marine invertebrates, such as 
coral bleaching and microbial pathogenesis. Looking backwards at the evolutionary 





immunological systems, especially in organisms that are environmentally sensitive and 











peptides Tincu and Taylor, 2004; Margolis et al., 2021 
Toll-like 
receptors Brennan and Gilmore, 2018 
Interleukin 
receptors Huang et al., 2015 
Complement Nonaka and Kimura, 2006 
Cytokines Melillo et al., 2018 
Lectins Ocampo et al., 2015 
cGAS/STING Brennan and Gilmore, 2018 
Scavenger 
receptors  Ocampo et al., 2015; Neubauer et al., 2016 
NOD-like 
receptors Yuen et al., 2014; Melillo et al., 2018; Parisi et al., 2020 
Nitric Oxide 
(NO) Parisi et al., 2020; Mansfield et al., 2019 
TRAF Anderson et al., 2016; Brennan and Gilmore, 2018; Seneca et al., 2020; Parisi et al., 2020 




molecules  Reference 
NF-κB   Wolenski and Gilmore, 2012; Mansfield and Gilmore, 2019; Williams et al., 2018, 2020, and 2021; Williams and Gilmore, 2020 
IRF Mansfield and Gilmore, 2019; Seneca et al., 2020 
NFAT Collins and Meyer, 2012 
TGFβ Detournay et al., 2012 
AP-1 Traylor-Knowles et al., 2017; Mansfield and Gilmore, 2019 
Caspase-3 Mansfield and Gilmore, 2019 









Figure 6.1 The Evolution of NF-κB.  
Prior to the rise of holozoan life, Ankyrin repeats (ANK, red) were present in bacteria 
and archaea. The appearance of an RHD-containing protein (green) likely led to RHD-
only proteins that diversified in choanoflagellates and to an RHD-ANK fusion in an 
ancestor of Capsaspora. Metazoans generally retained the full-length NF-κB, although in 
some cnidarians (e.g., Hydra and Nematostella) there were gene splitting events that 
created separate RHD and ANK repeat proteins. Eventually a series of duplication events 
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